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This progress report from the Biomedical Computer Laboratory (BCL) 
summarizes activities during the period from July 1, 1983 through June 30, 
1984. The Biomedical Computer Laboratory collaborates with research 
investigators throughout the Washington University School of Medicine and 
its affiliated hospitals in the application of advanced computer techniques 
to problems in biology and medicine. This often requires work in areas 
stretching from basic physiology through mathematical models to equipment 
design. Our orientation is interdisciplinary with the recognition that 
effective communication for workers with differing backgrounds comes only 
through extended collaboration and mutual respect. 
The vigorous development and evolution of specialized computer 
systems for use in the solution of research and clinical problems has 
continued to be the central focus of BCL activities. Several systems now 
in clinical use have seen a progression from exploratory pilot studies, to 
major developmental project, to local clinical trial, to clinical trials in 
multiple locations, to public availability through commercial manufacture. 
Perseverance in this sometimes tedious chain of development has found 
reward in the effective fielding of specialized computer systems to the 
medical community. 
One class of computer applications requires strong coupling of the 
computer to its environment for digital signal processing. These 
applications typically involve the use of commercially available 
minicomputers and microprocessors in conjunct+on with specialized hardware 
designed and built locally. We have pursued many such applications by 
bringing signals from hospital wards and research laboratories to BCL by 
means of either analog or digital tape recordings or telephone lines and, 
more frequently, by taking the computers to the investigator's laboratory 
or the patient's bedside. In this context, of particular importance to 
current and future BCL projects is the development, in a closely related 
sister lab (Computer Systems Laboratory, or CSL), of a capability for the 
design and fabrication of custom very-Iarge-scale integrated (VLSI) 
circuits. The realization of such circuits through collaboration with CSL 
is already opening up new opportunities for solving problems intractable 
with conventional computing devices. 
For those classes of applications dominated by information 
processing requirements, provisions have matured from telephone lines 
linking our minicomputers to the IBM System/370 at the Washington 
University Computing Facilities, through development and support of a 
minicomputer based MUMPS system, to the establishment of independent groups 
such as the Medical Computing Facility and the Medical Computing Service 
Group which serve the local medical complex. Diverse needs continue to be 
met by these various options while collaborative work continues on more 
advanced information-processing developments. 
Still another class of applications requires extensive use of large­
scale computational services. Many investigators are assisted in theirt 





statistical routines. This work is carried out in part by staff members of 
BCL, but primarily by members of the Division of Biostatistics and under 
direction of Dr. Dabeeru C. Rao, and the University Computing Facilities 
whose director is Robert J. Benson. I 
The BCL enjoys collaboration with most departmental divisions within 
the medical school but also finds support and enrichment through close ties I
with other facilities throughout the University. These arrangements are of 
benefit both to the BCL and to graduate students who find projects and 
employment among the activities in the laboratory. The Department of IComputer Science is under the direction of Dr. Jerome R. Cox, Jr., past 
Director of the BCL. Close collaboration with the department has 
emphasized the area of information systems. Strong ties with the 
Department of Electrical Engineering are sustained through the Engineering I 
School's Biomedical Engineering Program and common interest in digital 
signal processing techniques. The Department of Electrical Engineering is 
chaired by Dr. Donald L. Snyder, past Associate Director of BCL. I 
A major development completed during the past year has been the 
establishment at Washington University of an interschool Institute for 
Biomedical Computing. The new Institute encompasses the Biomedical I 
Computer Laboratory and the Computer Systems Laboratory in an 
organizational setting designed to recognize and foster the joint interests 
in biomedical computing of the School of Medicine and the School of I 
Engineering and Applied Science. The purpose of the reorganization is to 
recognize that the development and application of advanced computing and 
engineering technology to problems in biomedical science are essential Icomponents of the research and teaching activities of Washington 
University. Accordingly, attention has been given to the development of a 
stable organizational structure that will 1) provide a means by which the 
primary academic affiliations of its faculty can be in an organizational I 
setting with an adequately broad commitment to research and teaching in 
biomedical computing; 2) establish a formal administrative connection to 
the School of Engineering and Applied Science that will facilitate the Iinvolvement of its students and faculty in research and instructional 
activities in biomedical computing; 3) establish mechanisms for 
adminstration, funding, and review of appointments, promotion, and tenure Ifor the academic staff of this activity; 4) foster organizational and 
procedural coherence between the Biomedical Computer Laboratory and the 
Computer Systems Laboratory by placing them within a common administrative 
structure; 5) create a focal point for interdisciplinary teaching and I 
student research, both in the School of Medicine and the School of 
Engineering and Applied Science, in areas that do not fit comfortably into 
existing departments; and 6) encourage a scholarly environment for the I
activities of the two computer laboratories that will promote and encourage 
teaching, research, and publication as vehicles for personal development 
and academic contribution. I 
In addition to current BCL and CSL space on the Medical School 
campus, space for part of the activities of the Institute has been provided 
on the Engineering School campus by completion of a fifth-floor addition to I 







 called the Edward L. Bowles Laboratory, is immediately adjacent to the 
Departments of Computer Science and Electrical Engineering. 
I 
I The Institute for Biomedical Computing (IBC) now replaces the former 
Washington University Computer Laboratories (WUCL) which was a less formal 
federation of BCL and CSL plus working groups within the Departments of 
Computer Science and Electrical Engineering. Dr. Charles E. Molnar, 
Director of the Computer Systems Laboratory, and Dr. Lewis J. Thomas, Jr., 
Director of the Biomedical Computer Laboratory, have been appointed asI respective Director and Associate Director of the Institute. Both BCL and CSL continue to retain their identities and internal organizations. 
Accordingly, this Progress Report addresses activities centered primarily
I	 within BCL. 
I 
Planning and policy development of the Institute are overseen by a 
Governing Board, the membership of which is drawn from both Schools. The 
present composition of the Governing Board is: 
J. R. Cox, Jr., Chairman, Department of Computer ScienceI	 R. G. Evens, Head, Department of Radiology M. K. King, Dean, School of Medicine 
D. M. Kipnis, Chairman, Department of Internal Medicine 
I	 E. L. MacCordy, Associate Vice-Chancellor for Research J. M. McKelvey, Dean, School of Engineering and Applied Science 
C. E. Molnar, Director, Computer Systems Laboratory 
P. Needleman, Head, Department of PharmacologyI D. L. Snyder, Chairman, Department of Electrical Engineering L. J. Thomas, Jr., Pirector, Biomedical Computer Laboratory 
I	 To aid in long-range planning of the health-related activities of 
I 
the Institute, a National Advisory Panel is convened periodically. 
Particular attention is given to the confluence of important needs in 
biology and medicine with the technical advances capable of meeting these 
needs. Successful development may suggest implementation on a larger, 




I P. H. Abbrecht, Professor of Physiology and Internal Medicine,
 




H. L. Bleich, Associate Professor of Medicine, Harvard University 
I 
W. A. Clark, Consultant and former Director of CSL, New York, 
New York 
J. N. Gray, Tandem Computer Company, Cupertino, California 
F. E. Heart, Bolt, Beranek & Newman, Cambridge, Massachusetts 
D. M. Kipnis, Professor and Chairman, Department of Internal ~'I Medicine, Washington University 
B.	 W. Matthews, Professor of Physics and Director of the Institute 






J. M. Smith, Computer Corporation of America, Cambridge, 
Massachusetts 
E. A. Stead, Jr., Professor of Medicine, Duke University 
C. Vallbona, Professor and Chairman, Department of Community I
 

































II. SOURCES OF SUPPORT
 
During the period covered by this report the primary source of 
support for the Biomedical Computer Laboratory was from two grants from the 
National Institutes of Health, Division of Research Resources. 
RR 01380 A Resource for Biomedical Computing.
 
RR 01362 Tissue Characterization via Ultrasonic Imaging.
 
NHLBI contract N01 HV 72941 continues to fund a Holter Monitoring 
Core Laboratory to support a Multicenter Investigation of Limitation of 
Infarct Size. 
NCHSR grant HS 03792, to develop a medical information systems 
design methodology, continues to support the research in the Computer 
Science Department and this Laboratory. 
Collaboration with other investigators often involved work already 
supported by other grants. 
Public Health Services Grant. 
AM 07296 Cell Biological Approaches to Diabetes Research, 
AM 20579 Diabetes Research and Training Center, 
EY 03703 Chromatic Static Perimetry in the Diagnosis of 
Glaucoma, 
GM 07564 Analytical and Computational Methods in Physiology, 
GM 27889 Yeast TRNA Genes, 
GM 28232 Physical Mapping of Yeast Chromosomal DNA, 
HL 12839 Erythrocyte Deformability and Vascular Pathophysiology, 
HL 13851 Cyclotron Produced Isotopes in Biology and Medicine, 
HL 17646 Study of Ischemic Heart Disease, 
HL 25430 Characterization of Left Ventricular Diastolic 
Function, 
HL 25944 Time-of-Flight Positron Tomography for Cardiac Imaging, 
HL 28995 Adrenergic Factors and Arrhythmogenic Metabolites, 
HL 28998 Tissue Characterization with Ultrasound, 
HL 29229 Familial Hypercholesterolemia in Cultured Cells, 
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NS 06833 An Interdisciplinary Stroke Program, 
NS 14834 Mechanisms of Seizures and Anticonvulsant Drugs, 
NS 15070 Regeneration and Functional Recovery in Cerebral 
Cortex, 
RR 01379 Research in VLSI Systems for Biomedical Applications, 
RR 01828 A New Approach to Fast Gamma-Radiation Detection. 
National Science Foundation Grant. 
ECS-82-15181 Study of Time-of-Flight Tomography. 
Research support was also received from the following industrial 
collaborators. 
Biosensor Corporation, Brooklyn Center, Minnesota, 
Computer Services Corporation (CSK), Tokyo, Japan, 




I III. PERSONNEL 
I EMPLOYEES 
I 
Personnel employed by the Biomedical Computer Laboratory during the 
period covered by this report were: 
Director 
I Lewis J. Thomas, Jr., M.D., and Associate Director of Institute for 
I 
Biomedical Computing, and Associate Professor of Anesthesiology, 
Physiology and Biophysics, Biomedical Engineering, and Electrical 
Engineering 
Associate Director 
I G. James Blaine III, D.Sc., and Affiliate Associate Professor 
of Electrical Engineering and Computer Science, and Senior 
Research Associate, Computer Systems LaboratoryI Senior Research Associates 
I Jerome R. Cox, Jr., Sc.D., and Chairman and Professor of Computer Science, and Professor of Electrical Engineering, and Senior 
Research Associate, Computer Systems Laboratory 
I Harold W. Shipton, C.Eng., and Chairman and Professor of Biomedical Engineering Donald L. Snyder, Ph.D., and Chairman and Professor of Electrical 
Engineering, and Senior Research Associate, Computer Systems 
Laboratory:,1 
Business Manager
'I Virginia M. Bixon, B.S. 
Research Associates l~1 ~ Robert J. Ph.D., and Computer Systems Laboratory:~ Arnzen, 
::: 
R. Martin Arthur, Ph.D., and Associate Professor of Electrical~I Engineering~~ ,~ 
~ Kenneth W. Clark, M.S.
 
James G. Dunham, Ph.D., and Associate Professor of Electrical
 
Engineering 
Robert O. Gregory, D.Sc., and Professor of Electrical Engineering 
Kenneth B. Larson, Ph.D. 
James G. Miller, Ph.D., and Professor of Physics, and Associate 
Director for Biomedical Physics, Laboratory for Ultrasonics, 
and Research Associate Professor of Medicine 
Michael I. Miller, Ph.D., Assistant Professor of Electrical 
Engineering 
Frederick U. Rosenberger, D.Sc., and Associate Director, Computer 





David E. Beecher, M.S., Lecturer in Computer Science
 
Steven R. Broadstone, B.A., B.S.
 I 
John C. Chabut, B.S., B.A. 
John D. Gorman, B.S. 
Russell E. Hermes, M.S. ITimothy J. Holmes, M.S.
 
Patrick H. Johnston, M.A.
 
Joanne Markham, M.S., Research Instructor in Medicine
 ICharles N. Mead, M.D. 
J. Philip Miller, A.B., and Associate Professor of Biostatistics 
in Preventive Medicine
 
Stephen M. Moore, M.S.
 I 
Jack G. Mottley, M.A. 
John M. Ollinger, M.S. 
David G. Politte, M.S. IKenneth B. Schechtman, Ph.D., Instructor in Biostatistics in
 





Stanley R. Phillips, A.A.S. I 
Technical Assistants IKristin K. Foss, B.S. 
Kathleen A. Madden, B.A. 




Donald w. Stein, Jr. 






Monica w. Shieh, M.L.S. I 












The following members from other departments and divisions have 
joint appointments with the Biomedical Computer Laboratory to facilitate 
collaboration and enhance interdisciplinary research: 
H.	 Dieter Ambos, Research Assistant Professor of Medicine 
(Cardiology) 
A.	 Maynard Engebretson, D.Sc., Assistant Director of Research in 
Engineering, Central Institute for the Deaf, and Affiliate 
Associate Professor of Computer Science 
William	 M. Hart, Jr., M.D., Ph.D., Associate Professor of 
Ophthalmology 
Rexford L. Hill, III, M.S., Associate Professor of Computer 
Applications in Radiology 
J.	 Stevadson Massey, M.S., Research Assistant in Neurological 
Surgery 
John	 W. Wong, Ph.D., Assistant Professor of Radiation Physics 
in Radiology 
In addition, the following people worked at the laboratory for 
brief periods: 






Rosalie J. Paisley, M.S.
 
David F. Sandel, B.S.
 
RESEARCH COLLABORATORS 
During the period covered by this report the following investigators 
from other laboratories, departments, or institutions, collaborated with 
BCL staff members on problems of joint interest. 
D. R. Abendschein, Ph.D., Medicine 
J. Achtenberg, A.B., Medical Computing Service 
G. G. Ahumada, M.D., Medicine 
H. D. Ambos, Medicine 
T. R. Baird, Medicine 
W. E. Ball, D.Sc., Computer Science 
B. Becker, M.D., Ophthalmology 
R. J. Benson, J.D., Computing Facilities 
S. R. Bergmann, Ph.D., Medicine 
D. R. Biello, M.D. Radiology
 
W~ R. Bosch, M.S., Computer Systems Laboratory
 
S. R. Broadstone, B.A., B.S., Electrical Engineering 
T. L. Buettner, Medicine 
M. E. Cain, M.D., Medicine 
T. J. Chaney, M.S., Computer Systems Laboratory 
K. C. Chang, Ph.D., Pathology 
P. A. Cole, B.S., Pathology 
J. D. Collins, B.S., Computer Systems Laboratory 
P. B. Corr, Ph.D., Medicine and Pharmacology 





R. D. Edelman, B.S., Computer Systems Laboratory 
J. O. Eichling, Ph.D., Radiology 
J. D. Eisenberg, M.D., Medicine 
P. R. Eisenberg, M.D., Medicine I 
S. E. Elnahas, M.S., Electrical Engineering 
B. Emami, M.D., Radiology 
R. G. Evens, M.D., Radiology ID. C. Ficke, B.S., Radiology 
L. Fields, M.D. Medicine 
K. A. A. Fox, M.B., Ch.,B., Medicine IP. T. Fox, M.D., Neurology and Radiology 
M. S. Frank, M.D., Genetics 
M. H~ Gado, M.D. Radiology 
E~ D. Galie, R.N., Medicine I 
R. A. Gardner, Ph.D., Mechanical Engineering 
E. M. Geltman, M.D., Medicine 
w. D~ Gillette, Ph.D., Computer Sciences IR. M~ Glueck, M.D., Medicine 
S. Goldring, M.D., Neurological Surgery 
M. E. Gordon, Ph.D., Ophthalmology 
A~ M. Grace, Medicine I 
E. M. Gregorie, M.D., Neurological Surgery 
R. L. Grubb, Jr., M.D., Neurological Surgery 
W. M. Hart, Jr., M.D., Ph.D., Ophthalmology IK. H. Haserodt, M.S., Computer Science 
H. Hashimoto, M.D., Medicine 
P. Herscovitch, M.D., Neurology and Radiology IG. R. Hoffman, B.A., Radiology 
J. T. Hood, B.S., Radiology 
B. Hughes, Ph.D., Medicine 
S. Igielnik, Ph.D., Medical Computing Facilities I 
A. S. Jaffe, M.D., Medicine 
G. C. Johns, B.S., Computer Systems Laboratory 
E. G. Jones, M.D., Ph.D., Anatomy IR. G. Jost, M.D., Radiology 
M. A. Kass, M.D., Ophthalmology 
E~ W~ Kiebler, M.S., Computer Systems Laboratory IR. M. Knabbe, Ph.D., Medicine 
S~ J. Kovacks, Jr., M.D., Ph.D., Medicine 
J. B. Kramer, M.D., Medicine and Surgery 
A. Kumar, B. Tech., Radiology I 
P. B. Kurnik, M.D., Medicine 
J. L. Lauter, Ph.D., Central Institute for the Deaf 
F~ Lifshits, Medicine IB. D. Lindsay, M.D., Medicine 
P~ Lombardo, B.A., Neurological Surgery 
P. A. LUdbrook, M.D., Medicine 
E~ T. Macke, M.S., Computer Systems Laboratory I 
J~ S. Marvel, B.S., Pathology 
J. W. Matthews, D.Sc., Computer Systems Laboratory 
J. M~ McAninch, Medicine I 
T~ R. Miller, Radiology 
M~ A. Mintun, M.D., Neurology I 
-15­ I 
C. E. Molnar, SC.D., Computer Systems Laboratory 
R. A. Moses, M.D., Ophthalmology 
S. R. Mumm, Medicine 
H. Nomura, M.D., Medicine
 
M~ V. Olson, Ph.D., Genetics
 
R~ E. Ostlund, Jr., M.D., Medicine
 
D~ S. Payne, Medicine
 
C. A~ Perez, M.D., Radiology
 
J~ E~ Perez, M.D., Medicine
 
D~ G. Politte, M.S., Radiology
 
W. J. Powers, M.D., Neurology and Radiology 
J. L. Price, Ph.D., Anatomy 
J. A. Purdy, Ph.D., Radiology 
M. E. Raichle, M.D., Neurology and Radiology 
D. C. Rao, Ph.D., Biostatistics 
C. S. Ritter, Medicine 
A. P~ Rueter, B.S., Radiology
 
J~ E. Saffitz, M.D., Pathology
 
M. L. Sieger, B.S., Electrical Engineering 
B. A~ Siegel, M.D., Radiology 
B. E. Sobel, M.D., Medicine 
J. J. Spadero, Jr., M.D., Medicine 
A. W. Strauss, M.D., Biochemistry 
S. P. Sutera, Ph.D., Mechanical Engineering 
A. G. Swift, B.A., Radiology 
M~ M. Ter-Pogossian, Ph.D., Radiology 
W~ J. Thomas, M.S., Electrical Engineering 
A~ J. Tiefenbrunn, M.D., Medicine 
R. G. Tilton, Ph.D., Pathology 
A. W~ Toga, Ph.D., Neurology 
D. F. Wann, D.Sc., Electrical Engineering 
M~ R~ Weber, Electrical Engineering 
M. J. Welch, Ph.D., Radiology
 
R~ A~ Wettach, Medicine
 
J. R~ Williamson, M.D., Pathology
 
F~ X. Witkowski, M.D., Medicine
 
K. F. Wong, M.S., Computer Science 
J. W. Wong, Ph.D., Radiology 
A. L. Ysaguirre, Medicine 
J. D. Zions, Pathology 
Columbia University, New York, New York 
J. T. Bigger, Jr., M.D. 
Creighton University, Omaha, Nebraska 
F. M. Nolle, D.Sc. 
Z. Zencka, M.D. 
Hahnemann Medical College, Philadelphia, Pennsylvania 





Indiana University School of Medicine, Indianapolis, Indiana 
C. Fisch, M.D. 
S. B. Knoebel, M.D. I 
Jewish Hospital, St. Louis, Missouri IB. R. Hieb, M.D. 
R. E. Kleiger, M.D.
 
R~ J. Krone, M.D.
 IR. Ruffy, M.D. 
Massachusetts General Hospital, Boston, Massachusetts I 
H. K. Gold, M.D.
 
H~ W~ Strauss, M.D.
 IPennsylvania State University, University Park, Pennsylvania 
D. B. Geselowitz, Ph.D. I 
Peter Bent Brigham Hospital, Boston, Massachusetts 
E. Braunwald, M.D. I 
Research Triangle Institute, Research Triangle Park, North Carolina IW. K. Poole, Ph.D. 
Roosevelt Hospital, New York, New York I 
H. M. Greenberg, M.D. 
St. Louis University, St. Louis, Missouri I 
E. D. Slessinger, B.S. IUniversity of Illinois at Chicago Circle, Chicago, Illinois 
R. Langendorf, M.D. I 
University of Iowa, Iowa City, Iowa 
R. C. Arzbaecher, Ph.D. I 
University of Kentucky College of Medicine, Lexington, Kentucky 
IB. Surawicz, M.D. 
University of Louisville School of Medicine, Louisville, Kentucky I
N. C. Flowers, M.D. 
I 
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University of Texas Health Science Center, Dallas, Texas 
J. T. Willerson, M.D. 
University of Vermont College of Medicine, Burlington, Vermont 
D. S. Raabe, M.D. 
As in the past, collaborative efforts with various commercial firms 
continue (see Section VI). This year projects of joint interest have 
involved: 
Biosensor Corporation, Brooklyn Center, Minnesota, 
Computer Services Corporation (CSK), Tokyo, Japan, 
International Business Machines (IBM) Biomedical Systems, 
Hopewell Junction, New York, 
Mead Johnson, Pharmaceutical Division, Evansville, Indiana, 
Medicomp, Inc., Melbourne, Florida, 





IV. PHYSICAL RESOURCES 
The Biomedical Computer Laboratory (BCL) was formed on April 15, 1964 
and the original staff moved into 3,800 square feet (net) of laboratory I 
space at 700 South Euclid Avenue in St. Louis. While remaining at this 
location, adjacent to the Washington University School of Medicine's main 
bUilding complex, the floor space has been increased to the present 12,000 I 
square feet (net). As a result of the establishment of an interschool 
Institute for Biomedical Computing at Washington University, space for part 
of the activities of the Institute (which encompasses both the BCL and the 
Computer Systems Laboratory (CSL) has been created on the Engineering I 
School campus by completion of a fifth-floor addition to Lopata Hall. This 
new space (about 6000 square feet), called the Edward L. Bowles Laboratory, 
is immediately adjacent to the Departments of Computer Science and I 
Electrical Engineering. It became available in December, 1983. In 
addition to the 700 South Euclid and Bowles Laboratory space, BCL staff 
members and systems frequently occupy other areas within the Washington IUniversity Medical Center at the sites of collaborative project activities. 
IDuring the past twenty years BCL has addressed diverse biomedical 
problems for which digital computing techniques seemed promising and 
appropriate. A single Laboratory Instrument Computer (LINC) provided the 
original staff with an opportunity to apply digital computing to a few Iinteresting problems in medicine and biology. Currently BCL has interest 
and involvement in several specialized instrumentation and computing 
systems which provide access to diverse image-data sources (modalities) and Ioffer opportunities for collaborative research in biological modeling and 
algorithm development. BCL has primary responsibility for a complement of 
computing hardware and software from a variety of system manufacturers. 
These resources include: PDP-l1 's and LSI-ll 's from Digital Equipment I 
Corporation, TI-980's from Texas Instruments Incorporated, l35's from 
California Data Processors and Versamodule M68000's from Motorola, Inc. An 
MMS-X stroke graphics display system developed by the Computer Systems ILaboratory, a Lexidata raster-graphic display system and a MASSCOMP raster­
graphic workstation are available for biomedical imaging studies. IA local computer network, TERRANET, provides remote terminal-to­
computer and inter-computer data communications at rates up to 9600 bps 
among thirty stations including terminals and processor ports located 
throughout the laboratories. Personal-class microcomputer systems have I 
been incorporated into the design of biomedical research systems and 
numerous special-purpose devices have been developed using microprocessor 
chip-sets and microcomputer board-level assemblies. I 
A machine shop and reference room are located on the 700 S. Euclid 
premises and shared with CSL. Other physical resources include a well­
stocked electronics shop, a large inventory of electronic and computer test I 
eqUipment, a variety of digital system modules and both analog and digital 
recording instruments. Systems for use in developing eight-bit, sixteen­






V. RESEARCH PROJECTS 
Introduction 
The research program of the Biomedical Computer Laboratory (BCL) is 
organized into several major project areas with the staff grouped into 
teams whose interests are focused correspondingly. For this Progress 
Report, the following paragraphs offer a brief orientation to the headings 
under which research activities are discussed. For each category, a 
summary is provided on the first page of the corresponding section. 
Ischemic heart disease and ECG analysis (Section A) continues to be 
a major category of research activity, but the development of new 
algorithms for ECG processing has become less prominent than in the past as 
a result of a shift in emphasis to exportation of the latest version of our 
"Argus" algor i thm. More prominent than before are modeli ng, signal 
processing, and data analysis work in collaboration with the division of 
Cardiovascular Medicine as part of their broad program addressed to 
ischemic heart disease. 
Information extraction from quantitative biomedical images continues 
to increase in prominence within the BCL program. Accordingly, last year's 
organization of such activities into three categories (by imaging modality) 
is continued this year. The work in ultrasonic tissue characterization 
(Section B) now emphasizes the interpretation of backscatter to achieve 
quantitative estimates of tissue properties, including anisotropy and the 
state of contraction of cardiac and skeletal muscle, while parallel efforts 
are directed toward design of a system to employ adaptive beamforming for 
backscatter measurements. 
Work in radiation treatment planning (Section C) has moved ahead 
with enhancements and evaluations of our "delta volume" algorithm for 
three-dimensional absorbed-dose calculations, display experiments employing 
high-performance stroke graphics (MMS-X system), and the recent submission 
for fabrication of two VLSI circuits for expeditious achievement of a 
demanding kernel of the computations (3-D ray tracing). 
For positron-emission tomography (Section D) work in support of 
applications and system improvements have continued on several fronts, but 
the main thrust of BCL activities has been in research on algorithms. 
Emphasis has been on application of the maximum-likelihood method for 
improving image quality and for achieving better estimates of physiological 
parameters through studies of dynamic distributions of tracers. 
Systems for Specialized Biomedical Studies (Section E) embraces a 
':'	 variety of projects that are less broad in scope either because they are in 
an earlier stage of development or because the nature of the work is 
necessarily more specialized. The biomedical-imaging theme is well 





Projects reported under Resource Development Activities (Section F) 
are directed toward improving the Laboratory's capabilities for addressing 
the needs of more than one project area. Again. the biomedical-imaging 
theme is manifest in work to upgrade BeL's resources for communicating and I
 


































A. Ischemic Heart Disease and ECG Analysis 
The projects reported in this section continue longstanding work in 
real-time and high-speed ECG analysis. Many of the clinical studies 
reported here are natural outgrowths of the ECG-analysis work, as are the 
strong interests in the evaluation of automated arrhythmia detectors. 
Modeling and signal-processing endeavors in the field of cardiology have 
supported collaborations which address other aspects of ischemic heart 
disease, such as myocardial metabolism and blood flow, the 
electrophysiologic characterization of abnormal myocardial depolarization, 
various antidysrhythmic drug studies, infarct-size modification, and the 
study of ventricular diastolic mechanics. 
A real-time computer-based arrhythmia monitoring system, called 
Argus, in operation in the Barnes Hospital Coronary Care Unit from 1969­
1975, w~ replaced in 1975 by "Argus/Sentinel," a commercially available 
version developed through collaboration with the Mennen-Greatbatch Company. 
The experience garnered with Argus led directly to the development of a 
system, called Argus/H, for the high-speed (60 times real time) processing 
of long-term ECG recordings. Argus/H has since processed several thousand 
recordings for a study of ventricular arrhythmias in survivors of 
myocardial infarction and several hundred recordings for a host of other 
studies. Extensive evaluations have verified the integrity of the analysis 
algorithms, proven the value of the quantified results as compared to 
conventional manual-scanning techniques, and confirmed the consistency of 
results on reprocessing. The importance of such issues stimulated the more 
recent development of a stochastic model for the performance evaluation of 
event detectors. 
By the mid-1970's, it was apparent that Argus/H could not support 
rigorous algorithm development, could not efficiently process the now more­
popular dual-channel recordings, and could not meet the demand for the 
system from the growing volume of recordings resulting from interests in 
therapeutic trials of antiarrhythmic agents and interventions designed to 
protect the ischemic myocardium. A newer system, called Argus/2H, emerged 
in 1977 and was duplicated in 1978. The two Argus/2H systems have 
processed long-term ECGs for national multicenter clinical studies of 
interventions to limit infarct size and of post-infarction risk 
stratification. The systems also provide the power and flexibility 
necessary for work on algorithm revision and on new signal-processing 
strategies and they have further served the analysis and documentation 
needs of other work to generate an annotated digital ECG database for the 
evaluation of automated arrhythmia detectors. Newer signal-processing 
strategies employing frequency-domain analysis of the ECG are now bearing 
fruit and have led to a continuing industrial collaboration to implement 
the algorithms in a CMOS processor for real-time dysrhythmia analysis in 





A-1. Argus Algorithm Development 
Personnel:	 K. W. Clark, BCL 
K. B. Larson, BCL I 
C. N. Mead,	 BCL 
D. W. Stein, Jr., BCL 
L. J. Thomas, Jr., BCL I 
Support:	 RR 01380 
Biosensor Corporation IWashington University 
For more than 15 years, this laboratory has been developing I 
algorithms for efficient analysis of the surface ECG signal (PR 19, A-1). 
These efforts have culminated in the implementation of a device designed 
and marketed by Biosensor Corporation (see VI. Industrial Collaboration). IThe device is a portable "real-time analyzer" which continuously monitors a 
patient's ECG, records clinically significant data (heart-rate trends, 
ectopic depolarizations, waveform examples), and transmits stored 
information to a central station. The central station prints a summary for I 
the patient's physician. Much of the past year was expended assisting 
Biosensor with their implementation and debugging. I 
Concurrently, additional efforts have focused on improvements in 
several areas of the time-domain-based QRS detector/delineator algorithm. 
First, logic was added for inclusion of small septal vectors at the leading Iedge of QRS complexes. Second, the logic for detecting low-amplitude 
events was completely redone; the prior version performed well for isolated 
events but not so well for consecutive and interpolated low-amplitude 
events. Third, the noise rejection logic was completely redone and is I 
still undergoing evaluation and tuning. 
There have been several enhancements in the area of QRS I
classification. First, the QRS centroid replaces the point of maximum 
sample difference as a fiducial point for aligning QRS complexes to be 
correlated in the frequency domain. The correlation is performed when the Ialgorithm updates the ideal "time-local" normal against which suspicious 
beats are compared. For purposes of speed, the centroid computation uses 
Aztec data rather than raw data. Second, the frequency-domain logic, 
invoked when time-domain analysis has flagged a QRS as non-normal (PR 19, I 
A-2), is being translated from FORTRAN in a time-shared environment (where 
it was developed) to assembly language in a (faster than) real-time 
environment. Third, plans have been laid for a Sequence processor to Ifollow QRS classification. Sequence may re-Iabel one or more QRS complexes 
after examining those complexes in their larger neighborhood of several or 
many QRSs. Ideally, Sequence mimics the cardiologist who looks at beats in 
context and their relationships to one another rather than judging isolated I 
complexes. 
In the next several months, when these enhancements have been put in I 
place, we plan to evaluate the full system against the American Heart 




I A-2. Processing of Long-term ECG Recordings 
I Personnel: K. W. Clark, BCL K. A. Madden, BCL 
M. A. Marlo, BCL 
I C. N. Mead, BCL A. W. Stangl, BCL 
I Support: RR 01380
 Biosensor Corporation
 Jewish Hospital 
Mead-Johnson Pharmaceuticals 
I 
After many years of analyzing long-term ECG recordings for a variety 
of local studies and multicenter trials, these activities have been greatlyI reduced. A few recordings (10-20 per month) are still analyzed for Jewish Hospital patients who are being studied with a variety of antiarrhythmic 
agents. A few recordings are analyzed for Mead-Johnson Pharmaceuticals in 
I
 a multicenter, placebo-controlled study of an antidepressant agent,
 trazadone (see VI, Industrial Collaboration). 
I Biosensor Corporation, which recently implemented and now markets a portable device for analyzing ECG signals in real time (see VI, Industrial Collaboration), has enlisted our help in providing them with a variety of 
ECG arrhythmias in digital form against which they might test theirI product(s). After Biosensor analyzes those digital signals and sends to us 
I 
their beat-by-beat results, we plot waveforms and labels in condensed 
fashion for rapid review and analysis. The arrangement has allowed 
Biosensor access toa wealth of diverse waveforms and precluded the 






IA-3. Assessment of Vascular Integrity of the Myocardium Following 
Ischemic Inj ury 
Personnel: R. G. Tilton, Ph.D., Pathology I 
K. C. Chang, Ph.D., Pathology 
P. A. Cole, B.S., Pathology 
R. A. Gardner, Ph.D., Mechanical Engineering IK. B. Larson, BCL 
J. S. Marvel, B.S., Pathology 
B. E. Sobel, M.D., Medicine IS. P. Sutera, Ph.D., Mechanical Engineering 
J. R. Williamson, M.D., Pathology 
J. D. Zions, Pathology ISupport: RR 01380 
AM 07296 
HL 12839 IHL 17646 
The Kilo Diabetes and Vascular Research Foundation 
I 
We have continued our previously reported studies (PR 15, A-10; PR 
16, A-10, PR 17, A-7; PR 18, A-7; PR 19, A-7) of the pathophysiology of 
ischemic injury to the heart. In these studies, we employed bolus­ Iinjection, external-detection radiotracer techniques to quantify albumin 
transport across the coronary vasculature under physiological conditions, 
and during reperfusion after selected intervals of global, no-flow ischemia Iin isolated-perfused rabbit hearts. The resulting residue-detection data, 
analyzed on the basis of a two-compartment model of tracer transport, were 
used to estimate parameters indicative of microvascular integrity such as 
permeability and ultrafiltration conductance of the endothelium. Our I 
continuing goal has been to understand the role of endothelium in the 
pathogenesis of the vascular hemodynamic and permeability changes 
associated with ischemia and reperfusion. I 
We have studied the effects of diltiazem on coronary vascular 
hemodynamics and permeability changes during reperfusion after ischemia. 
Four-~M diltiazem significantly increased total water content (8.5%) and I 
decreased perfusion pressure (11%), left ventricular developed pressure 
(22%), and +dP/dt (24%) in nonischemic control experiments, but did not 
affect estimates of vascular volume, interstitial fluid volume, mean­ I
transit time, or albumin permeation. Four-~M diltiazem blocked ischemia­
and reperfusion-induced increases in water content, interstitial fluid 
volume, vascular resistance, vascular volume, and vascular permeability to I125I-BSA, without reducing left ventricular developed pressure or +dP/dt 
relative to nonischemic diltiazem controls. These data suggest that 
production of ischemic myocardium by diltiazem is mediated, at least in 
part, by preservation of vascular functional integrity. I 
To study the effect of selective phospholipase A2 damage to 
endothelium, we have developed techniques for covalently linking Iproteolytic and lipolytic enzymes to uniformly sized O.2-~m spherical 
I 
-25­ I 
carboxylate-modified, polystyrene particles. In preliminary experiments, 
we have assessed vascular permeability and myocardial contractility changes 
in isolated, buffer-perfused rabbit hearts exposed to phospholipase A2 
bound to 0.2 ~m microspheres during 30 minutes of no flow. During 
reperfusion following the no-flow period, increases in vascular resistance 
were of equal magnitude in untreated and phospholipase-A2-treated hearts. 
Our interpretation of this observation is that the resistance increases are 
probably caused by ischemic injury to arterial smooth muscle which would be 
expected to be similar in both groups. On the other hand, albumin leakage 
in the phospholipase-A2-treated hearts was about twice that of untreated 
ischemic hearts during reflow, and was about six times that of nonischemic 
control hearts at comparable time intervals. 
We have carried out additional experiments to optimize conditions of 
bead concentration and duration of contact with the vasculature in which 
the duration of no flow is decreased by 50%. Changes in vascular tone and 
myocardial contractility are reversible after this brief interval of 
ischemia and vascular permeability is unaffected during reperfusion of 
control hearts. Experiments currently in progress are extending these 
initial findings and are evaluating effects of trypsin and phospholipase C 
on endothelium as well. 
To determine whether hypercholesterolemia renders vascular 
endothelium more susceptible to ischemia-reperfusion injury, we have 
utilized our external detection technique to characterize permeation of the 
coronary vasculature by 125I-BSA in hearts of rabbits fed a 2% cholesterol 
diet for 2-3 weeks. In these experiments, isolated rabbit hearts were 
perfused at constant flow for 1 hour prior to 30 minutes of global, no-flow 
ischemia, then reperfused for 3.5 hours. In continuously perfused controls 
and in ischemic hearts of animals on a normal cholesterol diet, indices of 
vascular and myocardial function were identical to the values reported in 
our previous studies with this model. Albumin permeation across the 
coronary vasculature was twice that of control values prior to ischemia in 
hearts from hypercholesterolemic rabbits and, during reflow, was two to 
three times the values in ischemic hearts of animals on a normal diet. 
During reperfusion of hypercholesterolemic hearts, vascular resistance 
increased 85%, while vascular volume increased about eight times over 
baseline (compared to 58% and 37% increases, respectively, in hearts from 
normal cholesterolemic animals). We have attributed the dramatic increase 
in vascular volume to a breakdown of the endothelial cell barrier to 
albumin. 
In these studies, we have shown for the first time that after 
rabbits have been kept on a high cholesterol diet for only 3 weeks, 
coronary vascular permeability is significantly increased even before 
ischemia, and the damaging effects of ischemia on vascular integrity are 
far greater than in control animals. These changes are independent of the 
presence or absence of atherosclerotic occlusive disease of the coronary 
vasculature and therefore suggest an important, independent mechanism 
whereby hypercholesterolemia may render an individual at increased risk for 
ischemic heart disease. In studies currently in progress we are assessing 
the effect of still shorter durations of hypercholesterolemia (7-10 days), 





In our previous isolated-heart experiments, flow rate was held 
constant; if perfusion pressure has been held constant, presumably the flow 
rate would have declined and left-ventricular contractile function would 
not have recovered during reperfusion. In future experiments, we shall I 
test this hypothesis and examine the impact of these vascular changes on 
myocardial contractile performance during reperfusion following ischemia. 
Alternate hearts will be perfused under conditions of constant pressure or I
constant flow. We anticipate that when hearts are perfused under 
conditions of constant flow, myocardial contractile function will be 
preserved but that increases in perfusion pressure during reflow after 
ischemia may further damage vessels, contributing to increased vascular I 
leakage and myocardial edema as we have observed previously. On the other 
hand, during reperfusion under conditions of constant pressure, we 
anticipate that vascular leakage and interstitial myocardial edema may be I 
somewhat reduced, but that flow rate also will be reduced causing 
deterioration of myocardial contractile function. If these predictions are 
confirmed, the experiments would demonstrate the potential importance of Icompromised vascular integrity, induced by ischemic injury, in the 
pathogenesis of ischemic heart disease caused by transient vasospasm or 
vascular narrowing. I 
In additional experiments planned for the future, we shall evaluate 
vascular permeability changes in hearts from alloxan-diabetic rabbits to 
assess the effects of diabetes on the susceptibility of the vasculature to I 
ischemic injury. We shall investigate these problems in rabbits with 
experimental diabetes of two to three months duration using both constant­























Personnel:	 A. S. Jaffe, M.D., Medicine 
H. D. Ambos, BCL 
J. D. Eisenberg, M.D., Medicine 
P. R. Eisenberg, M.D., Medicine 
E. M. Geltman, M.D., Medicine 
R. M. Glueck, M.D., Medicine 
S. J. Kovacs, Jr., M.D., Ph.D., Medicine 
P. B. Kurnik, M.D., Medicine 
B. D. Lindsay, M.D., Medicine 
P. A. LUdbrook, M.D., Medicine 
J. Markham,	 BCL 
B. E. Sobel, M.D., Medicine 
J. J. Spadaro, Jr., M.D., Medicine 
A. J. Tiefenbrunn, M.D., Medicine 
Support:	 RR 01380 
HL 17646 
Studies were performed in the Cardiac Care Unit at Barnes Hospital 
to assess the effects of pharmacological therapy on infarct size. Infarct 
size was estimated from serial plasma creatine kinase changes and with the 
use of serial positron emission transaxial tomographs. Results in control 
were compared to those observed in the treated groups. During the past 
year our efforts have focused on the evaluation of thrombolytic therapy, 
treatment of extension of infarction, an important contributor to the 
overall infarct size in patients with non-transmural infarction, and 
defining the relationship of extension and the complications of infarction 
to abnormalities in platelet function as assessed by platelet factor 4 and 
beta thromboglobulin. 
To evaluate the effects of thrombolytic therapy directly on the 
heart, we studied 19 patients with first transmural myocardial infarction 
immediately upon admission and again 48 to 72 hours after the intracoronary 
administration of either tissue plasminogen activator or streptokinase. In 
all patients who received streptokinase, there was marked depression in 
fibrinogen, elevations of fibrin degradation products to a dilution of 
> 1 :16, abnormal thrombin times, prothrombin times, and partial 
thromboplastin times. Patients treated with tissue plasminogen activator 
did not manifest reductions in fibrinogen nor coagulation parameters. In 
nine patients, lysis was achieved with streptokinase and in two with tissue 
plasminogen activator. In eight patients, lysis was not achieved. The 
mean time to the onset of symptoms to the initiation of the infusion with 
streptokinase was 5.4 ±1.3 (SE) hours in the group that achieved lysis and 
9.9 ±2.8 hours in patients who did not achieve lysis. The two patients 
treated with tissue plasminogen activator received therapy in 3.8 to 7.5 
hours after the onset of symptoms. In all patients in whom lysis occurred, 
there was a prompt rise in creatine kinase which reached peak levels 
rapidly. This was not observed in patients who did not achieve 
thrombolysis. After thrombolytic therapy, patients were maintained on 
heparin to keep the partial thromboplastin time at approximately two times 
-28­
the normal level. Patients in whom thrombolysis was achieved, manifested a 
29% reduction in PET infarct size (areas manifesting < 50% of maximal 
ventricular counts). Improvement was 27% in patients with anterior 
infarction and 30% in those with inferior infarction. This was 
significantly different than the results in the patients in whom lysis 
could not be achieved. Only two patients in the latter group improved, and 
the mean change was an increase of 4 PETT gm-eq. An example of myocardial 
salvage documented by positron tomography is shown in Figure 1. Although 
myocardial salvage was documented by positron-emission tomography, overall 
the left ventricular ejection fraction did not change significantly (50.9 
±3.6% before to 51.4 ±4.1% after thrombolysis) although the trend was 
favorable in these patients. 1 
Encouraged by the beneficial effects indicated by positron-emission 
tomography in patients utilizing streptokinase, and aware of data reported 
in project 0-1 that tissue plasminogen activator (t-PA) had comparable 
benefit, we proceeded with a pilot project to evaluate the efficacy of t­
PA. Tissue plasminogen activator is a naturally occurring clot-selective 
activator of fibrinolysis similar if not identical to the activator found 
in uterus. Recent experiments by Dr. Desire Collen in Belgium indicated 
that it does not bind avidly to circulating plasminogen (Km = 65 ~M) but 
has a high affinity for fibrin (Kd = .16 ~M). Circulating plasminogen 
binds avidly to the tissue plasminogen activator fibrin c/mplex through the 
plasminogen lysine binding sites (Km = .14 ~M). Thus, plasminogen is not 
converted to plasmin in the plasma but is converted at the fibrin surface 
of the clot, making t-PA a very selective fibrin active agent with little 
effect on fibrinogen. Any plasmin that does escape into the circulation is 
rapidly inactivated by alpha-2 anti-plasmin. We utilized a t-PA product 
extracted from a melanoma cell culture line which we previously utilized to 
lyse clots in animals. We showed that prompt thrombolysis could be induced 
without effects on circulating fibrinogen or plasminogen or consumption of 
circulating alpha-2 anti-plasmin in seven patients studied with our Belgian 
colleagues. Coronary thrombolysis was induced in 19 to 50 minutes with 
either intravenous or intracoronary utilization of the agent. Circulating 
fibrinogen and alpha-2 anti-plasmin were not depleted in these patients 
except for the two patients who necessitated some degree of streptokinase 
therapy because the large amount of the clot exceeded the doses allowed for 
administration of tissue plasminogen activator (see Figure 2). In 
association with these findings, there was a prompt reduction in chest 
pain, resolution of 3T segment abnormalities and improved ventricular 
performance. We have followed those studies with a pilot trial looking at 
the efficacy of tissue plasminogen activator made in a different manner 
which would allow more extensive utilization. Positron-emission tomographs 
also have been obtained in such patients, however the experience to date is 
not ripe for analysis. The lack of changes in coagulation parameters or 
bleeding is encouraging and suggests that t-PA will be an important agent 









11Figure 1. Positron emission tomograms reflecting uptake of C-
palmitate in four 1.5 crn thick transverse sections from the base, 
high ventricle, midventricle, and apex of the heart before (left) 
and after thrombolysis (right) induced with t-PA. Compromise of 
myocardial metabolism in the anterior left venilicular wall is visualized 
as a confluent, diminution of accumulation of C-palmitate before 
thrombolysis (arrow). The anterior left ventricular regions indicated 
by arrows in the tomograms after thrombolysis show increased accumulation 
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Figure 2. Effect of Tissue-Type Plasminogen Activator (t-PA) and 
Streptokinase (SK) on the Fibrinolytic Systems of the Patients. I 
The triangle (Panel A) denotes the mean +S.E. Qf results in 17 











I An additional interest of ours for many years has been in the impact 
of recurrent injury on overall infarct size and our ability to reduce its 
incidence. We recently completed a 50-patient trial to assess the 
I 
contribution of coro~ary vasospasm to the pathogenesis of chest pain in 
patients with non-transmural infarction. We hypothesized that the 
mechanism of recurrent injury, which in many studies occurs in as many as 
40% of the patients, is likely similar to that which induces recurrent 
I 
chest discomfort. Since many feel that ST-segment depression at the time 
of presentation of acute infarction is indicative of subtotal coronary 
occlusion and a propensity to a high incidence of recurrent infarction, 
I 
coronary vasospasm has been suggested as a possible mechanism. Such a 
hypothesis has been bolstered by the suggestion that ST segment elevation 
occurs in some of these patients. In our randomized study, 50 patients 
with non-transmural infarction were randomized and received nifedipine or 
placebo in a double-blinded randomized manner. Chest pain occurred in 52% 
of the treated patients; 38 episodes on 33 days compared to 49% of control 
I 
[i'l patients; 42 episodes on 35 days. Concurrent therapy with beta blockers 
was utilized in 11 patients in the control group and 11 in the treated 
group, and with nitrates in 12 patients in the control group and 11 in the 
treated group. There was no relationship between concurrent therapy and 
"1 
the incidence of chest discomfort. Recurrent infarction occurred in 12% 
and was comparable between the groups. The incidence of recurrent 
infarction was identical to that of all patients with non-transmural 
infarction followed prospectively (12%). In an attempt to improve the 
sensitivity for the diagnosis of recurrent injury, we also evaluated MB 
creatine kinase data to select patients in whom a 50% change in the level 
". 
~.	 
of MB CK occurred regardless of whether or not the absolute value reached
'.1." 
the abnormal range. In patients stratified in this manner, 48% of the 
, treated group and 44% of the control group had evidence of recurrent 
ischemia/infarction by this measure. Accordingly, it seems unlikely that{~":.I..~~"	 the lack of a higher incidence of recurrent injury was related to a lack of
 
sensitivity of the MB creatine kinase criteria. Ejection fraction, which
 
was also monitored sequentially throughout the study, was identical between
 
the groups. It increased in six control patients, decreased in nine, and
 
did not change in six. In treated patients, ejection fraction increased in
 
seven, did not change in seven, and decreased in six. Logistic regression
 
failed to identify predictors for the recurrent chest discomfort or
 
extension. Accordingly, we felt that remediable coronary vasospasm is not
 
a likely cause of post infarction ischemia in these patients and therefore
 
attempts to preclude increases in infarct size by precluding extension will
 
likely have to focus on other interventions such as thrombosis, impaired
 
myocardial function, or fixed obstructive disease.
 
In an attempt to further understand the pathophysiology of acute 
infarction and its complications, we utilized serial determinations of 
platelet factor 4 and beta thromboglobulin to assess the possible role of 
platelet aggregation in the pathophysiology of these phenomena. Platelet 
factor 4 and beta thromboglobulin are protein constituents of platelet 
granules. Their elevation in plasma is a sensitive marker of platelet 
degranulation. We utilized both platelet factor 4 and beta thromboglobulin 
since the clearance of platelet factor 4 is qUite rapid, allowing for more 
precise timing of events, whereas beta thromboglobulin has a longer half­





rough handling of the sample or due to in vivo degranulation. Previous 
data had suggested that platelet factor 4 was elevated in patients with 
acute infarction and therefore was a reflection of coronary thrombosis. We 
evaluated 52 patients with acute myocardial infarction under rigorous I 
conditions verified to minimize platelet degranulation in vitro and 
performed correlative studies to detect left ventricular mural thrombus as 
well as other clinical complications of acute infarction. In a subset, I 
coronary thrombosis was evaluated with indium-labeled platelets. Platelet 
factor four was normal at the time of admission in patients with infarction 
averaging 6.3 ±3.3 nglml (SO), similar to values in 44 other patients with 
chest pain without subsequent infarction (5.7 ±2.7) and in 25 normal I 
subjects (4.3 ±1.6). Platelet factor four generally did not increase 
throughout the hospitalization in patients with infarction, recurrent chest 
pain, development of left ventricular thrombus, or documented recurrent I 
infarction. The mean level of platelet factor 4 over time did not 
correlate with transmural versus non-transmural infarction, the presence of 
diabetes, the location of infarction (i.e., inferior or anterior), the Iincidence of prior infarction, the use of anti-platelet drugs, the presence 
of prior bypass surgery, or clinical congestive heart failure. Platelet 
factor 4 was, however, increased consistently after invasive procedures. 
Elevations after invasive procedures accounted for 104 of the total of 110 I 
elevations that were seen. Such elevations were confirmed to be real by 
concomitant and sustained elevations (in the next sampling period) of beta 
thromboglobulin. An additional 86 elevations were thought to be due to in I 
vitro granulation since beta thromboglobulin returned promptly to normal in 
the next sampling period. In only six other samples, platelet factor 4 was 
found to be elevated in vivo as confirmed by persistent elevation in beta Ithromboglobulin. These six samples came from one young woman with acute 
anterior myocardial infarction who was receiving oral contraceptive agents, 
and subsequently appeared to have a recanalized left anterior descending 
coronary artery. In this patient massive thrombosis was likely the I 
etiology of her infarction. In patients studied with indium-labeled 
platelets, we were unable to delineate patients with positive or negative 
indium images on the basis of platelet factor 4. Thus, we found that Iplatelet factor 4 values generally remained normal despite myocardial 
infarction. The rare elevations that we found were due to sampling 
artifacts in vitro which could be corrected with the use of beta Ithromboglobulin due to invasive procedures. Thus, platelet factor 4 does 
not provide a definitive basis for the assessment of abnormalities either 
acutely or during the evolution of acute myocardial infarction. I 
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I	 The overall purpose of these studies is the correlation of 
electrophysiological derangements with biochemical and adrenergic neural 
factors underlying malignant arrhythmias associated with ischemia as well 
as evolving myocardial infarction. The overall concept of the research is
'·1 that potential arrhythmogenic metabolites accumulate in ischemic tissue and 
exert deleterious effects on membranes and that their effects may be 
exacerbated by the concomitant influences of the adrenergic nervous system.f -..i',l
';'" 
.	 Over the past several years studies have been completed demonstrating a 
major electrophysiological role of a-adrenergic stimulation during 
myocardial ischemia as well as reperfusion. In addition t it has been 
demonstrated using radioligand binding procedures that there is a 
reversible increase in a1-adrenergic binding sites in ischemic and 
reperfused myocardium. More recentlYt we have demonstrated that a­
adrenergic blockade specifically attenuates the increase in intracellular 
calcium associated with reperfusion in reversibly injured tissue. 1 Studies 
performed in our laboratory have also indicated that lysophosphatides t 
including lysophophatidyl choline (LPC) and ethanolamine (LPE) accumulate 
in ischemic myocardium in situ and have been implicated as potential 
mediators of arrhythmogenesis in the ischemic heart. 2 
During the past year t studies have been completed assessing the 
influence of a-adrenergic blockade on the functional abnormalities 
associated with reperfusion of ischemic tissue. These studies were 
performed to assess whether a-adrenergic blockade could attenuate the 
depression in mitochondrial function associated with 35 minutes of ischemia 
followed by 10 minutes of reperfusion in vivo. After the ischemic and 
reperfusion interval t hearts were excised t rinsed in saline (40) and 
anterior ischemic and posterior normal zones were removed and placed in 
sucrose (4°). Mitochondria were isolated by differential centrifugation 
and their function was assayed polarographically. State III oxygen 
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Iconsumption (Q02) was significantly depressed in the untreated group, n = 8 
(195 ±11 natoms 02/min/mg in the normal zone versus 138 ±5 natoms/min/mg in 
the ischemic zone, p < 0.01). Treatment with phentolamine (1 mg/kg), 2 to 
4 min prior to reperfusion (n = 7), prevented the depression of I 
mitochondrial function in the ischemic zone (185 ±18 natom/min/mg) as 
compared to the nonischemic zone (194 ±12 natoms/min/mg). Thus, blockade 
of a-adrenergic receptors during reperfusion in reversibly injured tissue Ienhances mitochondrial functional recovery independent of changes occurring 
during the antecedent ischemic interval. Currently, studies are underway 
to assess whether long-term ischemia (2 to 3 hours) with subsequent 
reperfusion can be influenced by a-adrenergic blockade just prior to the I 
reperfusion interval. 
Since delayed after-depolarizations (DADs) and triggered activity I(TA) have been implicated in arrhythmogenesis in the ischemic heart, a 
series of studies have been completed recently to determine whether 
lysophosphatides, which accumulate within minutes in ischemic tissue, could Iinduce DADs and TA in normoxic canine Purkinje fibers superfused with Krebs 
buffer studied with standard microelectrode procedures (n = 10). When 
maximum diastolic potential (MDP) was modestly depressed by -11.5 ±4 mV and 
amplitude by -18.8 ±5 mV, p < .01, 8 of 10 fibers exhibited DADs with a I 
mean amplitude of 7.8 ±1.2 mV. Triggered activity was seen in 4 of 10 
fibers, even at an extracellular calcium concentration of 3.0 mM. 
Treatment with epinephrine (10-6 M) in the presence of LPC, increased the IDAD amplitude nearly 2-fold to 13 ±2.9 mV (p < .05). Five of 6 fibers 
exhibited TA. Increases in extracellular calcium increased DAD amplitude 
as well without increasing the incidence of TA. Thus, LPC-induced DADs and 
TA may contribute to initiation of arrhythmias in the ischemic heart and I 
these effects appear to be enhanced by catecholamines. This lends further 
support to the contention that lysophosphatides accumulate in the ischemic 
heart and may contribute substantially to arrhythmogenesis and that I 
inhibition of their accumulation is likely to influence the generation of 
malignant arrhythmias during myocardial ischemia. IPreviously, transmural isochronic and isovoltaic mapping from 
multiple simultaneous sites has been limited by the need for analysis of 
stable repetitive rhythms. In a new system recently developed in our 
laboratory, electrograms from epicardial and transmural electrodes can be I 
simultaneously recorded from up to 240 sites. 3 Likewise, this system is 
now operational in the cardiothoracic operating room for detailed 
transmural mapping for use in the surgical interruption of refractory I 
atrial and ventricular arrhythmias. With the aid of this unique three­
dimensional mapping system, we have recently identified a specific 
mechanism responsible for inducible ventricular tachycardia in 11 dogs 3 to I7 days after transient coronary occlusion. Analysis of data recorded 
simultaneously from 232 bipolar sites at 4 intramural levels showed that VT 
in each dog was due to intramural reentry comprising endocardial bi­
directional conduction block, a fast alternate limb of endocardial I 
conduction (1.1 ±0.1 M/sec during sustained VT), slow intra-myocardial 
conduction (0.4 ±0.1 M/sec), with return to the endocardium initiating the 
next beat. The slow limb of the reentry was subepicardial in each dog with I
sustained VT (n = 5), and greater epicardial delay was evident in this 



















(epicardial activation time = 46 ±5 versus 24 ±1 ms; p < .01) and with 
pacing (68 ±3 versus 54 ±3 ms; p < .02). Animals with only nonsustained 
ventricular tachycardia exhibited reentry confined to subendocardial 
zones. These findings demonstrate, for the first time, intramural reentry 
in vivo and delineate the critical factors important for development and 
assessment of therapeutic interventions. 
Invasion of inflammatory cells during evolving myocardial infarction 
occurs in association with maximal arrhythmogenesis and we have recently 
shown that this is reflected by increased capacity for synthesis of 
thromboxane A2 (TXA2), a putative arrhythmogenic metabolite. 4 Using 
programmed electrical stimulation in conscious dogs, we demonstrated no 
limitation of ventricular tachycardia (VT) by thromboxane synthetase 
blockade despite verified inhibition within the infarct. With the three­
dimensional cardiac mapping system, we assessed simultaneous regional 
activation information at 232 sites from 4 intramural layers in 5 
anesthetized dogs 3 to 7 days after transient coronary artery occlusion. 
Infusion of OKY-1581 (100 ~g/kg/min) a thromboxane synthetase inhibitor, 
did not alter ventricular refractory periods during pacing at 300 ms (ERP = 
156 ±12 to 172 ±31 ms, NS) or 250 ms (ERP = 145 ±8 to 146 ±12 ms, NS). 
OKY-1581 did not affect epicardial activation time in sinus rhythm (34 ±8 
to 33 ±8 ms, NS) or with pacing 60 ±6 to 61 ±5 ms). It also did not alter 
transmural activation time in normal or peri-infarct zones with sinus 
rhythm (peri-infarct transmural activation time = 11.1 ±1 to 11.1 ±1 ms) or 
pacing (9 ±2 to 9 ±1 ms). Thus, inhibition of thromboxane synthesis during 
infarction fails to protect against arrhythmogenesis and exerts negligible 
electrophysiological effects. 
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The research in this project is designed to define the kinetics of 
positron-emitting tracers that are potentially useful for the noninvasive 
characterization of myocardial perfusion and metabolism and for the 
determination of adrenergic-receptor occupancy. Studies are conducted in 
isolated rabbit hearts perfused with washed sheep erythrocytes suspended in 
a modified Krebs-Henseleit buffer. The methodology permits control of 
factors that can modify myocardial perfusion and metabolism. Studies are 
also conducted in anesthetized, open-chest dogs prior to the implementation 
of approaches of proven value in studies using positron-emission 
tomography. 
The development of accurate, quantitative, noninvasive measurements 
of myocardial metabolism and perfusion is dependent on the thorough 
characterization of the factors that can influence tracer kinetics. Since 
fatty acid is the major fuel for the myocardium under normal circumstances, 
we currently utilize 11C-palmitate to estimate myocardial metabolism. In 
addition to the external detection of myocardial time-activity curves via 
coincidence detection of emitted gamma photons in isolated hearts and via a 
B-probe in open-chest dogs (with data fed to the isolated-probe data­
acquisition system) we measure a number of myocardial and metabolic 
functions such as left-ventricular pressure and arteriovenous differences 
of substrate simultaneously. Washout curves of 11C-palmitate are analyzed 
and correlated with myocardial work and substrate utilization. Assessments 
of myocardial metabolism based on external detection of accumulation of 
radiolabeled substrates may be influenced as a result of alterations in 
flow, by altered substrate delivery as well as altered work (with 
concomitant changes in metabolic requirements). 
To determine whether reduced delivery limits substrate utilization 
under defined conditions of reduced perfusion, an isolated rabbit heart 
preparation was employed in which flow was reduced but myocardial oxygen 
consumption (MV02) and work were kept constant by adjustment of left 
ventricular end-diastolic pressure and heart rate. During the past year we 
completed a study in 27 isolated perfused rabbit hearts to determine 







under conditions of low flow. 1 Myocardial work was kept constant by 
adjustment of left ventricular end-diastolic pressure and heart rate while 
flow was reduced from 1.S to O.S mg/min. Consumption of 11C-palmitate 
remained constant (48.8 ±11.6 in low work hearts and 68.8 ±23.3 nmols/g/min 
in high work hearts) because the proportion of palmitate extracted 
increased (8.8 ±4 to 29.1 ±7.2% and 10.3 ±3.4 to 21 ±6.1% in high work 
hearts). The results of the study indicate that despite reduction of flow, 
hearts at constant work loads can extract increasing proportions of 
delivered substrates such that net utilization remains constant until flow 
is reduced below the level required to maintain cellular function. They 
suggest that under conditions of low flow, impaired extraction of 
substrates reflects either primarily or secondarily depressed myocardial 
metabolism rather than simply decreased delivery of substrate. The study 
has implications on the interpretation of remote detection of radiolabeled 
fatty acid clearance from hearts either with isolated-probe data­
acquisition systems or with positron-emission tomography. The question 
addressed is whether altered extraction of substrate reflects reduced 
metabolic demand or decreased substrate availability per see The results 
suggest that decreased net extraction of radiolabeled palmitate in zones of 
transient ischemia in vivo (detectable by positron-emission tomography) is 
not attributable simply to decreased substrate delivery. They suggest that 
impaired net extraction of substrates reflects either transiently or 
persistently depressed regional metabolism. 1 
In the past year we have extended and completed a series of studies 
for the measurement of myocardial blood flow with H21S0.2,3 Noninvasive 
quantification of regional myocardial blood flow is necessary for the 
assessment of dynamic and fixed coronary vascular obstruction and for 
objective assessment of therapy designed to augment nutritional perfusion. 
The current approach for the measurement of blood flow with diffusible 
tracers derives from the work of Kety and Schmidt. 
Using H21S0 (t1/2 = 2.1 min), we demonstrated that a modification of 
the tissue autoradiographic approach permitted quantification of myocardial 
blood flow (MBF) in open-chest dogs with direct myocardial tissue assay and 
that noninvasive estimation with positron-emission tomography (PET) 
delineated relative MBF in intact dogs. In open-chest anesthetized dogs, 
the single-pass extraction fraction of H21S0 averaged 96 ±S% at flows of 80 
to 100 ml/100 g/min. This high extraction fraction did not differ 
significantly over the range of 12 to 238 ml/100 g/min. MBF calculated 
after a 60 sec i.v. infusion with H21S0 and direct tissue analysis 
correlated well with results obtained with results obtained with 
microspheres (r ~ .94, n = 9 dogs). Subsequently the approach was adapted 
for preliminarr use with PET. Estimation of myocardial content of 
radiolabeled H2 So after i.v. infusion of 20 to 30 mCi of H21S0 was 
corrected for vascular-pool radioactivity with the use of tomographic data 
obtained after separate administration of C1S0 (to label red blood cells). 
Tomograms obtained in vivo in six dogs with either normal or reduced 
regional blood flow correlated closely with the tomographically detectable 
distribution of 68Ga-labeled microspheres (r = .93) and with microsphere 
distribution determined post-mortem (r = .9S). The technique accurately 
reflects myocardial blood flow. Using PET, rapid sequential noninvasive 
estimation of relative regional MBF has been demonstrated and should 
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ultimately permit improved objective assessment of nutritional blood flow 
in patients in res~onse to medical and surgical interventions designed to 
augment perfusion. ,3 
We have previously shown that myocardial washout of extracted 
llC-palmitate is quantitatively diminished with ischemia or hypoxia. To 
define the quantitative influence of back diffusion of non-metabolized 
tracer, llC-palmitate was injected intracoronarily in 15 open-chest dogs 
with the LAD perfused extra-corporeallY.~ Myocardial blood flow (MBF) was 
measured with H2150. Arterial and coronary-venous total fatty acids, 11C02 
, llC-palmitate, lactate, and 02 were measured directly. Under baseline 
conditions or under conditions with no intervention (control), 60.0 ±13% 
(mean ±SD) of initially extracted l1 C- pal mitate was oxidized to 11C02' and 
10.1 ±6.2% was liberated unaltered as from 1 to 20 min after injection of 
tracer. With ischemia (arterial flow (20% of control, n=6), or hypoxia 
(perfusion of venous blood at normal flow, n=6), (25% of initially 
extracted llC-palmitate was oxidized to 11C02 but >17% appeared as 
unchanged llC-palmitate. Quantitative analysis of efflux from 1-20 min 
revealed that with ischemia and hypoxia llC-palmitate back-diffusion 
comprised ~O.3 ±11 .2% and ~8.9 ±17.3% of total efflux compared with 10.5 
±3.6% in controls. The fraction of extracted llC-palmitate liberated as 
11C02 (in 1-10 min) correlated closely with MV02 (r=.82, n=27). Thus, with 
hypoxia or ischemia, assessment of oxidation of fatty acid based on 
analysis of residue time-activity curves must be corrected for back­
diffusion of initially extracted but non-metabolized fatty acid.~ 
To evaluate the extent of early recovery of l1C-palmitate (11Cp) 
metabolism after 20 minutes of myocardial ischemia followed by reperfusion, 
16 open-chested anesthetized dogs were perfused extracorporeally through 
the LAD or LCX. 5 Arterial and local coronary venous fatty acids, 11C02, 
llCp, lactate, glucose, and oxygen were measured directly and regional 
residue time-activity curves assessed with a B-probe after intracoronary 
injection of llCp. Under baseline conditions or those with no 
intervention, 66.1 ±11.5% of initially extracted llCp was oxidized to 11C02 
and 10.5 ±5.9% liberated from myocardium as unaltered l1Cp from 1 to 20 min 
after injection of tracer. With ischemia (flow ( 30% of baseline, n=6), 
25.5 ±13.8% of initially extracted llCp was oxidized to 11C02 and 17.2 
±9.3% released as llCp. After 30 min of reperfusion (n=7), ~2 ±19% of l1Cp 
was oxidized to ll C02 and 8.6 ±3.9% released as llCp while the 
monoexponential clearance of residual llCp (t1/2) increased from 5.3 ±0.9 
min to 9.5 ±3.2 min. MV02decreased from 16.9 ±5.0 (baseline) to 9.8 ±~.~ 
(reperfusion) ml/l00 g/min. Thus, despite brief (20 min) myocardial 
ischemia, myocardial metabolism of fatty acid remains depressed when 
accessed early after reperfusion. 5 
It has been established that adrenoreceptor number and binding 
affinities may change in a number of cardiac disease states such as 
ischemia and congestive heart failure. To assess the feasibility of 
characterizing cardiac B-receptors noninvasively, a study was completed in 
the past year in isolated, isovolumically beating rabbit hearts to extend 
our earlier observations. 125I-hydroxybenzylpindolol was added to the 
recirculating perfusate for ~O minutes. Uptake and release were monitored 
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externally with a single gamma probe and the isolated-probe data­
acquisition system. Specificity of binding was assessed by measuring the 
clearance of the ligand from the heart during perfusion with D- or 
L-isomers of adrenoreceptor agonists and antagonists. The L-isomers of 
epinephrine, norepinephrine and isoproterenol cause significant 
dissociation of the ligand from its binding sites, while no effect was seen 
1251­with D-isomers or perfusate. Thus specific binding of 
hydroxybenzylpindolol to cardiac B-receptors can be detected externally.6 
These earlier studies demonstrated that hearts from animals treated with 
thyroid hormone eXhibited increased uptake of the ligand 
(125I-hydroxybenzylpindolol) which was detectable externally and was 
confirmed by an increase in receptor number by means of Scatchard analysis 
of ventricular membrane preparations. In the past year these studies were 
extended to determine the feasibility of distinguishing specific and non­
specific binding. We conducted studies in vitro and in vivo with 
131I-labeled d- and l-pindolol (13 1I-d-P, 131I-l-P). Each isomer was 
iodinated with chloramine T and purified by high-pressure liquid 
chromatography. In rabbit left-ventricular-membrane preparations, binding 
of 131I-l-P (Kd=0.37 ±0.18 (SD) nM) was saturable and stereospecific. In 
contrast 131I-d-P did not exhibit specific binding over the concentration 
range of 0.05 - 10 nM. To determine whether specific binding could be 
assessed in vivo, we injected New Zealand white rabbits with 500 ~Ci (0.3 
nmols) 131I-l-P (n=4) or 131I-d-P (n=4) and sequential one-minute 
scintigrams were obtained for eight minutes. 131I-l-P exhibited marked 
uptake in the lung and heart, which was blocked by pretreatment with 0.2 
mg/kg propranolol. Binding of 131I-d-P was diffuse and not affected by 
propranolol. Thus, with the use of labeled isomers and ligands, the 1­
isomer for detection of specific and non-specific sites, and the d-isomer 
for detection of non-specific sites, noninvasive visualization and 
quantification of specific receptor binding is possible in vivo under 
conditions devoid of disruption of the normal receptor environment. 7 
Cardiac dysfunction seen in hearts from diabetic animals has been 
attributed to vascular atherosclerotic lesions even though specific 
cellular metabolic defects have been observed as well. To characterize the 
relationship between MV02, substrate utilization, and myocardial work we 
evaluated hearts isolated from normal (n=13) and alloxan-induced diabetic 
rabbits (na 8). The paced, isovolumically beating hearts were retrogradely 
perfused with RBC-enriched buffer. Hearts from diabetic rabbits exhibited 
diminished peak LV systolic pressure (55 ±8 (SE) versus 88 ±5 mm Hg in 
hearts from normal rabbits). Similarly dP/dt was reduced (670 ±122 versus 
1091 ±88 mm Hg/sec) and LV pressure-time index was also reduced in diabetic 
hearts (LVPTI, 2024 ±298 versus 3198 ±210 mm Hg.sec/min) (p < .01 for 
each). Levels of LVEDP and coronary flow were equivalent. Despite 
diminution of levels of work of >35% compared to hearts from normals, MV02 
in hearts from diabetic rabbits diminished only 16%. MV02/LVPTI, an index 
of 02 utilization/unit work, was higher in hearts from diabetics (1.88 
±0.17 versus 1.41 ±0.12, p < .05). Exogenous palmitate utilization was not 
different between the two groups, but hearts from diabetics produced 
lactate (613 ±337 nmols/g/min) compared with net extraction of lactate in 
normals (-253 ±114, P < .01). The results are consistent with a partial 
uncoupling of MV02 from myocardial work and suggest that a metabolic defect 
independent from vascular damage may contribute to the dysfunction of 





The studies performed in the past year with 11C-palmitate have 
permitted a better understanding of factors that influence the uptake and 
efflux of this tracer in intact animals and specifically have looked at the 
influence of back diffusion of nonmetabolized 11C-palmitate. Studies I 
planned for the next year include further characterization of the kinetics 
of 11C-palmitate handling in association with direct kinetics of 
11C-palmitate handling in association with direct determinations of efflux. IIn addition, preliminary investigations will be undertaken to evaluate the 
handling of fatty-acid analogs, including beta-methyl-heptadecanoic acid, 
under conditions of normoxia and ischemia. The studies performed in the 
past year have confirmed and validated the H2150 diffusible tracer I 
technique for the measurement of myocardial perfusion. The studies of 
H2150 have been extended to intact animals and patients and tissue 
perfusion has been characterized based upon the clearance of H2150 with the I 
use of positron-emission tomography. The results of studies with beta­
adrenoreceptor ligands have been encouraging and raise the possibility that 
receptor occupancy may be detectable by positron-emission tomography in Ivivo. Finally, the studies in diabetic hearts have suggested partial 
uncoupling of myocardial oxygen consumption from myocardial work in this 
model, and will lead to further investigation of mitochondrial function in 
diabetic hearts in the next year. I 
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Subforms of individual CK isoenzymes were delineated with a non­
denaturing procedure developed to permit quantification. Analysis of 2-ml 
plasma samples precipitated with ETOH to remove globulins was accomplished 
with 2- to 10-~1 aliquots subjected first to agarose electrophoresis. Each 
aliquot contained between 1 and 10 mIU of MM CK activity. Separated 
subforms of the MM isoenzyme (isoforms) were transferred to nitrocellulose, 
treated with anti-MM CK and 125I-anti-IgG. The resulting native blot was 
exposed to film, isoforms localized autoradiographically, and isoforms 
quantified by well counting. Reproducibility was consistently within 11%. 
Intrapreparative conversion of one isoform to another did not occur. 
Values were linear from 1 to 10 mIU for each isoform (MMA' MMB, and MMC) 
with correlation coefficients of .93 to .96 (n = 225 determinations). 
Results correlated closely with those obtained by chromatofocusing, a more 
laborious procedure developed and validated previously (average difference 
= 0.3 ±1.4 (SE) %, n = 74). The blot procedure was 100-fold more 
sensitive, permitted assay of as many as 40 samples simultaneously, and 
provided quantitative assessment of isoform profiles in 2-ml plasma samples 
under conditions preclUding intrapreparative conversion. 
With the use of the isoform analysis procedures developed in this 
project, studies were performed to evaluate the potential of isoform assays 
for early detection of myocardial infarction. Eight conscious dogs were 
subjected to coronary occlusion. Plasma samples were obtained before 
occlusion and serially thereafter for analysis of MMA' MMB' and MMC. In 
control samples values averaged 12 ±5 (SO), 22 ±6, and 66 ±10% of total MM 
CK respectively. The fraction of MMC, the isoform formed slowly in plasma 
from MMA via MMB, decreased within 1 hr (p < .01), reached a minimum of 14 
±4% of MM in 5 ±1 hr, and returned to baseline in 13 ±3 hr. Thus, even 
though total CK activity did not become significantly elevated for 4 hr 
after coronary occlusion, early significant changes in plasma isoform 
proportions permitted detection of infarction within 1 hr after coronary 
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Iocclusion. Changes in isoform proportions were consistent, independent of 
peak total CK activity or cumulative CK release over a 10-fold range, and 
antecedent to elevated total CK regardless of infarct size. I 
Ongoing activities in this project include mathematical modeling of 
processes involved in isoform release, clearance, and interconversion with 
correlative experiments designed to assess the applicability of assumptions Iin models undergoing development and the utility of models in delineating 
precisely the time of occurrence of initial myocardial irreversible injury 
on the one hand and reperfusion with accelerated washout of the tissue 
isoform on the other. Appropriate application of validated models should I 
permit differentiation between reperfusion with accelerated washout of 





A-8. Multicenter Investigation of Limitation of Infarct Size (MILlS) 
Personnel:	 A. S. Jaffe, M.D., Medicine I 
G. G. Ahumada, M.D., Medicine
 
H~ D. Ambos, BCL
 
D. R. Biello, M.D., Radiology IT. L. Buettner, Medicine 
K. W. Clark, BCL 
E. D. Galie, R.N., Medicine IE. M. Geltman, M.D., Medicine 
F. Lifshits, Medicine 
J. M. McAninch, Medicine 
J. P. Miller, BCL I 
S. R. Mumm,	 Medicine 
D. S. Payne, Medicine 
J. E. Perez, M.D., Medicine IC. S. Ritter, Medicine 
B. A. Siegel, M.D., Radiology 
B. E. Sobel, M.D., Medicine IL. J. Thomas, Jr., BCL 
A. J. Tiefenbrunn, M.D., Medicine 
R. A. Wettach, Medicine 
A. L. Ysaguirre, Medicine I 
Support:	 RR 01380 
HV 72941 IWashington University 
IThe MILlS protocol was initiated on August 1, 1978. The goals of 
the study were to evaluate the efficacy of the administration of 
hyaluronidase and of propranolol in limiting the extent of myocardial 
infarction. The primary end-point selected for analysis was MB-CK infarct I
size corrected for body surface area. Other end-points included 
ventricular function as assessed by radionuclide ventriculograms, the I 
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incidence of positive pyrophosphate images, determinations of infarct size 
from the pyrophosphate imaging, total creatine-kinase infarct size, 
mortality and dysrhythmias at 10 days. Data were collected from five 
clinical centers including Washington University, the Massachusetts General 
Hospital, the Medical Center of Vermont, Parkland Hospital in Dallas, and 
the Peter Bent Brigham Hospital. All data were analyzed in core laboratory 
facilities in a blinded fashion. The Creatine Kinase Reference Laboratory 
and Holter Analysis Reference Laboratory were at Washington University. 
The Electrocardiographic Reference Laboratory was at the Peter Bent Brigham 
Hospital. The Infarct Scintigraphy Laboratory was at Parkland Memorial 
Hospital. The Radionuclide Ventricular Function Laboratory was at Duke 
University. Data from the clinical centers and core laboratories were 
centrally analyzed at the Data Coordinating Center at the Research Triangle 
Institute. 
The Washington University components of this project included the 
Clinical Unit, directed by the Clinical Unit Director, Dr. Allan S. Jaffe, 
the Creatine Kinase (CK) Core Laboratory, directed by Dr. Burton E. Sobel, 
and the Holter Core Reference Laboratory, directed by Dr. Lewis Thomas, Jr. 
The Principal Investigator for this study at Washington University was Dr. 
Jaffe. 
In February of 1983, the Policy Board mandated that propranolol 
administration be discontinued. All investigators were notified, reviewed 
the data and supported the recommendation of the Policy Board. 
Subsequently, an abstract of the propranolol data was presented at a 
session of the American Heart Association meeting in November of 1983. The 
data from that abstract are summarized in Table I. Two hundred sixty-nine 
patients were randomized to receive propranolol or beta blockers on the 
basis of at least 30 minutes of chest discomfort and ST-segment change, 
either elevation or depression of 1 mm or greater. Only patients who could 
receive therapy < 18 hours from the onset of their chest-pain syndrome were 
included. One hundred thirty-four patients were randomized to receive 
propranolol and 135 served as controls. Propranolol was given in a dose of 
.1 mg/kg intravenously over an initial three minute period, followed three 
hours thereafter by a second dose of half the initial dosage, and then oral 
therapy for the next nine days. In 18 patients who received propranolol 
and 14 patients in the control group, infarct size could not be calculated. 
Infarct size was not different between treated and control groups for the 
total group or for subsets stratified by time from the onset of symptoms to 
therapy into subsets treated 0 to 8 or 8 to 18 hours after onset. In 
addition, there were no significant differences between propranolol and 
control groups in the incidence of infarction, the amount or percentage of 
R-wave loss on the electrocardiogram, the change in left ventricular 
ejection fraction between 0 and 10 days, the incidence of positive 
pyrophosphate images, or mortality. The mean time to therapy was 8.9 ±0.2 
hours. It is conceivable that the overall negative results were due to 
late administration of drug since other studies utilizing beta blockers 
have suggested salutary effects on infarct size when earlier administration 
of therapy is initiated. 1,2 
The hyaluronidase arm of the study was terminated on December 31, 
1983. By that time 9,444 patients had been screened for eligibility and a 
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Itotal of 985 had been randomized. Washington University contributed 244 
patients (25%) of the overall recruitment. Analysis of the hyaluronidase 
data is ongoing and presently principal investigators who have been 
unblinded to the data are restricted from discussing the information until I 
such time as the true nature of the data can be more completely defined. 
During the last several years, several data bank studies from the IMILlS investigation have reached fruition. Such investigations had 
involved a variety of different components of the MILlS effort at 
Washington University. Data from MILlS compared the clinical and 
electrocardiographic criteria for acute myocardial infarction. Diagnosis I 
by MB creatine kinase was utilized as the reference standard. The presence 
of 30 minutes of chest discomfort and either new Q waves, 1 mm of ST 
elevation or depression in two of the three inferior leads, two of the six I 
precordial leads, or in 1 or L, or left-bundle-branch block had an overall 
sensitivity of 81% for infarction. The overall infarct rate in this 
population, however, was 49%. The diagnostic specificity of these criteria Iwas 69% and the predictive value 72%.3 In addition, a computer algorithm 
was devised to estimate infarct size when the initial portions of the MB 
creatine kinase time-activity curves were missing. This investigation 
allowed for calculation of infarct size in an additional 20% of patients. I 
The basis of the computer algorithm were complete time-activity curves from 
120 patients. Estimates of CK infarct size based on data-inclusion 
intervals beginning at 24, 12, 8 and 4 hours before peak were 11, 14, 23, I
and 47% smaller than values based on complete curves but the correlations 
were good between complete and incomplete estimates with r values ranging 
from .91 to .98. When the correction factors which were derived from these 
relations were tested on a new population, the corrected estimates were I 
Within 7% of those based on the total curves. This correction was not 
different in relation to locus (transmural or nontransmural) or the 
location (anterior or inferior) of infarction. 4 The pathological I 
correlates and significance of persistently positive pyrophosphate images 
were also described. The data suggested that MB-CK-determined infarct size 
was similar between patients with and without persistently positive images, 
17.4 ±10.6 MB CK-gm-eq/m2 for patients with persistently positive I 
pyrophosphate scintigrams compared to 16.0 ±14.6 MB CK-gm-eq/m2 . 
Similarly, myocardial infarct areas by pyrophosphate images in patients who 
had well localized and intense uptake of tracer anteriorly were also not I 
significantly different, 33.7 ±13.4 for patients with persistently positive 
images compared to 34.4 ±13.1 cm2 for patients without persistently 
positive images. Nonetheless, patients with persistently positive images I 
had lower ejection fractions (0.42 ±0.14 ejection fraction units compared 
to .49 ±0.14, p < .01) early after the onset of infarction as well as 
subsequently. Therefore as expected, there was a greater incidence of Icongestive heart failure in these patients (41 compared to 24%, p < .01). 
It was speculated that the presence of a persistently positive 
pyrophosphate image in patients with similar infarct size but greater 
impairment in left ventricular function might reflect ongoing intermittent I 
necrosis or even perhaps "chronic ischemia,"S A large number of MILlS data 
bank studies are near completion at the present time and should be 
published in the near future. These include studies comparing the I
sensitivity of a variety of diagnostic measures for acute infarction, data 
evaluating the effects of infarction in patients with hypertension, an I 
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analysis of the predictive value of ventricular ectopic depolarization and 
left ventricular function on the incidence of sudden death, data on the 
effects of abrupt beta blocker withdrawal and a manuscript defining the 
relationship between morphometric measures of infarct size obtained at 
pathology and creatine-kinase determined infarct size determined at the 
central laboratory. The latter manuscript confirms the excellent 
relationship between morphology and creatine kinase determined infarct size 
in 49 patients. The overall correlation coefficient (Spearman) was .87 for 
the 25 hearts where enzymatic estimates of infarct size were available. 6 
The MILlS study was a very successful endeavor, both overall and for 
Washington University. In addition to continued analysis of the 
hyaluronidase data, more than 40 ongoing data bank studies are now 
proceeding in an attempt to define a variety of important clinical 
relationships in patients with acute infarction. Continued involvement of 
the investigators has been assured and analysis of the data will extend for 
at least one and perhaps two more years. 
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Table 1 
Infarct-Size Index and Peak Plasma MB Creatine Kinase 
Propranolol Placebo P Value 


























No. of patients 
Mean ±S.E. 
Range 
Early-randomization subgroup (0-8 hr) 
No. of patients 
Mean ±S.E. 
Range 
Late-randomization subgroup (8-18 hr) 
No. of patients 
Mean ±S.E. 
Range 
Peak plasma MB creatine kinase (IU/liter) 
Total population 
No. of patients 
Mean ±S.E. 
Range 
Early-randomization subgroup (0-8 hr) 
No. of patients 
Mean ±S.E. 
Range 
Late-randomization subgroup (8-18 hr) 




13. 3±1 .2 
0.0-58.1 
67 
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Personnel:	 P. B. Kurnik. M.D •• Medicine 
M. R. Courtois. M.A •• Medicine I 
P. A. LUdbrook. M.D •• Medicine 
J. Markham.	 BCL ISupport:	 RR 01380 
HL 17646 
HL 25430 
Barnes Hospital I 
Washington University 
I
During the past year. our studies of cardiac diastolic mechanics (PR 19. 
A-15). i.e •• the passive mechanical properties of the left ventricular (LV) 
muscle and chamber. have continued with emphasis on (1) refining our Itheoretical	 models of the stress-strain and pressure-volume relations and 
(2) evaluating these models in a number of physiologic and pathophysiologic 
situations in the animal and in the human catheterization laboratories. I 
Values for stress are computed from several variables including 
intra- and extra-cavitary pressures. measured in the cardiac 
catheterization lab using catheter-tip micromanometers. and the cavity I
radii calculated from the area and the longest chord of the ventricle as 
measured from single-plane angiographic silhouettes. To reduce the errors 
associated with the angiographic measurements. the area and the major chord 
were smoothed by fitting to a fourth-order polynomial. Stress can be I 
derived as a function of strain. and strain as a function of radius to 
yield a stress-radius relationship for estimating elastic stiffness of the 
LV muscle. Our technique has a number of unique advantages over previous I 
models. including (1) lack of explicit assumptions about the stress-radius 
relation. (2) avoidance of need for direct measurement of strain. and (3) 
performance of stress-strain analysis independently of pressure-volume Icalculation. 
A dedicated Hewlett-Packard 5600 M computer system is used for all 
phases of this diastolic modeling. As described in PR 19. the angiographic I 
data are digitized by sonic tablet and the raw areas. largest chords. and 
wall thicknesses are smoothed and utilized to derive volume and wall 
masses. In the last year. the system has been programmed to read I
hemodynamic information off-line from F-M magnetic tape and to detect and 
calculate a variety of pressure and dP/dt functions. The hemodynamic and 
dimensional data are now integrated automatically for calculation of a Ivariety of stress-strain and pressure-volume curves and indexes. Improved 
access to and utilization of the SAS statistical system has also been 
implemented. I 
The analysis of early diastole. particularly as regards pressure and 
stress decay. is of fundamental importance and complements our previous 
investigation of filling-phase characterization. Our computer system has Ibeen programmed to digitize the pressure decay at 5 msec intervals and 














r..1 Applications of our model to two important physiologic systems in 
man have been tested. Previous work by our group had demonstrated a 
'
reduction of LV end-diastolic pressure and volume by nifedipine, as well as 
'rD:1•.	 
a downward shift of the pressure-volume curve, without alteration of 
chamber stiffness. With our new model we have demonstrated that myocardial 
stiffness is also unchanged by nifedipine, indicating that constraints,kl 
rl
external to the LV mediate these effects of nifedipine. Additionally, this 
model was used to determine whether or not global myocardial stiffness 
differed between patients with normal LV function and those with LV 
function impaired by CAD. Despite differences in ejection fraction and 
fl 
end-diastolic pressure and volume, global myocardial stiffness was similar 
in the two groups. 
Since May, 1984, research has been extended into a dog model, 
utilizing full-scale high-fidelity angiographic and hemodynamic monitoring. 
This will allow more extensive instrumentation and intervention than is';'1 
available in the clinical setting, Which will greatly add to refinement and 
expansion of our diastolic modeling. In particular, the effects of 
thrombolysis on diastolic mechanics is being investigated.{I·
During the next year, efforts will be directed at developing models 
of regional stiffness which would greatly assist in characterization of,;, 
segmental diseases such as CAD. We plan to expand our hemodynamic 
, 
.	 




!.~rlr· o ,;" 
tl~ A-10. SCOR Patient Information Database 
~.; 
Personnel: K. B. Schechtman, BCL\.:1 H. D. Ambos,	 BCL 
E. D. Galie,	 R.N., Medicine 
"I	 E. M. Geltman, M.D., Medicine A. S. Jaffe, M.D., Medicine~ J. Markham, BCL 
B. E. Sobel, M.D., Medicine 
Support: RR 01380 
HL 17646 
The Specialized Center for Research (SCOR) database currently 
contains information pertinent to more than 1700 patients who suffered 
acute myocardial infarction. The variables contained in this database 
describe the patient's cardiovascular history, in-hospital course, and long 
term progress via follow-up examination. Until this year, the data have 
been entered into the Interdata 7/16 computer system in the coronary care 
unit and then transferred via magnetic tape to the IBM System/370 at the 
University's Computing Facilities. There, a permanent SAS database has 








Currently, the data entry and storage system is being redesigned. When 
this process is completed, data will be entered through the use of 
interactive SAS under the Conversational Monitoring System (CMS) operating 
system. This will permit on-line retrieval and editing of all data and I 
will provide on-line access to all SAS statistical procedures and data 
management capabilities. Through the use of CMS, all data will be stored 
on disk as SAS datasets. Backups will be maintained on tape. I 
Studies which have utilized the SCOR database include the use of 
positron-emission tomography to determine whether patients with myocardial Iinfarction (MI) and apparent reciprocal ST-segment depression exhibit 
abnormal metabolism in zones distant from the primary zone of infarction; a 
consideration of the etiology of elevations in plasma MB creatine kinase in 
patients after cardiac catheterization; a study of the effect of clot lysis I 
induced by intracoronary streptokinase on myocardial metabolic integrity 
and viability; a controlled trial employing prophylactic antivasospastic 
therapy to assess the contribution of coronary vasospasm to chest pain in Ipatients with non-transmural MI; and a study utilizing positron emission 
tomography to assess the effects on the heart itself of coronary 





A-11. Lipoprotein Kinetics in Familial Hyperlipidemia I 
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The objective of this project has been to determine parameters of Iapolipoprotein-B metabolism in subjects with familial hypercholesterolemia. 
Two unrelated patients with familial hypercholesterolemia but with 
divergent clinical features were chosen. One had classic disease with half 
of the expected cell-surface low-density lipoprotein apoB receptors and the I 
other had only a mild deficiency of low-density lipoprotein receptors but 
overproduction of cholesterol was present. ApoB in low density lipoprotein 
was labeled with 125-iodine and apoB in very-Iow-density lipoprotein was Ilabeled with 131-iodine. 
The data were analyzed using various multicompartment models. Low­ Idensity lipoprotein apoB turnover was found to fit a two-pool model 
consisting of a vascular space and a small extravascular space with 
irreversible removal of lipoprotein from the blood. The fractional rate of 






O.09/hr. in the classic patient and O.15/hr. in the patient with atypically 
high skin-fibroblast apoB receptor activity. These results support the 
physiologic relevance of the in vitro skin-fibroblast assay. 
Over the next year we expect to start studies of cholesterol 
turnover and high-density apolipoprotein turnover in humans. Data from the 





B. Quantitative Imaging: Ultrasonic Tissue Characterization 
IAlthough ultrasound has proven to be a useful source of diagnostic 
information, results of examinations based on current ultrasonic methods 
are primarily qualitative and pictorial. In a collaborative effort with 
Cardiology and the Department of Physics work has continued on methods of I 
tissue characterization via ultrasound. Our overall goal is to use 
ultrasound for the noninvasive identification of tissue pathologies within 
two-dimensional images of tissue properties. Specific objectives of this Ieffort are: 1) to investigate the. magnitude and character of anisotropy in 
tissue, 2) to systematize the representation of the ultrasonic field and to 
reduce the data needed to describe that field by determining the moments of 
the spatial distribution of energy over the receiver aperture, 3) to seek I 
improvement in measurement capability of imaging systems via interactive, 
adaptive beamforming for both linear and variable-aperture transducer 
arrays, 4) to test the hypothesis that quantitative images based on Iintrinsic tissue properties can be produced with reflected ultrasound, and 
5) to construct a digital mUltiprocessor system to perform post-echo 
ultrasonic estimation of attenuation, phase velocity and backscatter in two 
dimensions. I 
Quantitative images based on ultrasonic tissue properties have been 
made at the BCL for several years using transmitted ultrasound with a I 
multiple-frequency tomographic reconstruction system. In the past year we 
have extended that processing environment (B-7), so that it now supports 
acquisition, storage, and processing of reflected ultrasound from arrays, Ias well as transmitted ultrasound using single-element transducers. 
The cyclic variation in backscatter from canine myocardium that we 
reported previously was found to diminish during ischemia, but returned I 
following reperfusion (B-2). This study required development of extensive 
software to analyze time-varying ultrasonic parameters (B-1). In order to 
elucidate causes for the variation of attenuation and backscatter with I 
state of contraction in cardiac muscle, these parameters were measured in 
skeletal muscle as the state of contraction was changed (B-3). IThe other three studies we performed showed some of the limitations 
of the transducer on quantitative imaging. A two-dimensional receiving 
array was simulated by scanning a small-aperture, broadband piezoelectric 
transducer (B-4). The first three spatial moments of the acoustic field at I 
this simulated receiver gave a good description of the ultrasonic field 
after transmission through a polyethylene slab. We measured the pressure 
patterns generated by single-elements of linear-array transducers and the I
signal scattered from a slotted tube to develop a phenomenological model 
for the acousto-electric transfer function of transducer elements (B-5). 
The diffraction-limited performance of linear phased arrays in pUlse-echo Imode was simulated to provide estimates of the size of tissue regions which 







B-1.	 Software Development for Analysis of Time-Varying Ultrasonic 
Parameters 
Personnel:	 J. G. Mottley, BCL 







Analysis of the data reported in Section B-2 required the 
development of an extensive system of computer programs. The data 
consisted of simultaneously digitized recordings of the outputs of a 
spectrum analyzer and the time derivative of the left ventricular pressure. 
Backscatter data were recorded from separate sites in the apical region of 
the left ventricle under several conditions, i.e., normal (before arterial 
occlusion), during ischemia, and at several intervals after reperfusion. 
In order to properly synchronize the values of the ultrasonic 
parameters to the left ventricular pressure, the following processes were 
carried out. Data from the spectrum analyzer at each frequency were 
referenced to measurements from a planar reflector and expressed 
logarithmically. A typical example of the backscatter recorded at a single 
frequency (in this case 4 MHz) and from a single site in the apex is 
presented in Figure 1 along with the simultaneous recording of the time 
derivative of left ventricular pressure. 
In order to permit averaging of the data to enhance components of 
the backscattered signal which are synchronous with the heart cycle, and to 
deal with the variation in heart rate among animals and the changing 
fraction of the heart cycle occupied by systole as the heart rate changed,
.. the data acquired during each cardiac cycle were time-renormalized by 
dividing systole into one set of 16 uniform time windows and diastole into 
another set of 16 uniform time windows. 
Renormalization was accomplished by first finding the onset of 
systole, defined as the start of the upstroke of the derivative of left 
ventricular pressure, and the onset of diastole, defined as the nadir of 
the pressure derivative. The data recorded during each phase of the heart 
cycle were then distributed among 16 uniform time windows assigned to that 
phase. Data assigned to each window were then averaged. The measurements 
of the derivative of left ventricular pressure were time-renormalized in an 
analogous fashion. 
After time-renormalization had been accomplished, the frequency­
averaged (integrated) backscatter was calculated at each site. Within each 
time window, the integrated backscatter values from similarly defined 
regions of all animals were averaged. The average integrated backscatter 






































Figure 1. An example of the backscatter at 4 MHz from a single site in the 
apical region of a dog heart, recorded as a function of time. The back­
scatter is shown in units of decibels down from a planar, nearly-perfect 







In order to more clearly identify changes in the integrated 
backscatter throughout the cardiac cycle, the relative integrated 
backscatter was calculated by offsetting the integrated backscatter from 
each region of the heart by the time-average of the backscatter from the 
same region. The relative integrated backscatter is therefore centered 
around zero dB and has equal positive and negative excursions. 
For quantification of differences in amplitude of the cyclic 
variation of relative integrated backscatter for each condition of the 
heart, the relative integrated backscatter was Fourier transformed over the 
cardiac cycle, and the real and imaginary parts of the fundamental 
frequency (i.e., the frequency which would have one complete cycle over the 
cardiac period) were used to calculate the amplitude and phase of the 
cosine which would best fit the data. The cosine curve is mathematically 
identical to the curve which would be obtained by fitting the data with 
least-squared-error technique to a functional form Acos(wt+~) where A is 
the amplitude, w is the frequency of the fundamental, given by w = 2~/T, if 
T is the duration of the normalized cycle, and ~ is the phase offset. The 
amplitude of the fundamental was used as an index of the magnitude of the 
cyclic variation during each treatment. 
-
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The variation of the ultrasonic backscatter with contraction of 
canine myocardium (PR 19, B-1) was studied by dividing the cardiac cycle 
into 32 time windows and comparing the backscatter measured during each 
window (B-1). Backscatter of the muscle was measured over a range of 
..	 frequencies (3-7 MHz in 1-MHz steps). Simultaneous measurements of the 
time derivative of the left ventricular pressure were recorded. 
The apparent backscatter of the muscle increased significantly 
during diastole, relative to levels measured during systole (see Figure 1). 
Using the peak-to-peak amplitude of the time variation as an index, we 
observed in four canine preparations that transient ischemia of 5-10 





reperfusion, the pattern of variation returned slowly, with the amplitude
 
of variation returning to approximately 75% of pre-occlusion values in 2
 
hours (see Figure 2).
 I
 
The cyclic pattern of variation of the ultrasonic backscatter 
appears to correlate with local mechanical performance, which is similarly 
attenuated by ischemia and recovers 
periods of transient ischemia. 
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Figure 1. The relative integrated backscatter as a function of occurrence 
during the normalized cardiac cycle, shown with the time-renormalized 
time derivative of the left ventricular pressure. These data were acquired 
from the apical region of the hearts of 4 animals, prior to the induction 
of ischemia. The solid line is a cosine fit to the data, as described 
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Figure 2. The peak-to-peak amplitude of the fundamental frequency of the 
integrated backscatter is shown for different conditions of canine 
myocardium. Error bars represent the standard error of the mean, indi­ I
 
cating the extent of animal-to-animal variation (N=4). The numbers on 
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The variation of the ultrasonic attenuation coefficient and the 
backscatter with contraction of skeletal muscle was studied in an isolated 
frog gastrocnemius muscle preparation, in which electrical stimulation 
induced tetany of the muscle. Both backscatter and attenuation of the 
muscle were measured over a range of frequencies (2-8 MHz in 1-MHz steps) 
prior to and during ten successive stimulations of the muscle, which was 
suspended in a bath of amphibian Ringer's solution. Simultaneous 
measurements of the displacement of the end of the muscle acting against a 
stiff spring were recorded. 
Results of the measurements of the slope of the attenuation with 
frequency are illustrated in Figure 1, in which the average slope of 
attenuation from 12 muscles is plotted for successive stimulations. The 
slope of the attenuation increased significantly between rest and 
stimulation. The magnitude of the change between relaxation and tetany 
decreased with successive stimulations, presumably reflecting effects 
arising from fatigue. The apparent backscatter of the muscle (i.e., 
without compensation for the attenuation of intervening tissue and of the 
tissue within the electronic gate) did not increase significantly. After 
compensation of the backscatter for the attenuation, the intrinsic 
backscatter transfer function did increase significantly with contraction. 
The magnitude of increase was largest for the earlier stimulations and 
declined with successive stimulations, presumably indicating fatigue (see 
Figure 1). 
Research to elucidate the possible relationships between the force 
of the contraction and the magnitude of the change in attenuation or 
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Figure 1. The changes in ultrasonic parameters of bullfrog gastrocnemius I 
between rest and tetany are illustrated here. The upper panel shows
 
the slope of the attenuation coefficient as a function of frequency for
 
the two states, as successive tetanys are induced. The lower panel shows
 I 
3 4 5 6 7 S 9 10 
the integrated backscatter under the same conditions. 
standard error of the means, obtained from 12 muscles 
Error bars indicate 






B-4. Determination of the Spatial Moments of Acoustic Fields 
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We have proposed that the low-order spatial moments of the power in 
an acoustic field represent a limited variable set which contains most of 
the information that is meaningful for quantitative imaging in an 
inherently inhomogeneous medium such as soft tissue (PR 19. B-3). 
Specifically, the first three moments, MO through M2, allow one to 
calculate the total incident power 10 (for "Intensity"), lateral deviation 
~ (for "centroid"), and root-mean-squared beamwidth w (for "width") of the 
acoustic field according to 
10 = MO, 
+ + 
c = M1/Mo,	 (1) 
w2 = M2/MO - IM11 2/Mo2 . 
We have previously demonstrated (PR 19, B-3) the use of a two­
dimensional array simulated by scanning a small phase-insensitive 
acoustoelectric receiver. In this report we show results from measurements 
made by scanning a small-aperture (1.4 mm) broadband piezoelectric receiver 
fabricated in our laboratory. This approach allowed the measurement of 
broadband rf signals using a spectrum analyzer, which facilitated the 
measurement of the spatial moments of the received field as a function of 
frequency. A block diagram of the experimental arrangement is presented in 
Figure 1. The transmitted beam from a fixed transmitting transducer 
(Panametrics V309, 0.5" diameter. 4" focal length, 5-MHz center frequency) 
was scanned in a plane perpendicular to the transmitter axis using the 
small-aperture receiver. The received signal was amplified, filtered, and 
gated into a spectrum analyzer (HP8551A). Under control of an LSI 11/23 
computer, data from the spectrum analyzer was read via an IEEE-488 bus and 
stored on disc for subsequent processing. The computer also controlled the 
stepper-motor drives for the raster scanner. For this study, raster scans 
were made of either 11 x 11 elements with 1 mm spacing or 21 x 21 elements 
with 0.5 mm spacing to simulate a 1 cm by 1 cm sparsely sampled receiving 
array. 
The spatial distribution of power at 5 MHz in the focal zone of the 
transmitting transducer in a homogeneous water-only path is presented in 
Figure 2. Each pixel represents the measurement from a single element of a 
simulated two-dimensional array of 21 x 21 elements with 0.5 mm spacing. 
The 32 gray levels correspond to quantitative relative amplitudes ranging 
from the maximum (black) to the minimum value (white) measured by the 
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Figure 2. Gray scale representation of the spatial power distribution 
at 5 MHz in the focus of the transmitting transducer as measured by 
a 21 x 21 element simulated two-dimensional receiver array. 
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I 
Isimulated array. One can clearly see the main lobe of the beam, as well as 
the first sidelobe and parts of the second sidelobe in the corners. This 
figure serves to define our coordinate system, with the center element 
defined as the origin, and X and Y directions defined as horizontal and I 
vertical respectively. 
A one-dimensional graph of the power at 5 MHz measured by the Ireceiver elements lying along Y=O is presented as a solid line in Figure 3. 
The line is similar to the [2Jl(X)/x]2 form predicted for the power from a 
focused circular transducer as illustrated by the arrows which indicate 
predicted locations. I 
The distribution of power in the focal zone of the transmitting 
transducer in a water-only path is presented in Figure 4 for the I
frequencies 2, 5, and 8 MHz as measured by an 11 x 11 element simulated 
two-dimensional receiving array with 1.0 mm element spacing. These 
grayscale images demonstrate the variable width of the spatial distribution Iof acoustic power with frequency. The main lobe of power clearly decreases 
in spatial extent as the frequency increases. To the right of each 
grayscale image is a table of beam parameters based on the first three two­
dimensional spatial moments calculated for that image. The quantity I o is I 
the total relative power received by the array, and is expressed as dB 
relative to the power received at 5 MHz. The nominally 5-MHz center 
frequency transmitting transducer yields a maximum power which is down by I
approximately 10 dB at 2 MHz and at 8 MHz (i.e., by 9.9 dB and 11.6 dB 
respectively). The values of the x- and y-components of the measured 
centroid vector ~ are approximately zero (i.e., less than one half element Ispacing), indicating that the beam is aligned with the center of the 
receiving array. The width calculated from the spatial moments decreases 
with frequency in agreement with visual inspection of the grayscale images. I, 
The moments calculations tabulated in Figure 4 were performed using 
only values obtained from those elements which yielded signals no more than 
12 dB below the peak value measured. The significance of this truncation Iwill be addressed below. 
A measurement of the attenuation coefficient of a sample using the 
zeroth spatial moment is presented in Figure 5. The top curve in the upper I 
panel is the zeroth moment MO measurement for the transmitted beam in a 
water-only path as a function of frequency over a 21 x 21 element simulated 
two-dimensional receiver array with 0.5 mm spacing. The lower curve in the I 
upper panel corresponds to MO measured after insertion at perpendicular 
incidence of a 2 mm thick planar slab of polyethylene into the path of the 
beam. The attenuation coefficient is determined by comparing the two MO Icurves in the upper panel. The result is plotted in the lower panel as a 
solid curve. The dotted curve in the lower panel is a least squares line 
fit to the data, yielding a slope of 6.2 dB/em-MHz. For purposes of 
comparison, a relatively large aperture (0.64 cm2) acoustoelectric receiver I 
was also used to measure the attenuation of the polyethylene slab. The 
acoustoelectric measurement yielded a slope of 5.7 dB/em-MHz. The 
reasonable agreement (-7% difference) between the slope values obtained I 
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Figure 3. One-dimensional graph of the power measured at 5 MHz by the 
receiver elements lying along Y=O, showing locations of predicted peaks 
and zeroes. 
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Figure 4. Gray-scale representation of the spatial power distribution 
at 2, 5, and 8 MHz as measured by an 11 x 11 element simulated two­
dimensional array. The tables of beam parameters are based on spatial 
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In order to illustrate the use of the first spatial moment to 
identify lateral deviations of the transmitted beam. the 2-mm polyethylene 
plate was rotated in the path of the beam to an incident angle of 
approximately 45 degrees from the normal. The refraction suffered by the I 
5-MHz beam during passage through the plate is illustrated in grayscale 
format in Figure 6. In the upper panel is an image of the beam after 
transmission through a water-only path. Below is an image after the I 
insertion of the polyethylene plate at 45 degree incidence. The 
corresponding beam parameters calculated from the two-dimensional spatial 
moments are shown to the right of the images. We note a significant shift I
of the beam to the left after the polyethylene plate is inserted at 45 
degree incidence. The magnitude of the shift is determined to be 
approximately 1 mm on the basis of the change in value of cx • a result in Igood agreement with the result noted by visual inspection of the grayscale 
images. 
In the discussion accompanying Figure 2 we noted that the beam width I 
decreases with frequency. In order to assure that the width w calculated 
from the two-dimensional spatial moments of the beam reliably indicates 
beamwidth. a threshold criterion must be applied to the data prior to Icalculating the spatial moments. We will now describe the physical basis 
of the necessity for this cutoff procedure. 
IA two-dimensional moments calculation is very sensitive to the value 
of power measured by receiver elements far away from the origin (0.0). To 
illustrate this. consider a function F(r) defined from 0 to R in one­
dimension. The nth one-dimensional moment of F(r) is I 
R 
Mn f r n F(r) dr. (2) I 
o 
Hence the values of moments M1. M2 • ... are increasingly more sensitive to Ithe value of power measured at greater distances r from the origin. If the 
same function is rotated to produce a cylindrically symmetric two­
dimensional function. the nth two-dimensional moment is I 
R 
M f r n F(r) 2~r dr. 0)n 
o I 
Thus. the value F(r) at any distance r from the origin is weighted by an 
additional factor 2~r in the two-dimensional integral [Eq. (3)J as opposed I 
to the one-dimensional integral [Eq. (2)J. 
For the case of a transmitted beam considered here. the weighting Ifactor in the two-dimensional moments substantially magnifies the relative 
importance of the sidelobes and noise level measured at some distance from 
the center of the beam. Practical transducers have bandpass 
characteristics. so that at some frequencies there may be two sidelobes I 
above the noise level. while at other frequencies there is one or none 
above the noise. This variable signal-to-noise ratio over frequency may 
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Figure 6. Illustration of the detection of the centroid of the spatial 
power distribution at 5 MHz using the' first two-dimensional spatial 
moment. 
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received beam in broadband transmission measurements. Furthermore, because 
the beamwidth varies with frequency, a two-dimensional receiving array of 
finite size, say 1 cm, will capture a variable fraction of the total 
transmitted power, depending on the ratio of beam width to size of the 
aperture. These considerations indicate that it is necessary to truncate 
the beam function at some level above the noise level prior to calculating 
the spatial moments, and that care must be taken to restrict the range of 
frequencies measured in accordance with the size of the aperture. 
In order to illustrate the effects described above, we shall plot 
the beam width calculated from simulated receiving array data using a set 
of threshold-cutoff levels ranging from 3 dB to 21 dB. In Figure 7 we show 
a one-dimensional scan line through a 5 MHz beam showing the cutoff points 
to be used in two-dimensional moments calculations below. 
In Figure 8 we show the 5-MHz beam width calculated from data taken 
by a simulated 11 x 11 receiver array with 1.0 mm spacing, plotted as a 
function of the cutoff level used. In this and the remaining figures, the 
value of width calculated using no threshold is plotted as a 30-dB value. 
Also indicated are the levels at which the peaks of the first and second 
sidelobes occur, and the noise level eXhibited by the system during this 
measurement. The width calculated using a 3-dB cutoff is relatively small, 
because only the very top of the power distribution is used. The beam 
width increases smoothly as the cutoff level is increased. Between 15 dB 
and 18 dB, however, the calculation picks up the effects of the first 
sidelobe of the power distribution, and reflects this in an abrupt increase 
in the rate of rise of beam width as a function of cutoff level. As the 
cutoff level is increased beyond 21 dB, the entire aperture is included, so 
the width value becomes constant. 
In Figures 9 and 10 we illustrate the effect of signal-to-noise 
ratio on the selection of cutoff level. In Figure 9 we show the width 
calculated for an 8-MHz beam in a case of very good signal-to-noise ratio. 
The measured beam width is represented as the solid line. The noise level 
of approximately 29 dB is marked with a dash-dot line. Using the width w5 
determined at 5 MHz at each cutoff and an assumed inverse-frequency 
dependence for width, a predicted beam width w8 calculated according to 
w8 = (8/5)w5 is shown as the dashed curve. The measured beam width follows 
the predicted dependence well up to 18 dB. 
In Figure 10 we depict a case analogous to that in Figure 9, but 
with a relatively poor signal-to-noise ratio. The measured beam width is 
again plotted as a solid line, with the noise level indicated as a vertical 
dot-dash line and a predicted beamwidth based on the measured 5-MHz width 
is shown as a dashed line. In this case the estimated width deviates 
dramatically from the predicted width below a cutoff of 12 dB. This effect 
arises from the heavy weighting of the noise which is measured by pixels 
away from the center and which begin to be included at this cutoff level. 
A related effect resulting from the relative size of the beam and 
the receiving array aperture is illustrated in Figure 11. Here the beam 
width calculated for 2 MHz is shown versus cutoff level. The width w2 
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Figure 7. Cutoff levels for spatial moment calculations displayed across 
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Figure 8. Plot of beam width w based on two-dimensional spatial moments 
of received power at 5 MHz in a water path versus cutoff level applied. 
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Figure 9. Plot of beam width w based on two-dimensional spatial moments 
of received power at 8 MHz in a water path with good signal-to-noise 





4.0 I i I I Iii I I I I 





E'3.0 I- Measured 
E 
'-.../ 












1.0 l- I )/: 
I 




0 3 6 9 12 15 18 21 24 27 30 
Cutoff Level (dB) 
I I 
0.0 
Figure 10. Plot of beam width w based on two-dimensional spatial moments 
of received power at 8 MHz in a water path with poor signal-to-noise 
ratio, versus cutoff level applied. 
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Figure 11. Plot of beam width w based on two-dimensional spatial moments 
of received power at 2 MHz in a water path with poor signal-to-noise 
ratio, versus cutoff level applied. 
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line for comparison. The measured beam width rises with increasing cutoff 
in reasonable agreement with the predicted curve up to about 9 dB, after 
which the value remains constant. All the receiver elements received power 
within 12 dB of the peak because the main lobe of the beam fills the 
aperture. The square shape of the receiver aperture artifactually 
truncates the power distribution, and thus distorts the estimated beam 
width. 
The overall approach to quantitative ultrasonic imaging based on 
information derived from the spatial moments of the received ultrasonic 
field continues to look very promising. Work is continuing along several 
parallel lines, including an investigation of the interdependences among 
the size of simulated array aperture, frequency bandwidth, truncation 
level, and signal-to-noise ratio. 
B-5. The Electroacoustic Transfer Function of Linear Transducer Arrays 
Personnel:	 R. M. Arthur, BCL 
S. R. Broadstone, BCL 
M. L. Seiger, B.S., Electrical Engineering 
Support:	 RR 01362 
Washington University 
Transducer behavior must be taken into account in order to make 
quantitative ultrasonic measurements (PR 19, B-6). The energy transmitted 
or received by a transducer element is dependent on signal frequency and on 
the angle of propagation or incidence. It is also affected by cross-talk 
from nearby elements. A scanner was added to the processing environment 
(B-7) to permit mapping the pressure fields generated by individual 
elements of transducer arrays and to capture the signal received by the 
element when its transmitted beam is scattered by a reflector moved through 
its field of view. Broadband pulses were used to excite transducer 
elements in order to calibrate the element for quantitative pulse-echo 
imaging. 
The excitation pulse, the pressure field recovered by a hydrophone, 
and the scattered signal received by the element itself were recorded as a 
function of hydrophone or scatterer range and angle. Signals were sampled 
at 50 MHz with 8 bits of precision. Spectra were determined by Fourier 
transform. By comparing the received signals to the excitation pulse we 
calculated the ability of the element to insonify and its sensitiVity to 
scatterers in a given region of its field of view. We are now applying 
this technique to elements of 3.5 and 5 MHz, 32-element linear arrays, 
composed of piezo-electric material. 1 
I 
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These studies may also permit development of a phenomenological 
model for the transfer function of the transducer element itself, i.e. the 
relation between the electrical excitation and the motion of the face of 
the transducer. We hope to be able to infer transducer vibration modes by 
removing diffraction effects from the calibration studies described above. 
To characterize the transfer function of a given transducer we propose to 
model each element as a collection of facets or subelements. The 
diffraction patterns of these facets will be calculated using the impulse­
response method employed in our model for studying phased-array resolution 
(8-6). Calculations will be compared to the calibration measurements in 
order to fix facet motion on a least-squared-error basis. 
1. R. M. Arthur, M. L. Sieger, and D. W. Stein, "Assessing Ultrasonic 
Arrays for Imaging Tissue Properties," Ultrasonic Imaging, vol. 6, 
p. 209, 1984. 
8-6. Diffraction-Limited Lateral Resolution of Ultrasonic Phased Arrays 
Personnel:	 R. M. Arthur, 8CL 
Support:	 RR 01362 
Washington University 
The objective of this study was to determine the diffraction-limited 
resolution of an ultrasonic linear phased array as a measure of the maximum 
number, that is as a limit on the number, of independent scan lines 
appropriate for tissue characterization. The approach was to simulate a 
linear array, so that its ability to separate two point targets located on 
an arc in regions throughout the field of view of the array could be 
calculated (PR 19, 8-5). 
The simulated transducer was composed of 16 rectangular elements. 
Its center frequency was 2.25 MHz. In terms of wavelength in the medium, 
each element was 0.9 of a wavelength wide and 12 wavelengths high. The 
spacing between element centers was 1.8 lambda. The height and width of 
the array were 8 and 19.4 mm, respectively. Each element was driven by a 
sinusoid at the center frequency (2.25 MHz) with an exponential envelope. 
The excitation was applied to the elements of the array with delays to 
produce point focus and beam steering. The receive signal was formed using 
the same delays, that is, the focal point of the array was the same on both 
transmit and receive. 
The impulse response of an element in an infinite baffle which 
undergoes uniform logitudinal motion can be readily calculated using the 
method of Lockwood and Willette. 1 The impulse response is proportional to 
the pressure in the medium. The signal received by the array upon 





response of the array. The impulse response from target to array is the 
same as that from array to target. The array output was the sum of the 
signals from each of the targets in the medium. 
In this study the focal points on transmit and receive were moved 
together along an arc for various separations of two point targets which 
were also on the arc. A scan was generated from the peak of the received 
signal for a given look direction. In Figure 1 we see two scans. The 
dashed lines indicate the position of the point targets. As expected, the 
scan at 20 mm (the width of the array) is symmetric about the axis because 
the targets are symmetrically placed about the axis. In the scan for 
targets in the vicinity of 30 degrees at 100 mm, which is 5 times the width 
of the array, the peaks of the received signals are roughly an order of 
magnitude smaller than the peaks of vet) at 20 mm. Signal amplitude falls 
off both with an increase in radius and with an increase in off-axis angle. 
In order to resolve the two targets, the peaks in the scans must be 
distinct. In this study the criterion used was that the smaller peak must 
be at least 3 dB above the minimum between the two peaks. 
For that criterion we find the angular resolution shown in Figure 2. 
Angular resolution gets better then converges with an increase in radius. 
For radii equal to or greater than 3 times the width of the array, angUlar 
resolution as a function of off-axis angle is about the same. It is 
roughly linear and undergoes about a 2:1 change from 0 to 45 degrees. The 
angular resolution curves were used to find the number of independent scan 
lines in the 45-degree field of view of the 16-element array which was 
simulated. 
Simulations of 32-element arrays with element width the same or half 
as wide as that of the 16-element array showed that array width was the 
primary determinant of resolution and that the number of independent scan 
lines in the field of view of a linear array beyond a range two to three 
times the width of the array, the number of independent lines in the field 
of view is nearly constant. 
1.	 J. C. Lockwood and J. G. Willette, "High-Speed Method for Computing 
the Exact Solution for the Pressure Variations in the Nearfield of a 
Baffled Piston," Journal of the Acoustical Society of America, vol. 
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Figure 1. Scans at constant radius. 
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Figure 2. Angular Resolution. 
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B-7. The Processing Environment for Ultrasonic Tissue Characterization 
Personnel: R. M. Arthur, BCL 
S. R. Broadstone, BCL 
P. H. Johnston, BCL 
J. G. Miller, BCL 
J. G. Mottley, BCL 
D. W. Stein, Jr., BCL 
L. J. Thomas, Jr., BCL 
Support: RR 01362 
Major modification and upgrading of the processing environment for 
the tissue-characterization project (PR 19, B-7) is now complete. The 
processing environment is built around a DEC LSI-ll/23 microcomputer, which 
is interfaced to: 1) two 50-megabyte disk drives to provide programming 
storage; 2) an FPS 100E array processor to significantly improve execution 
time for both simulations and data analysis; 3) a 9-track, industry 
compatible tape drive for backup storage; 4) an electrostatic 
printer/plotter; 5) a digital plotter; 6) a 16-bit parallel input/output 
port for connection to a video display; 7) six serial lines; 8) analog-to­
digital and digital-to-analog converters; and 9) an IEEE-488 bus for 
communication with instrumentation, such as our data-acquisition circuitry. 
This year we added a Winchester drive with a total of 111 M bytes of 
storage. It houses our operating systems and signal and image processing 
libraries, which are too large for the RK05 drives. It also has sufficient 
capacity to store a typical tomographic or linear-array scan. In addition 
we added a scanner which can rotate and translate a linear array, to 
determine the behavior of individual elements throughout its field of view, 
as well as to collect signals for two-dimensional imaging with reflected 
ultrasound. Driver software for the Biomation recorder, stepper motors, 
and other hardware of the scanning systems is now operational. We can 




IC. Quantitative Imaging: Radiation Treatment Planning 
About half of all cancer patients are treated with ionizing 
radiation during the course of their disease. The goal of radiation I 
therapy is to control the malignant disease by delivering adequate 
radiation dose to the tumor volume while minimizing the dose to the 
surrounding normal tissues. I 
Treatment planning in radiation therapy is a procedure for 
appropriately selecting and placing sources of ionizing radiation so that 
their combined effect yields an optimal spatial distribution of absorbed I 
dose in a particular region of the body. In the presence of tissues with 
inhomogeneous scatter and absorption properties, presently available 
methods of absorbed-dose calculation are approximate. Thus, their real I
utility in radiation-treatment planning is limited. We and several other 
groups have recognized for a number of years that computed tomography (CT) 
may provide a remedy for the shortcomings of present methods of absorbed­ Idose calculatio~. Accordingly, in 1977 we began the development of a new 
approach to absorbed-dose prediction that is based on fundamental physical 
principles and takes advantage of information provided by CT scanning. I 
The general objectives of this project are to develop algorithms for 
computing three-dimensional dose distributions within inhomogeneous tissue 
regions valid for radiation fields of arbitrary shape and size, and to I
apply advanced computer technology in the implementation of these 
algorithms to render them clinically useful. A specific objective of our 
initial work was to investigate the validity of the physical basis of the 
mathematical model on which our method depends. Comparison between I 
measured and calculated dose in complicated geometric phantoms and in the 
Rando phantom show excellent agreement (C-1). In addition, a new 
investigation into treatment verification using our dose calculation I 
algorithm has been started (C-1). This may provide an effective way to 
verify that the planned treatment is actually delivered to the patient, 
which is as important as developing an effective plan in the first place. IAn integrated circuit to perform the ray-tracing part of the dose 
calculation has been designed (C-2) and is being fabricated, and 
preliminary work is in progress for display of information to aid treatment 
beam placement and display of calculated dose distributions to aid I 








C-1. Algorithm Development for Radiation Treatment Planning 
Personnel: J. W. Wong, Ph.D., 
K. B. Larson, BCL 
F. U. Rosenberger, 
E. D. Slessinger, B.S., 
Radiology 
BCL and Computer Systems Laboratory 
St. Louis University 
Support: RR 01380 
RR 01379 
Imperative in any radiation treatment planning (RTP)system is a 
method of accurate dose calculation. As mentioned in our last progress 
report, we have implemented on a VAX-11/780, a new delta-volume algorithm 
based on the work by Wong and Henkelman. 1,2 We have demonstrated that, in 
stringent phantoms irradiated by cobalt-60 beams, the calculation of 
correction factors agrees with measurements, usually to within one percent. 
During the past year we have continued our evaluation of the algorithm for 
cobalt-60 irradiations and are close to the completion of the important 
"photon-transport phase" of the RTP project where the incorporation of 
electron-transport for dose calculations is not necessary (e.g. cobalt-60 
or equivalent radiation beams). The work can be described in two parts: 
voxel-based dose calculations; and methods for treatment verification. 
We have performed verification studies in the more realistic 
Alderson Rando anthropomorphic phantom. X-ray CT scans of the Rando 
phantom in the upright position were made. In this manner, contiguous 
scan data at the desired x-ray beam width could be obtained without data 
interpolation and scan artifacts between the transverse sections of the 
phantom. The Rando phantom was irradiated anterior-to-posterior in the 
thoracic region with a 15 cm x 15 cm cobalt-60 beam. Dose measurements 
were made with high precision thermoluminescent dosimeters 3 placed 
primarily in the lungs and mediastinum of the Rando phantom. For dose 
calculations, the CT numbers were converted to electron densities 
determined by narrow-beam cobalt-60 transmission measurements through 
sections of the phantom composed of the various materials used in the 
phantom construction. Comparison of the calculations and measurements are 
shown in Figure 1 as a histogram distribution of percent differences. 
Linear interpolation of calculated values was used to account for the 
unavoidable positioning mismatch between the dosimeters and the calculation 
grid. The average difference of 60 samples of comparison was 
-0.25% ± 2.96%. 
The agreement is excellent considering the discrepancies in the 
positions of the measurements and calculations, and the errors introduced 
due to the finite dimensions of the input voxel data. 
This study demonstrates that we are able to perform accurate dose 
calculations based on actual CT pixel-based input data and is the first 
time that such a truly three-dimensional dose calculation has been 
attempted. With our prototype delta-volume implementation, actual clinical 
cobalt-60 dose calculations can now be made within the limitations of the 
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No. of 
Ave. Difference: samples 
12All samples (n=60) 
: -0·25% :t 2·96% I
Mediastinal samples (n=19) 10
 
: -2·67% :t 2·82%
 
Non-Mediastinal samples (n=41)
 I ~ Mediastinal sample: 0·84% :t 2·31% 8 
I All samples: 6SO/0 within :t 3% difference 
92% within :t 5% difference 
6 
Figure 1. Comparison of TLD tleasurements with ~-Volume Calculations 
present algorithmic design such as field dimensions, grid spacing, and 
computation time. 
Verification that the intended treatment plan is carried out is as 
important as development of the plan. While we may be able to arrive at an 
optimized treatment plan for the patient based on the delta-volume 
calculations, we have been concerned that to date, there is a paucity of 
non-invasive techniques to verify the execution of the plan. The customary 
practice of exposing port films with the irradiating beam on the exit side 
of the patient merely provides a test of the geometric reproducibility 
without verification of the dose calculations. Recently, we have begun 
investigating a new approach to treatment verification based on the 
comparison of the calculated and measured exit-dose distribution. Provided 
that the patient set-up remains the same for dose calculations and 
treatment, a necessary condition for treatment planning, such comparison 
should yield good agreement. A study was conducted using the phantom 
geometry shown in Figure 2a. The calculated correction factors for this 
phantom (i.e., the ratio of dose in medium to the dose in water) agreed 
very well with measurements. The average difference was 1.8% ± 1.4%. In 
Figure 2b, only two points of comparison show a difference larger than 3%, 
one of which is probably due to positioning error of the dosimeter (see 
axis (b» and the other is located in the more rapidly changing penumbral 
region (see axis (a». I 
I
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Figure 2b. Comparison of Calculated and Heasured Values I
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Encouraged by these results, we proceeded to apply this verification 
approach in the more realistic Rando phantom. Profiles of correction 
factors were measured at the exit side of the phantom using an ionization 
chamber. Figure 3 shows the results of two profiles 5 em superior and I
inferior to the horizontal axis of the beam. The measurements and 
calculations are shown as continuous and dashed lines respectively. 
Excellent agreement was obtained. Of the 57 points used for direct I
comparison, 80% agreed to within ± 3%. Largest errors occurred, once 
again, in the mediastinal and penumbral regions. The stUdy suggests that 
accurate prediction of the exit dose distribution may be used for non­
invasive treatment verification, a level of quality control that has not I
 
been attempted before. We hope that in the future, with a better detection
 
device, and appropriate methods for data analysis (see Section C-3 for the
 
gray-scale images of the exit-correction factors distribution), such an
 I

approach will place treatment planning closer to the clinical setting and 
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Next, we intend to: 
(1)	 Ini tiate the "photon-electron-transport" phase of the RTP project in 
order to extend the algorithm to higher photon energies. I
 
(2)	 Increase or modify the resolution of the primary intensities and dose 
calculation grids of our prototype algorithm for more appropriate I
comparisons with measurements and verification studies in high dose­
gradient region, and to accommodate larger field dimensions. 
I
(3)	 Perform actual clinical dose calculations, including exit dose 
verification studies based on film dosimetry, for patients receiving 
cobalt-60 irradiations in the head and neck, and thoracic regions. I
(4)	 Examine different methods of data (or image) analysis such as image 
subtraction so as to quantify our exit-dose treatment verification 
technique. I
 
(5)	 Investigate the subtraction from the digitized exit dose distribution 
obtained from port films of the calculated scattered dose 
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C-2.	 Integrated Circuit Implementation for Absorbed-Dose Computation 
in Radiation Treatment Planning 
Personnel: F. U. Rosenberger, BCL and Computer Systems Laboratory 
G. J. Blaine, BCL 
T. J. Chaney, M.S., Computer Systems Laboratory 
J. D. Collins, B.S., Computer Systems Laboratory 
R. D. Edelman, B.S., Computer Systems Laboratory 
E. T. Macke, M.S., Computer Systems Laboratory 
W. J. Thomas, M.S., Electrical Engineering 
J. W. Wong, Ph.D., Radiology 
Support: RR 01380 
RR 01379 
Washington University 
The design of two integrated circuits for ray-tracing and 
attenuation calculation for absorbed-dose calculations has been completed 
and both circuits have been submitted for fabrication, one to MOSIS1 and 
one to VLSI Technology Incorporated (VTI). We expect to receive the 
fabricated circuits and to start testing and evaluating them in August or 
September. The two circuits implement different versions of the ray­
tracing algorithm for dose calculations. The first IC, which is being 
fabricated by VTI, uses a fixed voxel size for attenuation calculations, 
and as a result, requires a long time for dose computation in large 
volumes. After initialization and loading of associated memory by a host, 
it calculates the sum of the augmented first-scatter dose at each voxel in 
the volume from each voxel. The circuit includes about 12,000 field-effect 
transistors, 168 cell definitions, and is about 6.5 mm by 6.1 mm with 5 
micron feature sizes. Figure 1 shows a plot of the finished design. 
The second IC, which was designed as a class project in EE563, 
calculates dose contribution from a volume of 8 by 8 by 10 voxels to a 
single voxel upon a command from the host. However, the IC can be used to 
calculate the dose with 1 cm voxels, 2 cm voxels, 4 cm voxels, etc. until 
the dose contribution from an entire volume has been calculated. This 
allows a much smaller number of attenuation calculations than the first 
method by using lower resolution for the scattering volume that is further 
away from the dose point. The time savings for calculation of first 
scatter dose using this technique is about an order of magnitude for 
volumes of 32 voxels per side. 2 This circuit includes about 6300 field­
effect transistors, 117 cell definitions, and is about 3.6 mm by 6.6 mm 
with 4 micron feature sizes. This second circuit requires less area 
because of the smaller feature size and because it requires more frequent 
attention from its host. However, under typical operating conditions, it 
will compute for about 10ms intervals before requiring a few words of data 
transfer to and from the host. 
The design of these two ICs has been a difficult and time-consuming 
experience and although we have learne~ much as a result, it is clear that 
a less labor intensive technique is required to provide new designs with 
less effort and to allow modifications and corrections to be incorporated 
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Figure 1. Plot of ~-Volume Ray-Tracing Integrated Circuit 
more easily into completed designs. We are obviously not the only 
organizatio~encounteringsuch difficulties and significant effort is being 
expended by other universities and by industry to reduce the time required 
for design and modification of integrated circuits. We presently have a 
preliminary version of the VIVID system being developed by the 
Microelectronics Center of North Carolina and expect to get a significantly 
improved version within a month or two. VIVID allows design to be 
completed without explicit specification of dimensions or absolute 
position, only relative position. When the design is complete, a program 
adds absolute coordinates and attempts to compact the circuit to remove 
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unneeded and wasted space. This makes initial design and subsequent 
changes much qUicker and easier than design that uses absolute coordinates. 
1.	 D. Cohen and G. Lewicki, "MOSIS -- The ARPA Silicon Broker," 
Proceedings of the Second Cal tech Conference on VLSI, pp. 29-44, 
January 1981. 
2.	 F. U. Rosenberger, K. Krippner, D. Stein, Jr., and J. W. Wong, 
"Implementation of the Delta-Volume Dose Calculation Algorithm," 
Proceedings of the Eighth International Conference on the Use of 
Computers in Radiation Therapy, pp. 78-82, July 9-12, 1984. 
C-3. Displays for Radiation Treatment Planning 
Personnel: R. E. Hermes, BCL 
J. W. Wong, Ph.D., Radiology 
Support: RR 01380 
Experimental displays of conventional treatment plans were 
demonstrated using the MMS-X system and reported on last year (PR 19, C-2). 
These displays were used to demonstrate their usefulness and practicality 
for improving the interpretation and development of radiation treatment 
plans. The displays utilized stroke graphics to represent isodose 
contours and outlines of anatomical features. 
Our Lexidata system has been used to display and photograph 
calculated and measured exit dose distributions (C-1) to allow subjective 
evaluation of the effectiveness of exit dose calculations. Figures 1a and 
lb show measured and calculated exit dose data as displayed for comparison 
and evaluation. The qualitative comparison is good, with the major 
difference due to the calculation being performed at only half the 
resolution of the measurements. 
The MASSCOMP MCS-SOO has stimulated work toward implementing raster 
displays similar to those achieved on the MMS-X. We are presently 
implementing a generalized set of display software for the graphics system 
to provide support for a variety of applications including the development 
and evaluation of displays for planning beam placement and for evaluating 
















Figure lb. The corresponding calculated correction factor image
 
of a 25 x 25 matrix, linearly interpolated for comparison to
 





Figure lao A gray-scale image of the digitized measured 
























'i O. Quantitative Imaging: Positron-Emission Tomography 
Stimulated by the clinical impact of the EMI transmission:··1,?"
. tomographic scanner in 1973, experimental studies were initiated in 
collaboration with the Division of Radiation Sciences to evaluate positron 
coincidence-detection as a method for emission reconstruction tomography.~I This collaborative activity resulted in a prototype scanner called PETT 
"I
(Positron-Emission Transaxial Tomograph). Extensive studies in patients 
and animals were conducted with the PETT III scanner in collaboration with 
the divisions of Neurology and Cardiology. A subsequent scanner, PETT IV, 
utilized concepts developed with its predecessor but incorporated a novel 
technique for the simultaneous collection of four tomographic slices from a 
single set of detectors. PETT IV is now located in the Cardiac Care Unit 
for use in the SCOR project for the quantification of regions of myocardial 
ischemia and infarction (0-1, 0-2). Subsequent scanners have been 
developed that permit more rapid data collection and improved spatial 
resolution. One of these, PETT V, was used in experimental studies in dog 
hearts. PETT VI became operational during the summer of 1980 and employs 
fast detectors and an entirely circular motion for rapid data acquisition. 
Further experimental and clinical studies with this system occurred over 
this past year (0-3, 0-4). One of the most exciting recent developments 
for emission tomography results because of new developments in crystal 
technology and high-speed electronics. These now permit the propagation 
time of each of the two photons created in an annihilation to be measured. 
Theoretical and experimental studies of tomography systems that utilize 
this new information continued, and the software and hardware needed to 
realize the predicted benefits were developed (0-5 to 0-11); the new system 
is called Super PETT I. Studies of ways to improve the detector 
electronics for the improved measurement of time-of-flight continued during 
the year (0-12). Work was initiated on a new approach for estimating 
parameters in dynamic studies using list-mode data (0-13) and on using side 
information, such as CT and MR data, to improve PET reconstructions (0-14). 
A study of finite-register effects in implementing reconstructions from PET 
data has been initiated as a necessary step for special processor design 
(0-15). A new time-of-flight instrument for neurological studies is under 
development (0-16, 0-17). A reconstruction algorithm for single-photon 
tomography is being studied for use with data collected with a multiview 
gamma camera (0-19). 
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D-I. PETT	 Experimental Studies 
Personnel:	 S. R. Bergmann. Ph.D •• Medicine 
K. A. A. Fox. M.B •• Ch.B •• Medicine 
R. M. Knabb. Ph.D •• Medicine 
J. Markham. BCL
 
B~ E. Sobel. M.D •• Medicine
 
M. M. Ter-Pogossian. Ph.D •• Radiology 
M. J. Welch. Ph.D •• Radiology 
Support:	 HL 13851 
HL 17646 
The overall goal of this project is to implement and evaluate 
procedures required to translate into intact animals the results obtained 
with selected positron-emitting tracers used to characterize myocardial 
metabolism and perfusion in isolated hearts and anesthetized. closed-chest 
dog studies performed with the Isolated Probe Data Acquisition System 
(Project A-6). Utilizing positron-emission tomography with PETT VI. the 
distribution of tracer and the time course of its uptake and clearance from 
the myocardium can be quantified. Such studies are intimately related to 
the clinical studies using positron-emission tomography. 
During the past year. we have demonstrated that using H2150 
(t1/2 - 2.1 min) and a modification of the classical Kety-Schmidt 
autoradiographic approach. quantification of myocardial blood flow in 
anesthetized dogs was possible. The approach was adapted for use with PET 
by estimating the myocardial content of radiolabeled H20 after intravenous 
infusion of 20-30 mCi of H2150. corrected for vascular radioactivity with 
the use of tomographic data obtained after the administration of C150 by 
inhalation to label red blood cells. Tomograms obtained in vivo in six 
dogs with either normal or reduced regional blood flow correlated closely 
with tomographically detectable distribution of 68Ga-Iabeled microspheres 
(r = 0.93) and with postmortem microsphere distribution (r = 0.95). The 
technique thus accurately reflects regional myocardial blood flow and 
should permit improved objective assessment of nutritional blood flow in 
patients with medical and surgical interventions designed to augment 
perfusion. Absolute measurement of myocardial blood flow will necessitate 
correction of motion artifacts with gating, and algorithms for correction 
of partial volume and spillover effects. 1 
In pilot studies performed within the past year. we extended this 
technique to demonstrate that non-invasive determination of regional 
myocardial blood flow in response to pharmacologically induced vasodilation 
can permit detection of functionally significant coronary stenoses without 
coronary angiography. We used PETT VI to characterize myocardial blood 
flow before and after dipyridamole (1 mg/kg i.v.) in closed-chest dogs with 
50-70% reduction of LAD diameter produced by intraluminal placement of 
Teflon cylinders (i.d. 0.6-1.1 mm). Relative flow was determined following 
i.v. bolus in~ections of 40-60 mCi H2150 with correction for vascular 
tracer with C 50 and compared to the distribution of simultaneously 
administered radiolabeled microspheres. Control tomograms were homogeneous 
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whereas relative myocardial blood flow was markedly diminished in tomograms 
after dipyridimole. Although absolute myocardial flow distal to the 
stenoses increased after dipyridamole, relative flow determined with PET 
was only 43 ± 10% of normal, and correlated closely with the distribution 
of microspheres measured in vitro (r = .85). These studies demonstrated 
that the manifestations of coronary stenosis insufficient to cause resting 
ischemia can be detected by PET with dipyridamole-induced vasodilation. 
The approach developed should be applicable to noninvasive diagnosis and 
localization of stenoses in patients. 
We previously demonstrated that PET can be used to estimate the 
salutary response to coronary thrombolysis. These studies have continued 
during the current project year. Even though restoration of vessel patency 
after reperfusion is demonstrable angiographically, it has been reported 
that myocardial blood flow (MBF) declines below 20% of normal at 24 hours 
of reperfusion. To evaluate the extent to which externally measured MBF is 
maintained after coronary thrombolysis, occlusive thrombus was induced by 
placing a copper colI into the LAD in closed-chest dogs. One and one-half 
to two hours after thrombosis, lysis was induced with streptokinase. PET 
following i.v. administration of H2150 and inhalation of e150 was performed 
during ischemia, after streptokinase, and 24 hours after reperfusion. 
Radio-labeled microspheres were administered simultaneously at each 
interval. Myocardial blood flow was 11% of normal during ischemia, 
increased to 80% of normal immediately after reperfusion, and was 49 ± 17% 
of normal at 24 hours despite continued anglographic patency. From these 
studies, we concluded that MBF is reduced 24 hours after reperfusion and 
that sequential evaluation of MBF can be achieved conveniently with PET.2 
In the last year, we also studied the beneficial effects of coronary 
thrombolysis on myocardial metabolism as well as perfusion. In eight 
closed-chest dogs subjected to LAD coronary thrombus, perfusion was 
evaluated with the H2150 technique, and metabolism was assessed after i.v. 
injection of 11e-palmitate one to two hours after induction of thrombus. 
Tomographic data were acquired in the dynamic acquisition mode 
(2-minute scans). In normal regions, 11e-palmitate accumulated within two 
to four minutes, and the turnover of 1 e-activity from five to fifteen 
minutes was exponential with a t1/2 of 13 ± 5 minutes. In the regions 
supplied by the LAD, perfusion was diminished to 22% of normal and 
clearance of 11e-palmitate increased (tl/2 = 26 ± 4 minutes) indicating 
substantial recovery of metabolism. These results indicated that 
sequential PET permits prompt assessment of the responses of metabolism and 
perfusion to coronary thrombolysis. 3 
In addition, we have continued our studies of the salutary effects 
of coronary thrombolysis induced with tissue-type plasminogen activator. 
PET documented the recovery of metabolism and perfusion after thrombolysis 
induced with t-PA, suggesting that this promising agent which does not 
induce a systemic thrombolytic state, has salutary effects on perfusion and 
metabolism. 4,5 
The studies completed during the past year have demonstrated the 
utility of PET for the evaluation of myocardial metabolism and perfusion 
and are currently being implemented in patient studies being designed to 





During the coming year, we plan to continue our evaluation of the effects 
of coronary thrombolysis on the restoration of myocardial perfusion and 
metabolism with PET to better characterize the response to this promising 
intervention. Furthermore, we plan to evaluate algorithms, after I
 
institution of cardiac and respiratory gating, to correct for the effects 
of partial volume effects and count-spillover. This will enable 
measurements of perfusion in absolute terms. I
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0-2. PETT IV Cardiac Studies 
Personnel: E. M. Geltman, M.D., Medicine 
H. D. Ambos, BCL 
T. R. Baird, Medicine 
D. E. Beecher, BCL 
A. S. Jaffee, M.D., Medicine 
J. Markham, BCL 
B. E. Sobel, M.D., Medicine 
M. M. Ter-Pogossian, Ph.D., Radiology 
M. J. Welch, Ph.D., Radiology 
Support: RR 01380 
HL 13851 
HL 17646 
This project was designed to determine the utility of positron­
emission tomography (PET) for the assessment of myocardial metabolism after 
the intravenous injection of 11C-palmitate in patients with a variety of 
cardiac diseases. During the current grant-interval, patients were studied 
with ischemic heart disease and congestive cardiomyopathy of various 
etiologies to determine the extent of metabolic derangements and their 
response to therapeutic interventions. 
To determine whether coronary thrombolysis benefits the heart 
directly, we utilized positron-emission tomography with 11c-palmitate to 
characterize regional myocardial metabolism in 17 patients with initial 
infarction. That was performed immediately after admission, again after 
intracoronary streptokinase given within 18 hours, and 7 to 10 days later. 
Clots were persistent in 9 patients, despite a mean dose of 336,000 units 
and marked fibrinogen depletion. Only 2 of these patients exhibited 
improved regional metabolism (a decrease in defect size greater than 20%) 
in late, compared with early, tomograms. Without lysis, mean metabolic­
impairment increased by 4 ± 18% (SO). In contrast, all of the 8 patients 
who manifested lysis (mean time to lysis = 5.75 hrs after the onset of 
pain) exhibited improved metabolism with 75% eXhibiting more than 20% 
reduction in defect size in late compared with early studies, and a mean 
improvement of 28 ± 2% (p < 0.01) in the group as a whole. Results were 
comparable in patients with anterior and inferior infarction. Thus, clot 
lysis induced by intracoronary streptokinase exerts salutary effects on 
myocardial metabolic integrity and viability assessed with positron 
emission tomography. 
Work initiated previously to study the differentiation of ischemic 
from nonischemic cardiomyopathy by positron-emission tomography has been 
continued during the current grant-interval. We have now analyzed data 
from 12 patients with ischemic cardiomyopathy for comparison with 10 
patients with nonischemic cardiomyopathy. All patients were studied with 
positron-emission tomography after the intravenous injection of 15-20 mCi 
of 11C-palmitate intravenously. The spatial characteristics of the 
distribution of 11C-palmitate within myocardium of the 10 new patients with 
nonischemic congestive cardiomyopathy were virtually identical to the 
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spatial charact~ristics of our 17 patients with nonischemic congestive 
cardiomyopathy previously studied. In contrast, the distribution of 
11C-palmitate in the myocardium of the 12 patients with ischemic 
cardiomyopathy were distinct from patients with nonischemic 
congestive-cardiomyopathy. Large defects encompassing more than 15% of the 
area of a transverse tomographic reconstruction, representing depressed 
accumulation of 11C-palmitate, were seen frequently in patients with 
ischemic cardiomyopathy. Ten of the 12 patients with ischemic 
cardiomyopathy demonstrated such a defect. None of the patients with 
nonischemic cardiomyopathy demonstrated these defects. When analyzed 
employing statistical methods previously described, the number of 
noncontiguous regions summed for 7 isocount thresholds was 12.1 ± 0.6 for 
patients with ischemic cardiomyopathy compared to 17 ± 0.6 among patients 
with nonischemic congestive cardiomfopathY. The frequency distribution of 
the relative myocardial content of 1 C-palmitate was shifted towards lower 
values in patients with nonischemic congestive cardiomyopathy compared to 
the non-infarcted zones of patients with ischemic cardiomyopathy or to 
normal subjects. Thus, positron-emission tomography, after the intravenous 
administration of 11C-palmitate, permits the objective identification of 
patients with ischemic from patients with nonischemic congestive 
cardiomyopathy, a finding which may have significant therapeutic 
implications. 
Positron-emission tomography is also being employed in the analysis 
of other interventions designed to salvage ischemic myocardium. It is 
being used as an endpoint for studies of the efficacy of nifedipine, a 
calcium channel blocker, for the salvage of ischemic myocardium in the 
setting of acute myocardial infarction. To date, over 40 patients have 
been studied in this randomlzed, double-blind trial. However, data have 
not been analyzed, since 5 additional patients are required before the 
stUdy is terminated and the code can be broken. These data should be 
available for the next progress report. 
Positron-emission tomography is also being employed as the primary 
endpoint for studies of tissue plasminogen activator (tPA) as a new 
thrombolytic agent for use in the setting of acute myocardial infarction. 
To date. a total of 7 patients have been studied with tPA derived from a 
melanoma cell line and. subsequently, 7 patients have been studied with tPA 
derived from recombinant DNA technology and studied under an IND provided 
by Genentec, Inc. Tomographic data indicate that the reduction in the size 
of the defect in accumulation of 11C-palmitate observed with positron­
emission tomography when lysis is achieved with tPA is at least comparable 
to that observed when lysis is achieved with streptokinase. Since lysis 
appears to be achieved more quickly with tPA, ultimately salvage may be 
greater. but definitive analysis will require the acquisition of more 
patient data. 
Studies in progress should complete the analysis of the effects of 
nifedipine on myocardial infarct size and the effects of tPA on the 
ultimate extent of infarction with positron-emission tomography as the 
primary endpoint. Additional studies are in progress which are designed to 
study the relationship between defects and cardiac metabolism detected by 
positron-emission tomography and abnormalities in proton spin resonance I 
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detected by magnetic-resonance imaging. These data will help clarify the 
impact of partial volume effects and wall-motion abnormalities in the 
fenesis of regions of decreased apparent myocardial content of 
1C-palmitate in patients with ischemic heart disease and congestive 
cardiomyopathy. 
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W. J. Powers, M.D., Neurology and Radiology 
D. L. Snyder, BCL 
A. G. SWift, B. A., Radiology 
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Because of the previously noted CPR 19, 0-3) deficiencies of 
compartmental models for estimating cerebral blood flow with PET using 
radioactive water as a tracer, we have been led to the formulation and 
testing of distributed models for this purpose. The distributed models we 
have investigated take into account longitudinal gradients of tracer 
concentration along the capillaries but assume that transverse gradients 
are zero. The resulting conservative conditions take the form of sets of 
partial differential equations in the concentrations, with axial distance 
and time as independent variables and with capillary and cellular 
permeabilities, surface areas, volumes, and thermodynamic activity 
coefficients as parameters. On the basis of solutions of these equations, 
we have constructed simulated residue curves and have compared these with 
high-temporal-resolution experimental radiowater residue histories obtained 
following intracarotid injections of tracer in rhesus monkeys. A two­
.t~'I barrier distributed model was found to provide a realistic simulation of ~~~ .. 
'1"1 the experimental curves using plausible assignments of parameter values. 





satisfactorily. We are therefore encouraged to believe that our two­
barrier distributed model can provide insight into the nature of in-vivo 
water transport in brain and will allow us to devise simplified versions 
suitable for use in our tomographic clinical applications. 
Studies of brain receptors have been performed using PET and labeled 
spiperone. A three-compartment model, developed previously to describe the 
kinetics of spiperone in brain tissue (PR 19, 0-3), was used to evaluate 
the PET-acquired time-activity curves of various regions of the brain after 
injection of 18F-sPiperone in twelve baboons. These studies demonstrated 
the repeatability of the method and the sensitivity of the procedure to a 
decrease in the number of receptors available for binding due to previous 
injections of unlabeled spiperone. Parameter values estimated from these 
data agreed with published values of blood-brain-barrier spiperone 
permeability and brain-receptor density. Specialized techniques are under 
development for estimation of the parameters for temporal data in each 
pixel of the PET reconstruction images. These techniques are based on 
sensitivity analysis relating variations in the tissue-activity curves 
calculated from the spiperone model to variations in the values of the 
parameters. Utilization of the relationships between the tissue-activity 
curves and the parameters should permit rapid and accurate estimation of 
the parameters and, consequently, generation of an image of receptor 
distribution in the brain for each study. 
0-4. Maximum-Likelihood Image Reconstruction for-PETT VI 
Personnel:	 J. O. Gorman, BCL 
M. A. Mintun, M.D., Neurology 
O. L. Snyder, BCL 




The maximum-likelihood image reconstruction algorithm for non-time­
of-flight PETT VI data was implemented on two general purpose computers 
(DEC POP-11, Perkin-Elmer 3240), and found to produce better images than 
those obtained from the filtered back-projection algorithm. Increases were 
observed in the signal-to-noise ratio and resolution, and background 
artifacts were decreased in the maximum-likelihood images as compared to 
images obtained with the linear-filtering algorithm. This is consistent 
with earlier studies done for Super PETT I data using a maximum-likelihood 
reconstruction algorithm that incorporates time-of-flight (TOF) 
information. 1 
The maximum-likelihood algorithm has also been applied to Super 
PETT I data where the TOF information has been suppressed. Images obtained 
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by using the non-TOF maximum-likelihood algorithm with Super PETT I data 
appear to be better in preliminary studies than those obtained with the 
confidence-weighting algorithm which does use TOF information. This 
indicates that the non-TOF maximum-likelihood algorithm may have 
applications in TOF PET studies where the TOF information would be used to 
improve the quality of the measured data by randoms rejection, and then 
suppressed for reconstruction. Processing times per seven-slice study on a 
VAX-class machine are on the order of seven hours for the non-TOF algorithm 
(which operates on two-dimensional data) and 630 hours for the TOF 
algorithm (which operates on three-dimensional data). 
1.	 D. G. Politte and D. L. Snyder, "Results of a Comparative Study of a 
Reconstruction Procedure for Producing Improved Estimates of 
Radioactivity Distributions in Time-of-Flight Emission Tomography," 
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 614-619, 
February 1984. 
D-5. Data-Acquisition for Super PETT I 
Personnel:	 D. E. Beecher, BCL 
D. C. Ficke,	 B.S., Radiology 
T. J. Holmes, BCL 




The software development for Super PETT I as described in PR 19, D-5 
has continued to be useful in prototype studies of the instrument. The 
list-mode, projection-array, and hybrid list-mode data collection protocols 
have remained unchanged over the past year and are in routine use. 
Auxiliary software to utilize the slice processors as offline array 
processors is still under consideration; however, this is not considered 






0-6. Time-or-Flight Data Acquisition System Development for Super PETT I 
Personnel:	 T. J. Holmes, BCL 
G. J. Blaine, BCL I 
D. C. Ficke,	 B.S., Radiology 
S. R. Phillips, BCL 
D. A. Schwab, BCL IM. M. Ter-Pogossian, Ph.D., Radiology 
Support:	 RR 01380 
HL 13851 I 
HL 17646 
I
The data acquisition system1 of Super PETT I consists of high-speed 
digital electronics for processing positron-annihilation positional­
measurements as they occur. When operating in the "list mode," the Idigitally encoded measurements are routed as they occur, at a maximum rate 
of 200,000 per second, to disk storage and are retrospectively retrieved 
for imaging. When operating in the "pre-processing mode," the measurements 
are processed as they occur at a maximum rate of 380,000 per second to I 
construct conventional projection arrays while using the time-of-flight 
measurements to rej ect most of the random-coincidences (0-10). In the 
"hybrid list-mode" the raw digital code of each measurement is transformed Iinto fields representing angle, distance, and time-of-flight while 
correcting for calibration of the time-of-flight measurement and a physical 
translation of the photon-detector array. These corrected measurements are Ithen transferred to disk storage as in the list-mode while they occur at a 
maximum rate of 200,000 per second. The pre-processing and hybrid 
list-mode are made possible by seven microcoded "slice-processors".2 I 
The Super PETT I instrument became operational in the list mod~ 
during May of 1982 and has since been used for medical research studies. 
At the present time, the seven slice-processors have been installed, and I
microcode for both the pre-processing and hybrid list modes has been 
written and tested. Preliminary tests with phantom radioactivity sources 
have shown occasional artifacts in the pre-processing mode. We have 
determined these artifacts to be due to capacitive signal coupling and I 
transmission-line reflections on the busses which transfer the measurements 
between various data-acquisition devices. Our current efforts are in 
addressing these bus anomalies while continuing to test the reliability of I 
the instrument. 
Current plans for the utilization of the system are as follows. The Ipre-processing mode is to be used for obtaining calibration data mentioned 
in PR 19, 0-13 and for obtaining conventional emission-images within a few 
minutes following data collection. Images reconstructed by the 
time-of-flight method1 will be obtained from list-mode data. The hybrid I 
list-mode may be used in the future if it becomes necessary to enhance the 




































1.	 G. J. Blaine, D. C. Ficke, R. E. Hitchens, and T. J. Holmes, "Data 
Acquisition Aspects of Super-PETT," IEEE Transactions on Nuclear 
Science, vol. NS-29, no. 1, pp. 544-547, February 1982. 
2.	 T. J. Holmes, R. E. Hitchens, G. J. Blaine, D. C. Ficke, and D. L. 
Snyder, "A Dedicated Hardware Architecture for Data Acquisition and 
Processing in a Time-of-Flight Emission Tomography System 
(Super-PETT)," IEEE Transactions on Nuclear Science, vol. NS-30, 
no. 1, pp. 170-174, February 1983. 
D-7. A Reduced Angle Reconstruction Algorithm for Super PETT I 
Personnel:	 D. G. Politte, M.S., Radiology 
D. E. Beecher, BCL 
D. C. Ficke,	 B.S., Radiology 
G. R. Hoffman, B.A., Radiology 
Support:	 RR 01380 
HL 13851 
HL 17646 
A new sof tware reconstruction system which uses the "reduced-angle" 
technique has been designed, implemented, and tested during the past year. 
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The memory requirements of the new 16-angle measurement array are 
only one-sixth as great as that of the 96-angle array. Therefore, data 
from several image slices can be accommodated in memory simultaneously . 
With the current memory of the Perkin-Elmer 3230 host computer, only two 
passes through the list-mode data file are required. (The first pass 
processes image slices 1 through 4; the second pass finishes with slices 5 
through 7). In addition, some of the subsequent processing steps, such as 
confidence-weighting and the coordinate transformation and superposition 
which form the preimage, are angle dependent and the time needed for their 
The angle reduction occurs because of the way the data are organized 
into a three-dimensional array of measurement points. Previously, the data 
had been organized into an array with three indices representing 96 
distinct angles, 128 distances from the center of the scanner, and 40 
differential time-of-flight values. In the new reduced angle scheme, data 
from 16 groups of 6 adjacent angles are coalesced so that the angle index 
of the measurement array now takes on 16 values. When the data are parsed 
into the 16 group angles, the distance and time-of-flight values are 
adjusted so that the location in space of the measurement point is 
unaffected, to within the quantization error. This reduced-angle 
measurement array is then reconstructed as before. 
This technique is due to Tomitani,1 who showed by simulation that the 
angular sampling requirements of time-of-flight tomography are less than 























computation scales linearly with the number of angles. The time to process 
7 slices of emission data with approximately one million counts per slice 
has been reduced from two and one half hours to forty-five minutes, 
assuming that the processing of the blank and transmission scans (used for 
calibration and data correction) has already been done. 
Images reconstructed from data organized into measurement arrays 
with 96 and 16 angles have been shown by Ficke to be of comparable 
quality.2 
1.	 T. Tomitani, "Simulation Study of Reconstruction with Practical 
Writing Functions and Noise Evaluation in Time-of-Flight Assisted 
Positron Computed Tomography," Proceedings of the Workshop on 
Time-of-Flight Tomography, IEEE Catalog No. 82CH1791-3, Washington 
University, St. Louis, Missouri, pp. 117-124, May 1982. 
2.	 D. C. Ficke, D. E. Beecher, G. R. Hoffman, T. J. Holmes, and M. M. 
Ter-Pogossian, "Recent Developments in Image Reconstruction Using a 
Time-of-Fl1ght Assisted Posi tron Emission Tomograph: Super PETT I," 
IEEE Transactions on Nuclear Science, vol. NS-31 , no. 1, pp. 605-608, 
February 1984. 
D-8.	 A Comparative Study of Image-Reconstruction Approaches for Super 
PETT I 
Personnel:	 D. G. Politte, M.S., Radiology 
D. L. Snyder, BCL 




We have compared the performance of two image-reconstruction 
algorithms for time-of-flight tomography, the confidence-weighting (CW)1 
algorithm and the estimated posterior-density weighting (EPDW) algorithm. 2 
The EPDW algorithm is a non-linear iterative approach, and predicting its 
performance analytically has proven intractable. Therefore, our approach 
for comparison has been to implement both algorithms on real and simulated 
data in order to compare specific performance-metrics. The results have 
been reported;3,4 we briefly summarize them below. 
Resolution. The CW algorithm uses an adjustable filter which 
controls the resolution of the images. The resolution is a measure of the 
smallest features which are distinct. The best resolution obtainable by 
the CW algorithm is limited by the geometric resolution, which is a 
function of the detector size and placement. However, we have found that 
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features as small as half of the geometric resolution can be made distinct 
with the EPDWalgorithm. 
Signal-to-noise ratio. We find that the EPDW algorithm improves the 
signal-to-noise ratio in the myocardium of a simulated left ventricle by at 
least 2.1 db over the CW reconstruction. The amount of gain is dependent 
on the resolution of the image and is greatest when the resolution is best. 
Contrast. The EPDW algorithm provides superior contrast between the 
simulated left ventricle and its blood pool. 
Background artifact. Registration of activity in regions where 
there is none is lessened with the EPDWalgorithm. 
Reconstruction time. Computation of images with the EPDW algorithm 
is approximately 100 times slower than the computation of images with the 
CWalgorithm. 
The current implementations of the EPDW algorithm are too slow for 
routine clinical use. Further research is needed to explore methods for 
speeding its computation. 
1.	 D. L. Snyder, L. J. Thomas, Jr., and M. M. Ter-Pogossian, "A 
Mathematical Model for Positron-Emission Tomography Systems Having 
Time-of-Flight Measurements," IEEE Transactions on Nuclear Science, 
vol. NS-28, no. 3, pp. 3575-3583, June 1981. 
2.	 D. L. Snyder and D. G. Politte, "Image Reconstruction from List-Mode 
Data in an Emission Tomography System Having Time-of-Flight 
Measurements," IEEE Transactions on Nuclear Science, vol. NS-30, no. 
3, pp. 1843-1849, June 1983. 
3.	 D. G. Politte and D. L. Snyder, "Results of a Comparative Study of a 
Reconstruction Procedure for Producing Improved Estimates of 
Radioactivity Distributions in Time-of-Flight Emission Tomography," 
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 614-619, 
February 1984. 
4.	 D. G. Politte, "Reconstruction Algori thIns for Time-of-Flight Assisted 
Pos i tron-Emi ss ion Tomographs," Department of Electrical Engineering, 






D-9.	 Count Normalization for Conventional and Time-of-Flight Tomography 
Personnel:	 T. J. Holmes, BCL 
D. C. Ficke, B.S., Radiology I
 
D. L. Snyder, BCL 








Two of the fundamental operations of a positron-emission tomograph 
are the sorting and counting of discrete recordings of positron­ I
 
annihilation events according to measurement vectors which they carry. 
Part of the reconstruction process includes the normalization of these 
counts with respect to scintillation-detector efficiency, spatial-sampling I
density, and photon absorption. There are several ways to combine and 
normalize these counts during the image-reconstruction process. We have 
performed a statistical analysis on these methods to determine their 
relative performance. The combined, normalized counts are treated as I
 
parameter estimators, and the metrics of their performances are their
 
biases and variances. These results have been published,1 and have
 
implications on the complexity of the reconstruction process.
 I
 
1.	 T. J. Holmes, D. L. Snyder, and D. C. Ficke, "A Statistical Analysis 
of Count Normalization Methods Used in Positron-Emission Tomography," I
 






D-10.	 Modeling of Random-Coincidence Detections in Time-of-Flight 
Tomography I
 
Personnel:	 T. J. Holmes, BCL 
D. C. Ficke, B.S., Radiology 












A random coincidence is defined as the erroneous registration of two 
photons, originating from separate positron annihilations, as having 
originated from the same positron annihilation. Previous analyses which I
did not consider random coincidences indicated that for a certain 






In addition to improvements in signal-to-noise ratio, the trends in 
positron-emission tomography have been toward images of higher resolution. 
The fundamental parameter that determines this metric is the width of the 
scintillation-detector crystal. With linear-filtering reconstruction 
methods, a resolution of approximately 0.6 of the detector width is 
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I 5 dB is achieved by the time-of-flight method over the conventional method. 
Subsequent experiments1 have validated this prediction in low counting rate 





tl significantly larger gain of about 9 dB, which was attributed to the way in 
which the time-of-flight method suppresses the degrading effects of random 
coincidences.~.,.c.1 
We have developed and published an analytical model2 which extends a 
previous model 3 to consider random coincidences. Calculations of signal­
to-noise ratio, using this model, compare well wi th the experiments and 
show that the additional gain is indeed due to the treatment of random 
coincidences. An understanding of the model leads to an intuitive 
explanation of the gain mechanism and a determination of an effective 
..·,·'·'I' 
;~-
".t·'I· coincidence-timing window that is achieved by the time-of-flight method. 
}J 
I 1. M. Yamamoto, D. C. Ficke, and M. M. Ter-Pogossian, "Experimental 
I 
Assessment of the Gain Achieved by the Utilization of Time-of-Flight 
Information in a Posi tron Emission Tomograph (Super PETT I)," IEEE 
Transactions in Medical Imaging, vol. MI-1, pp. 187-192, November 
1982. 
tl 2. T. J. Holmes, D. L. Snyder, and D. C. Ficke, "The Effect of Accidental Coincidences in Time-of-Flight Positron Emission Tomography," IEEE 
Transactions in Medical Imaging, to appear. 










Mathematical Model for Positron-Emission Tomography Systems Having 
Time-of-Flight Measurements," IEEE Transactions on Nuclear Science, 
vol. NS-28, pp. 3575-3583, June 1981. '~'I 
(~C,I 
\' 0-11. Effects of Positron-Emission Tomography Scintillation Detectors on ~UI Resolution and Sensitivity 
I}~'k''\-(; Personnel: T. J. Holmes, BCL 
D. C. Ficke, B.S., Radiology~.'I·7: M. M. Ter-Pogossian, Ph.D., Radiology 
""
Support: RR 01380 
~(,1'1 
I 
Iapproximately equal to the full-width at half-maximum (FWHM) of the line­
spread function seen in the center of a conventional projection array. 
This FWHM is not constant throughout the profile. It is I
significantly greater at the edges of the profile, manifesting a 
degradation in image resolution, because the geometry of the scintillation 
detectors is such that the gamma-photons penetrate a crystal and are Ierroneously absorbed by adjacent crystals. The chosen crystal-geometry and 
inter-crystal septa have an impact on this phenomenon and on the detector 
sensitivity, which depends upon the radiation's angle of incidence. I 
Exploiting the methods of Lecomte et al,1 we have analyzed various 
high-resolution scintillation detectors for resolution and sensitivity. In 
particular, the effects of using a triangle-shaped face and inter-crystal I 
septa are studied for both BaF2 and BGO crystals. The results indicate 
that usage of the tungsten septa alone causes an improvement in resolution 
in areas away from the center of the image but also causes a degradation in Isensitivity in those areas, and that usage of a triangle face alone causes 
no improvement in resolution, while usage of septa and a triangle face in 
combination causes a similar resolution improvement with a lesser 
degradation in sensitivity. Current plans are to analyze a wider range of I 
detector geometries at various angles of incidence. 
I1•	 R. Lecomte, D. Schmitt, and G. Lamoureux, "Geometry Study of a High 
Resolution PET Detection System Using Small Detectors," IEEE 





0-12. Studies of Detector Electronics for Time-of-Flight Tomography ISystems 
Personnel:	 R. O. Gregory, BCL IG. L. Engel, BCL 
Support:	 RR 01380 
RR 01828 I
Washington University 
IDuring this time period, work was initiated on a novel gamma ray 
detector. In time-of-flight positron-emission tomography machines, such as 
Super PETT I and II, gamma photons are detected via their interaction with 
a scintillator crystal and a photomultiplier tUbe. The intent of the novel I 
detector is	 to combine the scintillator and photomultiplier tUbe in one 
structure, with a view towards an improvement 
of the time-of-flight measurement. A proposal 
and Human Services in Spring 1983 describes 
detail. 1 
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in time and space resolution 





Work carried out subsequent to July 1, 1983 has been mainly in the 
area of photocathode deposition. We have been depositing thin films of 
antimony and alkali metals, including cesium, sodium, and rubidium, on 
glass substrates and measuring their photoemissive characteristics. These 
materials, deposited in the proper proportions, constitute the bulk of 
commercial photocathodes described in the literature. Development of this 
technique was felt to be necessary because photocathodes, once deposited, 
are extremely sensitive to trace amounts of oxygen or water vapor and so 
are not transportable outside of an ultra high vacuum environment. We have 
deposited photocathodes with what appears to be adequate quantum 
efficiency; however, we have not been able to obtain photocathodes whose 
photo-emission does not deteriorate with time. We have concluded that the 
reason for this is because we have been depositing the photocathodes in a 
large6 demountable vacuum system with attainable vacuums in the 5x10-7 to 5x10- range. Although these vacuum values are within the range considered 
appropriate for this work,2 in large systems the attainable vacuum is 
strongly dependent on the pumping rate and a high capacity pump may mask 
leaks that would be apparent in a smaller or non-pumped enclosure. The 
solution is to move to a small, bakeable envelope, which is in fact the 
technique used in ordinary photomultiplier construction where evaporation 
takes place from sources placed within the tube itself. Although we are 
reluctant to do so because our available volume is small, it appears that 
we will have to move to this technique also; and so we are in the process 
of assembling suitably small emission sources and arranging with a glass 
blower for the necessary envelope. 
1.	 "A New Approach to Fast Gamma-Radiation Detection," Grant Application 
to DHHS under the BRP Small Grants Program for Pilot Projects, January 
27, 1983. 
2.	 A. H. Sommer, Photoemissive Materials: Preparation, Properties, and 
Uses, John Wiley, New York, 1968. 
D-13. Maximum-Likelihood Estimation of Parameters in Dynamic Tracer 
Studies 
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The primary advantage of positron emission tomography over other 
imaging modalities is its ability to provide information on physiological 
and biochemical processes. Although this information is both temporally 






The temporal aspects and display only the spatial variations of the data.
 
The goal of this research is to utilize the time-dependency of the data to
 
estimate physiological parameters of interest.
 I 
Analyses of biological processes using compartmental models
 
represent the tracer activity distribution (intensity) as a linear
 
combination of the solutions to a set of linear differential equations.
 I
 
Physiological parameters of interest, e.g. blood flow or blood volume,
 
appear as coefficients in these equations. The intensity can therefore be
 
represented as a sum of decaying exponentials convolved with an input
 Ifunction: 
IM A 
A(t) a i(t) * L ~ exp(-t/Tm),
ma1 Tm I
 
where the input function, i(t), is proportional to the tracer concentration
 
within the blood, and is assumed to be known. Snyder 1 proposed a method I
 
which estimates the Am and Tm of this equation. The analytical solution of
 




The method can be summarized as follows. After a number of images
 
have been reconstructed, regions of interest are specified in each. Data
 
from the images are then used to weight each event in the list-mode data
 I
 
with the probability that it occurred in the region of interest •. The EM
 
algorithm of statistics, as discussed by Dempster, Laird, and Rubin,2 is
 
then used to find the maximum-likelihood estimates of the parameters from
 I 
histograms formed from the weighted list-mode data. The number of
 
reconstructed images is small, perhaps only one in some clinical studies.
 
The principal advantage of the EM algorithm over other maximum-likelihood
 Itechniques is that it decouples the set of equations which must be solved. 
Evaluation of the method to date has concentrated on the estimation 
step. I
Testing of the histogram-generation step will be done in the near 
future. 
The algorithm was evaluated for a bolus input-function by comparing
 Iit to a gradient method of maximum-likelihood estimation proposed by
 
3
Markham,3 which in turn was compared favorably to several other methods. 
The EM algorithm always converged to a unique solution, even for very poor
 
initial estimates. The variance of the estimation error and the bias were
 I
 
consistently lower than that of the gradient method, and were considerably
 
better for small numbers of bins. This algorithm is, therefore, an
 
attractive approach for an impulsive input-function.
 I 
The extended algorithm for arbitrary input functions is of greater
 
practical interest, since non-bolus input functions are frequently
 Iencountered in practice. This algorithm is currently being evaluated. 
Issues to be addressed include the uniqueness of the solution, sensitivity 





form of physiological parameters measured in other tests. This version of 
the algorithm could be applied to several experiments currently being 
performed at the Mallinckrodt Institute of Radiology if these issues are 
satisfactorily resolved. 
1.	 D. L. Snyder, "Parameter Estimation for Dynamic Studies in Emission 
Tomography Systems Having List-Mode Data," IEEE Transactions on 
Nuclear Science, no. 2, pp. 925-932, April 1984. 
2.	 A. P. Dempster, N. M. Laird, and D. B. Rubin, "Maximum Likelihood 
from Incomplete Data via the EM Algorithm," J. R. Statistical 
Society, vol. 39, pp. 1-38, 1977. 
3.	 J. Markham, D. L. Snyder, and J. R. Cox, Jr., "A Numerical 
Implementation of the Maximum-Likelihood Method of Parameter 
Estimation for Tracer-Kinetic Data," Mathematical Biosciences, 
no. 28, pp. 275-300, 1976. 
0-14.	 Utilization of Side Information in Image Reconstruction 
Personnel: D. L. Snyder, BCL 
Support: RR 01380 
RR 01379 
ECS 8215181 
Anatomical information derived from x-ray and magnetic-resonance 
tomographic sections is useful for producing mare accurate reconstructions 
of radioactivity distributions in the same section from emission-tomography 
data. Additionally, attenuation information acquired for calibration in 
emission tomography is necessary for producing accurate reconstructions of 
activity. An algorithm based on the maximum-likelihood method of 
statistics has been identified for utilizing both of these forms of side 
information. 1 
1.	 D. L. Snyder, "Utilizing Side Information in Emission Tomography," 
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 533-537, 
February 1984. 
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0-15.	 Effects of Finite-Precision Arithmetic on the Maximum-Likelihood 
Algorithm for PETT Image Reconstruction 
Personnel: J. O. Gorman, BCL 
O. L. Snyder, BCL 
Support: RR 01380 
RR 01379 
ECS 8215181 
Since the introduction of the maximum-likelihood algorithm for PET 
image reconstruction,1,2 there has been increasing interest among 
researchers to use this algorithm for reconstruction in clinical studies. 
Although the algorithm has produced better images than other available PET 
reconstruction techniques,3 it is also more computationally burdensome. 
Reconstruction times for the maximum-likelihood algorithm implemented on a 
VAX-class machine are too long for the algorithm to be of practical use 
clinically. A specialized hardware processor, perhaps implemented using 
VLSI,4 could supply the additional computational speed needed to make the 
algorithm useful in the clinical environment. 
A study has been initiated to investigate the effects of finite­
length registers and finite-precision arithmetic on the algorithm. 
Knowledge of the effects of fixed-point arithmetic and tradeoffs in image 
quality as a function of register sizes are the first steps toward an 
efficient hardware implementation of the algorithm. 
1.	 L. A. Shepp and Y. Vardi, "Maximum-Likelihood Reconstruction for 
Emission Tomography," IEEE Transactions in Medical Imaging, vol. MI-1, 
no. 2, pp. 113-121, October 1982. 
2.	 O. L. Snyder and O. G. Politte, "Image Reconstruction from List-Mode 
Data in an Emission Tomography System Having Time-of-Flight 
Measurements," IEEE Transactions on Nuclear Science, vol. NS-30, 
no. 3, pp. 1843-1849, June 1983. 
3.	 o. G. Politte and O. L. Snyder, "Results of a Comparative Study of a 
Reconstruction Procedure for Producing Improved Estimates of 
Radioacti vi ty 0 istri but ions in Time-of-Flight Emission Tomography," 
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 614-619, 
February 1984. 
4.	 C. E. Molnar, "VLSI Systems for Time-of Flight PET," Proceedings of 
Workshop on Time-of-Flight Tomography, IEEE Catalog No. 82CH1791-3, 
Washington University, St. Louis, Missouri, pp. 167-170, May 1982. 
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D-16. Slice	 Processor Selection for Super PETT II 
Personnel:	 D. E. Beecher, BCL 
D. C. Ficke,	 B.S., Radiology 
Support:	 RR 01380 
HL 13851 
The motivation for the utilization of seven slice-processors is a 
result of considerable experience gained in the design, fabrication, and 
use of Super PETT I, which uses the list-mode data collection and time-of­
flight information in the image-reconstruction process. While these two 
concepts have proven to be useful and desirable, they both place high 
demands on the supporting computer system. 
The incorporation of list-mode data-collection requires list-mode 
events first to be buffered in computer memory and then transferred to disk 
as they occur. If lOOK events/second is used as a target goal for the 
count rate in each slice, the computer system's I/O throughput capacity 
must be able to sustain 1.4M bytes/second, and the disk subsystem must be 
able to sustain a 700K event/second rate. 
In addition, the proper incorporation of the time-of-flight 
information and its associated correction factors for the "confidence 
weighted" pre-image and the subsequent two-dimensional f 11 ter ing to form 
final images are formidable CPU intensive tasks. This problem is 
compounded by processing seven simultaneously collected slices from the 
event list. 
In the development of Super PETT I, it was recognized that auxiliary 
processing power was necessary to use the time-of-flight information 
effectively. For this reason, seven specialized slice-processors were 
designed and built to form attenuation arrays and aid in on-the-fly data 
corrections before recording the data in the event list. From this 
experience it was apparent that the design, fabrication, debugging and 
software development involved in such specialized hardware components was a 
formidable task and has yielded results which are less than desirable, 
although at that time this approach was perhaps the only available. In 
Super PETT I, the event rate is limited to about 400K events/second in the 
list-mode, and post processing requires about 35 minutes for a set of seven 
slices, each containing about 1 million events. 
Recently however, several commercially available 32-bit processors 
were introduced which we felt could be used successfully in this 
environment, and we began to explore these possibilities for Super PETT II. 
There are several reasons why this particular approach is very attractive. 
The general scheme consisting of individual low-cost processors and disks 
for each slice very much improves total system event-rates since each slice 
is serviced by a single processor and disk. This implies no contention 
between slices for DMA input and storage. The reconstruction process is 
also enhanced by allowing each slice processor to reconstruct one slice in 





that these systems are equipped with the total complement of support 
software found on larger machines which greatly reduces the software 
development time associated with the slice processors. Vendor supplied 
systems can also be placed under maintenance contracts to avoid excessive I 
down time due to hardware and software related problems. 
Several systems were examined and tested to determine their Ipotential usefulness. They were: Perkin-Elmer 3205, Digital Equipment 
Corporation (DEC) Micro-VAX, and Hewlett-Packard (H-P) 9000. Due to our 
existing in-hoUse expertise with Perkin-Elmer, we were somewhat predisposed 
to a Perkin-Elmer solution if indeed it proved to be competitively cost­ I 
effective. However, we realized that it could be advantageous to switch to 
DEC or H-P if conditions dictated. In an evaluation effort, we designed a 
specialized interface to simulate event generation from Super PETT II and I 
ran a series of tests involving the list-mode data transfer and the ability 
to do on-the-fly processing. We ran these tests initially on the Perkin­
Elmer 3205 and obtained good results with the ability to collect Iapproximately 200K bytes/second of event data per slice. With proper 
hardware preprocessing each event may be reduced to 2 bytes yielding 700K 
events/second for the entire system. For instance, one preprocessing 
strategy reduces each event to 5 bits of angle information, 4 bits of time­ I 
of-flight information, and 7 bits of displacement information. 
Similar tests on a Micro-VAX system yielded only 120K bytes/second I
from a single slice which translates into 420K events/second for the total 
system. This drop in effective throughput was deemed unacceptable given 
that the Micro-VAX and 3205 are comparably priced. The H-P 9000 was not Idirectly tested. However, we did speak at length with H-P technical 
personnel and discovered that the 9000 did not readily allow the 
incorporation of custom-designed interfaces; and the machines cost was 
substantially higher than that of the Micro-VAX or the 3205. I 
The combination of price, performance, and compatibility indicated 
that the 3205 was the best choice for this application. The Perkin-Elmer I3205 processor is implemented as a single-board CPU with built-in hardware 
floating point, a high-speed DMA port, and memory which can be expanded on 
the single board to 1 megabyte. An additional memory board can be added to 
expand the total memory to 4 megabytes. A second board contains the I 
medium-speed multiplexor bus, a multiple peripheral controller, universal 
clock, watchdog timer, loader storage unit, 8-line communications 
mUltiplexor, line printer interface, and high-speed data handling I 
capabilities. Figure 1 shows the internal configuration of a single slice 
processor. Each 3205 is also configured with an 80 megabyte fixed disk 
drive fo~ data storage and a dual-port option for intersystem I
communication. Figure 2 illustrates the entire proposed configuration to 
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D-17. Super PETT II Detector Design 
~'.'[11
g;,'~ Personnel: D. C. Ficke, B.S., Radiology 
l· T. J. Holmes, BCL~'. 
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Figure 1. The Super PETT II petector module is shown with its 
measured spatial resolution. 
3000 
A new detector module has been designed, fabricated, and tested for 
use in Super PETT II, a time-of-flight assisted positron-emission tomograph 
which is currently being developed. 
M. M. Ter-Pogossian, Ph.D., Radiology 
When this module is tested by scanning a line source, the response 
as shown in Figure 1 is obtained which indicates a spatial resolution of 
4 mm FWHM. 
Support: 
The detector module as shown in Figure 1 consists of eight barium­
fluoride scintillation-detectors coupled to five high speed photomultiplier 
tubes. In this arrangement, four tubes are each coupled to two detectors 
for the purpose of photon timing and energy information, while the central 
tube is coupled to four detectors for resolving the photon positional 











I0-18. Three-Dimensional Image Construction and Display 
Personnel: D. E. Beecher, BCL 
J. R. Cox, Jr., BCL I
L. J. Thomas, Jr., BCL 
Support: RR 01380 IHL 13851 
Work has continued on the research as described in (PR 19, 0-6) and I 
the results of this research have been published. 1 Further research is 
planned in the following areas: I1. Three-Dimensional Object Definition 
Current techniques employ a simple thresholding algorithm to define Ithe object(s) of interest in a scene. Although this technique has proven 
to be useful in pilot studies, new techniques are being explored in order 
to define three-dimensional objects more effectively. Gradient techniques 
which define object boundaries based on changes in a local neighborhood may I 
yield superior results. Also transparency techniques may prove to be quite 
effective in alleviating the need to do any object definition. I2. Parallelism 
The algorithm as described in (1) has a very high degree of 
parallelism which may be exploited via a custom-designed VLSI I 
implementation. This may make real-time shaded-surface display possible. 
3. Shading Algorithms I 
Initial efforts in this area were very simplistic in that only a 
depth cue was utilized to produce the three-dimensional effect. Much work Iis planned in this area to improve the visualization by enhancing the 
shading algorithm used in view generation. The concept of local 
neighborhoods will be studied to determine the orientation of planes which 
may exist within the object. This information when combined with angle I 
information, should substantially improve the views generated. 
4. Generation of Non-Orthogonal Views I 
The system as originally implemented generates only orthogonal views 
of the voxel volume. Generation of non-orthogonal views will require Islight modifications of the original algorithm but should not substantially 
increase view generation time. 
5. Multiple-Intensity Level Displays I 
The current scheme thresholds at a single intensity level to 
determine an object space. However if color is used as a secondary cue, I
multiple intensity levels can be displayed simultaneously which should 
improve the contextual information contained in the visualization. 
I 
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1.	 D. E. Beecher, J. R. Cox, Jr., and L. J. ThOlllas, Jr., "A New Voxel­
Model Approach for Three-Dimensional View Generation," Proceedings of 
the Eighth Conference on Computers in Radiology, St. Louis, Missouri, 
May 23-25, 1984, in press. 
D-19.	 Maximum-Likelihood Estimation for Single-Photon Emission Computed 
Tomography 
Personnel:	 D. L. Snyder, BCL 
M. I. Miller, BCL 
T. R. Miller, Radiology 




An algorithm is being developed for producing maximum-likelihood 
estimates of activity distributions for emission-tomography systems which 
employ tracers that emit single photons. This algorithm takes into account 
both the depth-dependent point spread function of single-photon detectors 
and the non-uniform attenuation of photons from the emission point to the 
detector. More accurate quantitative reconstructions of activity 





E. Systems for Specialized Biomedical Studies 
This section reports on a variety of instruments, systems, and 
methods which are not easily grouped under the major report headings. I
 
There is one common thread; much of the work relates directly to the
 
nervous system. For example, the data recording system described in PR-19
 
(E-3) is being combined with a versatile and remotely controllable signal
 I
amplifier and conditioner. This should find general application in future 
projects. In a related study large-scale electrode arrays receive signals 
from the brain which are then analyzed by computers. I
 
Electrical concomitants of nervous system actiVity are no longer the 
only minimally invasive method of studying the functional anatomy of the 
brain. The PETT system shows promise of displaying a variety of responses I
 
to sensory stimulation and software for this purpose is under development. 
Studies of the auditory nervous system are helped by the application I
of statistical methods originally designed for use in nuclear medicine, 
whilst a computer is providing information on the responses of the eye to 
colored stimuli. This is finding clinical use in cases with retinal or 
optic nerve diseases. The remaining neurological project has been the I
 
introduction of the autoradiographic analysis method, using computer
 
imaging of silver grains, to the Laboratory for Neuro Imaging (LONI) where
 
it is co-located with larger computer systems.
 I
 
There are a number of projects which involve the development of 
specialized mathematical 
imaging and work continues 
restriction mapping. 
algorithms especially related to biomedical I





















E-1.	 An Automated Autoradiographic Analysis System for Neuroanatomical 
Studies 
\;-I 
Personnel:	 R. E. Hermes, BCL 
E. G. Jones, M.D., Ph.D., Anatomy 
S. R. Phillips, BCL 
J. L. Price, Ph.D., Anatomy 





The silver grain counting system developed several years ago for 
automated analysis of neuroanatomical autoradiographs (PR 18, C-1; PR 19, 
E-1) was moved to the Laboratory for Neuro Imaging (LONI). The LONI 
laboratory consists of a VAX 11/750 with an image display system. An 
Eikonix flat bed scanner for digitizing images of interest is interfaced to 
the VAX. The LONI system serves as a general resource for neuroanatomist 
and other researchers. Placement of the silver grain counting system in 
close proximity to the LONI system has made use of the system more 
convenient for users of both systems. 
The silver grain counting system has a well designed data 
acquisition and image display system. Data analysis software on the system 
is very specialized for the task of counting silver grains. The 
specialized nature of the analysis software has prohibited use of the 
system for other data ~nalysis problems which could take advantage of the 
data acquisition system. The current proximity of the LONI system makes 
possible the connection of the two systems where data may be acquired on 
the specialized syste~, and subsequent data analysis, display, and 
archiving may be conducted on the larger system. 
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IE-2. DNA Restriction-Mapping 
Personnel':	 J. G. Dunham, BCL and Electrical Engineering 
M. S. Frank, M.D., Genetics I 
M. V. Olson, Ph.D., Genetics 
M. R. Weber, Electrical Engineering ISupport:	 RR 01380 
GM 27889 
GM 28232 
Washington University I 
The DNA mapping project, under the direction of M. V. Olson of the I
Department of Genetics, will generate approximately 5000 fragments of DNA 
randomly sampled from a particular yeast. These fragments will be cloned 
using recombinant DNA techniques, completely digested with a restriction Ienzyme run on an agarose gel using electrophoretic techniques and 
photographed. An automated gel reading system was developed by BCL to 
determine the location of bands on the gel and has been reported. 1 I 
One effort has been to characterize the noise introduced by 
digitizing the gel photographs for further analysis. M. Weber has obtained 
a characterization of the system. 2 To summarize, an analysis of the I
various noise sources within the CCD camera of the digitizer suggests that 
the overall noise is a combination of Poisson and Gaussian components. 
Since these noises are quantized, the overall noise should appear as a Iquantized Gaussian whose variance is a linear function of the input light 
intensity. A histogram at 12 bits showed that the output was roughly a 
quantized Gaussian. In time, they were found to be uncorrelated, and hence 
independent. When Viewing a single sample, one gets approximately 6 bits I 
of useful information while temporal averaging of 32 samples yields 8 bits 
of useful information, useful in the sense that the true value is obtained 
with probability 0.95 or higher. After proper normalization, all the Ipixels seemed to consistently reflect the input intensity level on the 
average. However, a few pixels had a large variance, tending to fluctuate 
widely about the mean value. These wide fluctuations suggests that such 
pixels are unreliable and perhaps should be noted in later stages of I 
processing the digitized gel photographs. 
Accurate band detection and estimation of location is critical to I 
the success of the overall reconstruction of the yeast genome from the 
clones. A review early in the progress report period found that the 
original band detection algorithm was unsatisfactory for several reasons. ITwo approaches were undertaken to improve the band detection algorithms, an 
ad hoc approach by M. Frank and an analytic method based upon a statistical 
model of the overall gel photography by M. Weber. I 
The ad hoc approach by M. Frank reads the gel at two light intensity 
levels and attempts to compensate for nonuniform light intensities across 
the gel. First, peaks are detected which potentially correspond to bands. INext, several properties of the band shape are used to determine if a band 
is an isolated band or a cluster of bands. If an isolated band is found, I 
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then it is determined whether it is a singlet, doublet or triplet. If a 
cluster of bands is found, then further work is performed to determine how 
many bands are in the cluster and then their locations are estimated. The 
algorithm was implemented and found to yield improved performance over the 
original algorithm. 
Another approach was undertaken by M. Weber based upon a model 
described in Reference 2. Briefly, the model shows that the concentration 
of DNA from a band is approximately: 
-aX (x-J,J)2/202
C(x) • Co e e 
where x is the distance down the gel lance, Co is the actual DNA 
concentration, 2 is a factor related to gel mobility and the amount of time 
a gel is run, J,J is the true location of the band and 02 is the variance of 
the band shape. Since a negative is taken, the transmittance of the film 
is roughly proportional to 1/C(x) and implies that large concentrations 
appear as small transmittances. Some experimental work described in 
Reference 2 provides a partial verification of the model. 
Based upon the model for the digitizer noise process and the model 
for the band DNA concentration, a detector was developed using ideas from 
statistical detection and estimation theory. Two filters were developed, 
one to locate the center of bands and the other to estimate the 
concentration of DNA. Applying the filter to real data indicated that the 
approach has potential for estimating band location and concentration. 
Several potential problems were also observed. First, since a negative was 
taken, the digitized image must be numerically inverted and accuracy 
becomes a problem when using a linear analog/digital converter. Second, 
the large dynamic range of the light on the gel suggests that the gel needs 
to be" scanned at a multiple number of intensities, a conclusion 
independently reached by M. Frank. Third, not all gels give consistent 
results, for equimolar DNA samples. The cause of this problem has not been 
identified at the present time. Possible explanations include reciprocity 
failure of the film, incorrect film exposure and light-source problems. 
1.	 A. J. Gray, D. E. Beecher, and M. V. Olson, "Computer-Based Image 
Analysis of One-Dimensional Electrophoretic Gels Used for the 
Separation of DNA Restriction Fragments," Nucleic Acids Research, 
vol. 12, pp. 473-491, 1984. 
2.	 M. R. Weber, "Band Detection for DNA Electrophoretic Gels," Master of 
Science thesis, Department of Electrical Engineering, Washington 
University, St. Louis, Missouri, 1984. 
E-3. Development of Multi-Channel Analog Data Recorder 
Personnel:	 H. W. Shipton, BCL 
S. R. Broadstone, B.A., B.S., Electrical Engineering 
Support:	 RR 07054 
Washington University 
The prototype model described in PR-19 has been re-engineered and an 
improved filter system incorporated. The system has been tested in this 
new form but extensive trials in a realistic environment await the 
completion of the data acquisition system (E-4) with which the system will 
be packaged. 
E-4. Development of a Data Acquisition System 
Personnel:	 H. W. Shipton, BCL 
S. R. Broads tone , B.A., B.S., Electrical Engineering 
Support:	 Washington University 
Most biological amplifiers are direct descendants of the 
differential amplifiers developed early in the vacuum tube era and few 
systems exist which take advantage of the stability and reliability of 
solid state amplifiers. An investigation has been carried out into the 
desirable features of a "universal" biophysical amplifier than can be 
produced simply and incorporated into many different devices. The 
desirable features include low input-stage noise and the ability to accept 
high-impedance electrodes. They must also be capable of operating with 
considerable offset potentials since in clinical practice these often 
approach 200 millivolts. 
It is desirable that gain and filter settings be capable of control 
from devices (e.g. computers) which are located away from the biological 
preparation. 
The problem of common mode rejection ratio is frequently misstated. 
Obtaining ratios of the order of 130 db is trivial in a laboratory but 
neither necessary nor practicable under operational conditions. It is of 
considerable importance that CMRR should be preserved with 10-15% electrode 
impedance imbalances and also that it should not vary over the frequency 
range of the amplifier. 
Consideration of these factors led to the design of a system in 
which the input stage is a low gain JFET differential amplifier with a 
constant current injected into the source so as to stabilize the working 
point. It was found difficult to obtain a repeatable design owing to wide 
tolerances of obtainable commercial components. This stage is followed by 
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an instrumentation amplifier which has switch controllable gains in the 
sequence 1, 2, 5. Unfortunately, no available silicon switches have 
sufficiently low "on" resistances to permit them to be used to set the 
instrumentation amplifier. The necessity of using reed relays or DIP 
switches complicates gain control. It is understood that early next year 
at least one manufacturer will produce an instrumentation whose gain can be 
controlled by a typical computer bus. Samples of this are not yet 
available. 
A major advantage of the present system is that up to the output of 
the instrumentation amplifier, the system is directly coupled so that only 
one high pass filter occurs in the system. This has great advantages in 
minimizing blocking time, undesirable phase shifts and frequency dependent 
CMRR. The system can be adjusted over the entire range of commonly 
measured biophysical measurements by the adjustment of no more than one 
resistor and two capacitors. 
A multi-channel version of the system is currently undergoing tests 
and will form part of the analog tape system described in E-3. 
E-5. Color Perimetry Studies 
Personnel:	 W. M. Hart, Jr., M.D., Ph.D., Ophthalmology 





During the past year the color perimetry video system has been in 
clinical use at the Department of Ophthalmology. The system has been used 
for visual field evaluation of patients with known or suspected optic nerve 
and retinal diseases. The perimetry device consists of a color video~··.·Iy 
tangent screen with a diagonal size of 19 inches which is placed at a 
distance of 10 inches from the patient's eye. Colored test objects which.~rl· are square in shape and variable in size are presented on the tangent 
,. screen under real-time control by a graphics tablet. The test objects are 
of various colors and are presented in a background of a neutral gray 
color. Luminance values for the gray background and for the colored test~·I·t objects are calibrated by means of a digital video photometer which is used 
ii to generate a lookup table in the memory of a microcomputer (Motorola 
Exorset). Colored test objects are matched to a constant-luminance white 
':'.:'.i·
surround through the use of heterochromatic flicker photometry. Testil objects are	 then varied only in their size and degree of color saturation. 
Clinical studies1 ,2 over the past year have revealed that visual 
field defects resulting from retinal and optic nerve diseases, when plotted 
by color contrast perimetry, are identical in shape and size to those 
plotted by conventional luminance increment perimetry. No significant 
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difference was found either between the use of red or green vs blue test 
objects. Studies during the subsequent project year will involve the use 
of a yellow color for the adapting surround with test objects that are 
modulated in the blue direction from yellow passing through white into 
fully saturated blue. This strategy has been chosen because 
neurophysiologic studies of the primate visual system have revealed that 
the blue-yellow color-opponent channel is the only one that can be expected 
to be completely isolated from luminance difference detection mechanisms. 
1.	 W. M. Hart, Jr., R. K. Hagen, and K. W. Clark, "Color-Contrast 
Perimetry," Investigative Ophthalmology and Visual Science, 
vol. 25, pp. 400-413, 1984. 
2.	 W. M. Hart, Jr., and M. O. Gordon, "Color Perimetry of Glaucomatous 
Visual Field Defects," Ophthalmology, vol. 91, pp. 338-346, 1984. 
E-6. Isolated-Scintillation-Probe Data Acquisition System 
Personnel:	 D. E. Beecher, BCL 
H. D.	 Ambos, Medicine 
R. E.	 Hermes, BCL 
Support:	 RR 01380 
HL 13851 
HL 17646 
Hardware and software development has been initiated and continued 
over the past year using the newly acquired LSI 11/23 system configuration 
as described in PR-19, E-8. 
Software system development is now close to completion and will 
allow protocols not possible with the current configuration. The software 
system is highly modular which will allow the completed system to be easily 
maintained and modified in the future. Specifications are not yet complete 
for the analysis portion of the system, but will be developed shortly after 
the prototype has been finished. 
A new hardware probe interface has recently been developed and is 
now being tested on the new system. It utilizes a DMA interface to the 
LSI 11/23 and will enable real-time acquisition and display of the probe 
data. This will enable experiments to be aborted quickly if initial probe 
data curves are not promising. 
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E-7.	 Software Development for Neurological Sciences 
Personnel:	 D. E. Beecher, BCL 
P. T. Fox, M.D., Neurology and Radiology 
M. A. Mintun, M.D., Neurology 
Support:	 RR 01380 
NS 06833 
McDonnell Center for Studies of Higher Brain Function 
Work is currently underway on two separate neurology projects 
involving visual evoked response as measured by PET and redesign of a pre­
existing software system to analyze PET images. 
The software for visual evoked response is separated into three 
distinct subsystems. The first is a variable sized checkerboard pattern 
which has a user-selectable background and foreground colors. The 
remaining subsystems involve the generation of moving targets. The first 
generates a box of a specified size which can be moved at a user-selected 
rate. The moving target subsystems also have user-selectable background 
and foreground colors. 
The software system redesign involves a software analysis system 
which has been in place for several months. Although modifications are 
needed, the system is very large and the design is such that modifications 
to the existing code are very difficult. For this reason it was decided to 
redesign the system using structured desigrt techniques in order to make 
modifications and maintenance much more manageable than they are at 
present. Current efforts are concentrated on the development of libraries 
of low-level routines to handle the bulk of the device-dependent I/O 
functions necessary in a system of this size. Final system development 
should proceed rather qUickly after completion of the library primitives. 
E-8.	 Maximum-Likelihood Estimation Applied to Electron-Microscopic 
Autoradiography 
Personnel:	 M. I. Miller, BCL 
K. B. Larson, BCL 
J. E. Saffitz, M.D., Pathology 
D. L. Snyder, BCL 
L. J. Thomas, Jr., BCL 
Support:	 RR 01380 
Washington University 
For electron-microscopic (EM) autoradiography thin tissue sections 
containing beta-emitting radioactive material are overlayed by a 






and pass through the emulsion layers where they give rise to latent images 
which are subsequently developed into silver grains. The unused emulsion 
is dissolved. leaving final specimens consisting of thin sections Icontaining silver grains. the positions of which are a function of the 
distribution of radioactive tracer in the underlying tissue sections. The 
production of these autoradiographs at the electron microscopic level is a 
technique of growing importance as the tracer distributions offer a wealth I 
of information about the sites and activity levels of metabolic and 
pharmacologic processes of the subcellular organelles. We have developed 
new algorithms for localizing and quantifying. within ultrastructural I 
features. the radioisotope source distributions which are reflected in the 
observed silvep grain measurements. IThe quantitative analysis of EM autoradiographs used for identifying 
the distribution of radioactive sources must be a statistical one because 
of the nature of radioactive processes and the low number of radioactive 
events involved. Due to the nature of the radioactive emission spread. it I 
is not possible to assume a priori that a particular silver grain 
originated from radioactivity in the particular organelle over which it 
lies. Analytical methods taking both emission spread and cellular anatomy Iinto account are essential for estimating the relative concentrations of 
tracers in various cell compartments. One such analysis is the mask­
analysis technique of Salpeter and Bachmann' which may be used with the 
computer algorithm of Land and Salpeter. 2 The mask-analysis algorithm I 
utilizes a set of transparent plastic overlays (masks) containing 288 
equally probable source-grain pairs. each denoting the relative 
hypothetical positions of a point source of radiation and a silver grain I 
resulting from that point source. The hypothetical source-grain pairs are 
generated from a grain-distribution point-spread function that is 
characteristic of a given autoradiographic system and depends upon I
variables including isotope type. section thickness. emulsion type and 
thickness. and photographic parameters.,.3 The masks are manually placed 
over individual photographs and the tissue structures over which 
hypothetical source-grain pairs occur are recorded. The information I 
derived from the mask technique defines the relative sizes and 
juxtapositions of the tissue structures and is utilized to generate a table 
of transition probabilities which we call P(mli). All the algorithms I 
proposed to date are similar in that they require this table of transition­
probability estimates (Blackett and Parry4 call them cross-scatter 
estimates; Williams 5ca ll s them cross-fire estimates; Salpeter and 
coworkers3 call them source-to-grain probability pairs). The transition I 
probabilities p(mli) may be viewed as an estimate of the probability that a 
given disintegration occurring in one structure i may give rise to a silver 
grain measurement within some structure m. I 
Once the table of transition probability estimates has been 
generated. the silver grain measurement statistic N~in each organelle may Ibe computed using the circle method of Williams.~ The silver grain 
statistic Nm is generated by combining across all of the micrograph slices 
the number of silver grains located in a particUlar organelle structure m. 






least 8-10 silver grains measured in anyone organelle type. The Land and 
Salpeter routine minimizes the sum of the squared errors between the actual 
silver grain measurement statistics Nm and a linear weighted sum of the 
hypothetical estimates of the underlying sources of radioactivity. The 
squared-error statistic that is minimized is generally assumed to be 
Chi-squared, and it is for this reason that experiments are designed so 
that there are a minimum of 8-10 silver grains in anyone organelle. The 
distribution of radioactive-source estimates that minimizes the squared 
error statistic becomes the best guess of the distribution of the 
underlying radioactivity. 
One of the important features of the mask-analysis algorithm is that 
data derived from anyone micrograph are not preserved and processed 
individually for each EM slice. Rather, the silver grain measurement 
points are added within anyone organelle structure across all of the 
slices to generate the single measurement statistic Nm• Also, the 
transition probabilities are generated not for each slice geometry 
separately, but rather by applying to all of the different micrographs the 
mask method and then averaging these together to get estimates of the 
transition probabilities. It occurred to us that since the geometry of 
every EM slice is different, algorithms'which use the EM data obtained from 
each micrograph separately, may have a higher performance than those 
algorithms which average the measurement points together. Also, in using 
the mask method there are many overlays which must be applied to the large 
number of micrographs in order to obtain estimates of the transition 
probabilities. The errors in the radioactive-intensity estimates are due 
partly to statistical variations in the table of transition-probability 
estimates. These vary due to the random nature of the micrograph 
geometries and the limited sampling of the hypothetical source-grain pairs. 
Another issue which is of concern to us is that the mask method must be 
modified as the geometries of the cellular organelle structures change. 6,7 
Of particular difficulty are linear source compartments like cell 
membranes. Modifications to the point-spread function and mask setup must 
be included for proper utilization of the mask-analysis algorithm. 7 
From our study we have identified an algorithm using the technique 
of maximum-likelihood estimation based on Poisson emission and measurement 
statistics. Unlike present algorithms, our's uses knowledge of the number 
of measurements as well as the particular source geometry from which these 
measurements arose and then processes the data from each micrograph 
separately rather than the summed count statistic Nm• It maximizes the 
likelihood function of the data based on a recursive algorithm which is a 
nonlinear functional of the observed data and requires no minimum data 
collection in order for it to provide valid estimates of the radioactive 
intensities. Our algorithm does not use the mask analysis, nor does it 
generate the table of transition probabilities; what it requires is the 
form of the universal point-spread function describing the beta-particle 
emission spread. The maximum likelihood estimation scheme does not depend 







The new maximum-likelihood algorithm which we have developed for 
analyzing electron-microscopic autoradiographs is based on maximizing the I 
likelihood of observing the data by using a recursive procedure first 
introduced by Dempster, Laird and Rubin. 8 This approach was then used by 
Shepp and Vardi 9 and Snyder and coworkers10 ,11 for estimating radioactivity 
distributions in positron-emission tomography. The method we propose I 
utilizes information about the detected locations of the silver grain 
measurements to which the probability-density function representing the 
measurement uncertainty resulting from emission spread is applied. The I 
algorithm then recursively computes the most probable locations of the 
radioactive sources based on the maximum-likelihood method of statistics. 
The universal curves worked out empirically by Salpeter and coworkers1 ,3 I 
and analytically by us for isotopes used in autoradiography are used to 
describe the probability density of the measurement uncertainties. It 
exploits the a priori knowledge that we obtain from source modeling of the 
silver-grain emissions and measurements; i.e., the Poisson statistical I 
distribution of the emissions and the limit in measurement precision due to 
the finite silver-grain size and image spread. The results indicate that 
the data-acquisition requirements for the maximum-likelihood algorithm are I 
more extensive than those necessary for the mask-analysis algorithm, 
although our method does lend itself to computer-assisted data acquisition. 
The wide variation in geometries in the different micrographs dictates that I 
the measurements from each micrograph slice must be processed individually 
before estimates of the radioactive intensity within particular structures 
are derived from the array of micrographs. 
I 
1.	 M. M. Salpeter, and L. Bachmann, "Autoradiography," in Principles and 
Techniques of Electron Microscopy, Biological Applications, M. A. IHayat, ed., Van Nostrand Reinhold, New York, 1972. 
2.	 B. Land, and E. E. Salpeter, "Basis for Computer Program for Mask 
Analysis of EM Autoradiographs," Journal of Cell Biology, vol. 76, I 
p. 142, 1978. 
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Emission Tomography," IEEE Transactions on Medical Imaging, vol. 
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Measurements," IEEE Transactions on Nuclear Science, vol. NS-30, 
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E-9. Maximum-Likelihood Estimation of Auditory Nerve Fiber Responses 
Personnel:	 M. I. Miller, BCL 
W. R.	 Bosch, M.S., Computer Systems Laboratory 
C. E.	 Molnar, SC.D., Computer Systems Laboratory 
Support:	 RR 01380 
GM 07564 
RR 01379 
Many investigators have inferred details about intra-cochlear 
mechanisms by collecting data from the responses of single cochlear nerve 
fibers. These histograms are in general distorted by the existence of 
neural refractoriness; that is, the occurrence of a spike decreases the 
likelihood of a succeeding spike. Gray1 demonstrated that the relative 
frequency of discharge conditioned on the time r since a previous spike 
rises monotonically with r and levels off after 20-25 msec. Gray 
interpreted this as indicating a gradual recovery of the nerve fiber's 
excitability over an approximately 25 msec interval following a spike 
discharge. He concluded that the conventional PST histogram reflected the 
combination of both the characteristics of the stimulus related function 
and the refractory characteristics of the nerve fiber resulting in the 
observed recovery effects. More recently, Gaumond and coworkers2 have 
demonstrated significant differences between post-stimulus-time (PST) 
histogram estimates and estimates of the stimulus related function which 
have compensated for the recovery based distortion. Johnson and Swami 3 






which contain recovery functions that are similar in form to those measured 
by Gray and Gaumond, distortion is introduced that depends on both the 
signal being estimated and the recovery function. I 
For any studies which formulate mathematical and physical models of 
the cochlea based on neural discharges, it would be desirable to have 
histograms for which the recovery related distortion has been removed. I 
Gaumond has developed and applied a method for this compensation by 
separating post-spike recovery from the important stimulus related function 
that results from intracochlear mechanics. His model for neural discharge I 
basically contains two components. The first results from the excitation 
of the fiber, which is closely related to the mechanical motion of cochlear 
structures and the resulting action of the hair cells. The second Icomponent is related to the refractory properties of the nerve fiber and 
results in the neurons demonstrating recovery effects; i.e., an increase in 
the probability of discharge as the time since the previous spike 
increases. He denotes these functions as set) and r(r) respectively and I 
demonstrates that a reasonable model for the probability of discharge of 
the nerve fiber at time t is the product of these two functions. From this 
model, estimates can be derived for the set) and r(r) functions separately Iby maximizing the joint likelihood equations of having observed the neural 
event process. The likelihood equations of Gaumond that arise are based on 
a Markov-chain model of neural discharge in which the probability of Itransition from a state in the Markov-chain is dependent on both the 
acoustic stimulus during that time (s(t» and on the time since the 
previous discharge of the nerve fiber (r(r». The equations that must be 
maximized are quite complex and to date a closed form solution for both I 
set) and r(r) has not been identified. In order to get explicit estimates 
of the stimulus related function set) from the likelihood equations, 
Gaumond first obtains separately derived estimates of the recovery function I
r(r), and than maximizes the equation with respect to set) based on the 
previous estimate of r(r). 
IUnder the assumptions of the Gaumond model for separating the 
refractory related aspects of neural discharge from their time-varying rate 
of discharge due to the applied stimulus, Johnson and Swami3 have taken an 
alternative approach to solving for the maximum-likelihood estimate (MLE) I 
of set). Assuming an a priori knowledge of the recovery function r(r) they 
have derived the likelihood equation of the observed histogram based on an 
intensity description of the point process. The key concept for this Ialternative approach is that the Markov-chain can be considered as a 
self-exciting point-process in which the intensity depends on response of 
the nerve fiber. Following Johnson's previous work,4 Johnson and Swami 
compute what they call the "maximum-likelihood PST histogram" of the I 
responses of a model neuron to a periodic stimulus which compensates for 
the distortion introduced by the relative refractoriness of neural 
discharge. They define relative refractoriness to occur when the recovery Ifunction is known and is non-zero for all r, they show their histogram 
estimate to be an unbiased estimate of set); Johnson and Swami conclude 
that the distortions introduced by relative refractory effects are removed. IThey note, however, that this technique can not remove the effects of 
absolute refractoriness (i.e., the distortion introduced when the recovery 









The new approach which we have established has been motivated by the 
joint estimation equations of Gaumond under the condition that there is not 
a separate a priori knowledge of the recovery function r(r). If in 
different nerve fibers and under varying stimulus conditions the recovery 
function changes ,then an algorithm based on an a priori knowledge of r(r) 
derived from a previous estimation procedure is unacceptable. A scheme 
which from a single data set collected under a single stimulus condition 
provides estimates for the recovery function r(r) and the stimulus­
dependent function s(t) jointly is therefore invaluable. In order to solve 
the likelihood equations for s(t) and r(r) simultaneously when the recovery 
function is not known, we have formulated the estimation problem using an 
intensity description. This approach has allowed us to independently 
verify the MLEs derived by Gaumond and coworkers2 under conditions when the 
recovery function is known. By maximizing the likelihood-function with 
respect to s(t) under the constraint that the stimulus-related function 
s(t) is periodic we have also been able to derive estimates of the 
stimulus-dependent cochlear output function which does not suffer from 
absolute recovery related distortion in the same way as Johnson and Swami's 
recovery corrected PST histogram does. The technique of deriving MLEs 
subject to constraints, has been recently used and elaborated by Snyder. 5 
Finally, by adopting an intensity description of the process we have been 
able to adopt a recursive algorithm, introduced in the statistics 
1 i terature as the "EM" algorithm, 6 for der i ving the maximum-likel ihood 
estimates of both the stimulus related function s(t) and the recovery­
related components in the response histograms. 
We are excited about the suitability of the recursive algorithm for 
the removal of the distortion in cochlear histograms under conditions when 
the recovery function is unknown. This algorithm has been studied 
extensively for maximum-likelihood estimation in positron-emission 
tomography and has desirable global convergence properties. For maximizing 
the exponential family (Poisson as an example) of likelihood equations the 
recursive algorithm will in general converge. We show that under very mild 
conditions a unique maximizer of the likelihood equations arising from 
neural refractoriness exists and starting from any initial estimate the 
recursive algorithm will converge to that maximizer. 
1.	 P. R. Gray, "Conditional Probability Analyses of the Spike Activity 
of Single Neurons," Biophysical Journal, vol. 7, pp. 759-777, 1967. 
2.	 R. P. Gaumond, C. E. Molnar, and D. O. Kim, "Response of Cochlear 
Nerve Fibers to Brief Acoustic Stimuli: Role of Discharge History 
Effects," Journal of the Acoustical Society of Amer i ca, vol. 74 (S) , 
pp. 1392-1398, 1983. 
3.	 D. H. Johnson, and A. Swami, "The Transmission of Signals by 
Audi tory-Nerve Fiber Discharge Patterns," Journal of the Acoustical 
Society of America, vol. 74, no. 2, pp. 493-501, 1983. 
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4.	 D. H. Johnson, "The Relationship of Post-Stimulus Time and Interval 
Histograms to the Timing Characteristics of Spike Trains," 
Biophysical Journal, vol. 22, pp. 413-430, 1978. 
5.	 D. L. Snyder, "Utilizing Side Information in Emission Tomography," 
IEEE Transactions on Nuclear Science, vol. NS-31 , pp. 533-537, 1984. 
6.	 A. D. Dempster, N. M. Laird, and D. B. Rubin, "Maximum Likelihood 
from Incomplete Data Via the EM Algor i thm,," Journal of the Royal 
Statistical Society, vol. B39, pp. 1-37, 1977. 
E-10.	 An Automated System for the Monitoring of Patients with Epidural 
Electrode Arrays 
Personnel:	 J. S. Massey, BCL 
S. Goldring, M.D., Neurological Surgery 
E. M.	 Gregorie, M.D., Neurological Surgery 
P. Lombardo, B.A., Neurological Surgery 
Support:	 RR 01380 
NS 14834 
The purpo~e of this project as detailed in PR 18, E-14 and PR 19, 
E-9 is to develop a system which will permit simultaneous recording of the 
EEG and somatosensory evoked response (SER) from patients in whom epidural 
electrode arrays have been implanted for the purpose of localizing an 
epileptogenic focus. 
The CAESER system (computer-aided extraction of somatosensory 
evoked responses) consists of a sixteen-channel EEG amplifier, a 
sixteen-channel analog-to-digital converter, a Digital Equipment 
Corporation (DEC) MINC microcomputer, and a video module which displays the 
evoked responses on standard television monitors. 
Initially, the CAESER system used the sixteen Grass Instrument Company 8A5 
EEG amplifiers in our EEG machine. This meant that the EEG machine could 
not be used to monitor the patient for seizures while SERfs were being 
acquired. In August 1983, sixteen Grass Model 12 Computer Interface 
Amplifiers were installed in the CAESER system, making it possible to 
obtain patient SERs while simultaneously monitoring the patient for 
seizures. 
During the past year, a number of improvements were made to the 
original version of the software. The user is now able to view the signals 
coming from the EEG amplifiers on the CAESER displays, so that adjustments 
can be made to the amplifier settings before the acquisition of SERs 
begins. The software variables which the user sets for each run are now 




at several points, and error messages have been expanded and clarified. In 
addition, the MINC's original LSI-11/02 processor was replaced with a 
DEC LSI-11/23, resulting in a noticeable improvement in system performance. 
The system has been used to gather SER data from ten patients since 
December 1982. In four of these cases, SERs were obtained simultaneously 
with seizure monitoring. 
t 
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F. Resource Development Activities 
Resource development activities are those which contribute to the Igoals of more than one major program of the laboratory, address the needs 
of individual users who can benefit from the expertise of the BCL staff and 
the inventory of computing and specialized test equipment, or identify new 
technologies which may become appropriate foundations for new experimental I 
tools. Service to users does not follow the usual computation-center 
pattern with an established fee schedule and a highly centralized facility. 
Rather, senior laboratory staff members consider requests for assistance I 
from investigators who must address a particular biomedical computing 
problem. If an appropriate technology eXists, investigators may be 
referred to commercial vendors or fee-for-service organizations when these Iare available. In other cases, problems may be approached by the 
laboratory provided that the effort complements other activities of the 
laboratory. Many times the project can be assigned to a staff member with 
appropriate experience and completed in a short time. The investigator I 
then has his or her results, and a short note describing the work will 
appear in the annual report and perhaps the open literature. A few 
projects, however, may develop into major initiatives within the Ilaboratory. Most of the major projects began in this fashion and the 
opportunities that supporting activities provide are valued. IThe broad spectrum of projects reported on in this section may be 
categorized as biomedical applications, system development aids, digital 
hardware designs, and ad hoc studies. The biomedical applications 
represent new initiatives in which basic explorations are being conducted, I 
some having potential for becoming major, long term programs. 
System development aids primarily benefit BCL staff, but may also be I
used by others. Examples include microprocessor development support, 
RSX-11 system enhancements and extensions to the MASSCOMP raster graphics 
workstation. System software developments reported here also are widely 
utilized in a variety of projects. I 
Many digital hardware designs are one-time, special purpose 
projects. Others may have wide appeal and construction of multiple copies I 
is envisioned, examples being the TERRANET local network and the image 
buffer. IThe topics of the studies reported in this section are quite varied. 
Some are theoretical and address a highly specific problem; others are more 






F-1. Microprocessor Development Support 
Personnel:	 S. M. Moore, BCL 
R. E. Hermes, BCL 
S. R. Phillips, BCL 
Support:	 RR 01380 
HS 03792 
Locally developed FORTRAN-based cross-assemblers (FOCRAS) and 
intelligent consoles continue to play important roles in hardware and 
software development activities for 8-bit microprocessor-based systems. 
Porting of FOCRAS to a PDP-11/RSX system was completed and verified by 
transferring TERRANET software from a TI-980 to the RSX system. Future 
software will be done under RSX, FOCRAS support on the TI-980 system will 
be discontinued. 
Program development support for 16-bit Motorola M68000 (M68K) exists 
in many forms. The UNIX V7 operating system has been ported to the M68K 
based VERSAmodule system (F-8) which supports program development. 
C language programs can be entered, compiled and run directly on the 
system. C language compilers and cross-assemblers also exist on both PDP­
11/34 and VAX-750 systems for developing stand-alone software for the M68K. 
Computer controlled PROM programming capabilities are currently 
limited to 2 Kbyte EPROMs using the Intelligent Console and current FOCRAS 
software. Larger EPROMs ·can be programmed by reading and concatenating 
data from several smaller PROMs and then transferring to larger PROMS using 
the DATA I/O universal PROM/PLA programmer. The Data I/O programmer will 







F-2. Information Systems Group 
Personnel:	 J. R. Cox, Jr., BCL and Computer Science IG. J. Blaine, BCL 
S. M. Moore, BCL 
S. R. Phillips, BCL IL. J. Thomas, Jr., BCL 
Support:	 HS 03792 
Washington University I 
The Information Systems Group provided the collaborative structure Iwithin which participants from the Department of Computer Science, the 
Computer Systems Laboratory, the School of Medicine, and the Biomedical 
Computer Laboratory addressed the development of a methodology for the 
design of composite medical-information systems. The development I 
activities were divided into four major categories: model, design studies, 
implementation and Neonatology Database. The more theoretical portions of 
the work on a design methodology fall in the first category and the more I
applied tasks in the second. The Neonatology Database provided a relevant 
context for testing concepts, models and implementations. IThe primary goals of the group, supported by the NCHSR research 
grant HS 03792, are now complete. The accomplishments are summarized here 
for reference: 
1) a powerful data model, ADS; 
2) implementation of 
model; 
a data language 
3) experiments 
memory; 
with special hardware 
I 
consistent with the ADS I 
implementations for ADS I 
4)	 testing in a clinical database application; I 
5)	 performance studies of three software implementations of ADS; I6)	 demonstration of ADS as an intermediate language for database 
translation. 
IA final report contains specific details of these accomplishments 
and future plans. 1 
I 
1.	 J. R. Cox, Jr., and K. F. Wong, "A Medical Information Systems Design 











































F-3.	 Studies in the Design of a Coprocessor for Pattern Matching 
Personnel:	 S. M. Moore, BCL 
G. J.	 Blaine, BCL 
J. R.	 Cox, Jr., BCL and Computer Science 
Support:	 RR 01380 
HS 03792 
A version of ADS was implemented in C under UNIX to provide 
experimental tools for: 
1)	 studying the feasibility of implementing a truly usable version of 
the ADS data model, 
2)	 gathering initial workload and performance data to use as a guide 
for the design of a production version and customized hardware, 
3)	 trying different algorithms, and 
4)	 studying software portability issues. 
Examination of the performance of the ADS system suggested that a hardware 
pattern matcher might be necessary to speed operation in a production 
version of ADS. An algorithm was found which allows the data to be 
searched in time that is linear with the size of the data, and several 
archi~ectures for implementing this algorithm were studied. One 
architecture·was used as the basis for a processor which was designed and 
built using commercially available integrated circuits and wire-wrap 
technology. • 
The search processor serves as a coprocessor in the Motorola M68000 
(M68K) VERSAbus system (F-8). In addition to the search processor, a dual­
ported memory was built to provide I/O for the processor. One port can be 
accessed by the M68K system through the VERSAbus and the other by the 
search processor. 
A simple data retrieval system was designed on the M68K system using 
the pattern matcher as the search mechanism. A similar system was built 
which implemented the search algorithm in software. Comparisons between 
the two systems showed that the hardware search was 500 to 1200 times 
faster than the software search on the M68K. The pattern matcher searched 
memory 85 to 180 times faster than the ADS implementation on a VAX-750 on a 
per node basis. Other comparisons showed the speed of the pattern matcher 
to be nearly eqUivalent to the speed of other hardware-based searchers. 1 
1.	 S. M. Moore, 
of Science 
University, 
"A Pattern Matcher for Searching Binary Trees," Master 
thesis, Department of Electrical Engineering, Washington 






F-4. An Experimental Local-Area Network: TERRANET 
Personnel: S. M. Moore, BCL IG. J. Blaine, BCL 
J. R. Cox, Jr., BCL and Computer Science 
R. E. Hermes, BCL IS. R. Phillips, BCL 
D. F. Sandel, BCL 
D. A. Schwab, BCL I 
Support: RR 01380 
Computer Services Corporation 
Washington University I 
In the past year, TERRANET has gone from a successful experiment in 
local-area networking to an important part in the day-to-day operations of I 
BCL. TERRANET provides terminal-to-computer and computer-to-computer 
communications for most of the time-sharing computer systems in the 
laboratory. The current network configuration utilizes each of the Ipossible 30 stations. These stations include 15 terminals, 11 computer 
connections to 7 different machines, and 4 modem or other network gateway 
connections. Usage of the network is quite heavy and has indicated that Ithe overall number of stations in the system should be increased. Design 
studies are now in progress to determine how best to realize this increase. 
Possibilities include a second TERRANET network or increasing the number of 
stations on the current network by increasing the capacity of the network I 
or by decreasing the data rate per channel. 
No major revisions have been made in the hardware configuration of Itap units or insert units. Minor changes were made to one tap unit with 
appropriate changes in software to facilitate modem control. Several more 
general software changes were made to improve flow control in tap units 
connected to modems, terminals, and serial printers. Other software I 
modifications were done for an experiment which demonstrated that TERRANET 
could be connected to and implement the protocol of the GANDALF switch at 
the main computing facilities on the Hilltop Campus. All TERRANET software I 
was moved from the TI-980 system to the PDP-11/RSX system to take advantage 
of better software development and backup utilities available under RSX. IExperiments for integrating voice with data communication on the 
network were conducted using the test bus (PR 19, F-6). Three tap units 
were modified to accommodate the voice transmission. Two units were used 
for communication while the third unit was used to monitor the network and I 
to evaluate the stability of the system. Initial results show that voice 
communication is possible with the current design, but more revisions may 
be necessary to decrease noise and the cost of the tap units. I 
Higher level software to provide network services is currently being 
developed. A PDP-11/UNIX system will be used to monitor network activity. IStation-to-station connect time will be measured and used to determine 







transfer utilities were modified at the Hilltop Campus to recognize 
TERRANET and will be used at BCL. Software is currently being developed to 
allow file transfer between RSX- and UNIX-based systems over TERRANET 
channels. 
F-5. Inter-System Communication for Data Transfer 
Personnel:	 G. J. Blaine, BCL 
J. D. Gorman, BCL 
K. H. Haserodt, M.S., Computer Science 
R. E. Hermes, BCL 
E. W. Kiebler, M.S., Computer Systems Laboratory 
M. I. Miller, BCL 
D. W. Stein, Jr., BCL 
Support:	 RR 01380 
Washington University 
A working group was formed to discuss mechanics for data transport 
between various host computing systems, within our local Resource. Media 
transfers (9-track magnetic tape, floppy disk, and hard disk) have been 
primarily used for this purpose. 
The	 following types of information exchanges were identified: 
1)	 binary d;ta files to support acquisition analysis and display of 
medical images; 
2)	 electronic mail for both campus and national collaborators; 
3)	 remote program execution to allow data submission, application, 
execution and remote harvesting of results. 
The most immediate needs are based on system resources which include, 
VAX-11/750, 4.2BSD UNIX; VAX-11/750, VMS; PDP 11/34, 4.2BSD UNIX; 
PDP-11/34, RSX-11; LSI-11/23, RT-11; and MASSCOMP 500, UNIX-masscomp. A 
concensus suggested a first level solution to be based on the following 
design: 
Physical Layer	 serial, 9600 bps, asynchronous, RS-232, full 
duplex; 
Data Link Layer = small packets, error detection and retransmission. 
UNIX uucp services provide sufficient flexibility for data transfers 
between UNIX systems, likewise, DECNET is a proven means for communication 
between DEC operating systems. However, the local predominance of both 
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UNIX and RSX-11M necessitates a data transmission link between these 
systems as welL 
The RSX-11M terminal driver was studied to determine the feasibility 
of implementing data transfers via serial communication lines on a 
PDP 11/34. The driver was found to have limitations including input 
character buffers of limited size (36 characters), and the need for system 
interrupts on a character by character basis. Significant modification of 
the terminal driver could circumvent these limitations so that efficient 
block transfers of data could be accomplished. Alternatively, data 
transfers of small data packets (less than 20 characters) seems practical 
with no driver changes provided sufficient protocols are provided for data 
transmission, verification and correction. 
Recent acquisition of an inter-system communication software package 
called KERMIT may also prove helpful. KERMIT has been used elsewhere for 
communication between dislike systems, including RSX-11M, VMS, and UNIX. 
This software is known to work for transmission of ASCII character data, 
but tests are still to be conducted to determine its sUitability for binary 
data transmission. 
F-6. A Picture Communication System for Radiology 
Personnel:	 G, J. Blaine, BCL 
J. C. Chabut, BCL 
J. R. Cox, Jr., BCL and Computer Science 
R. L. Hill,	 BCL and Radiology 
R. G. "Jost,	 M.D., Radiology 
A. Kumar, B.Tech., Radiology 
S. R. Phillips, BCL 
A. P. Rueter, B.S., Radiology 
C. D. Shum,	 BCL 
Support:	 RR 01380 
RR 01379 
Mallinckrodt Institute of Radiology 
Washington University 
A pilot cable system to transport analog and digital radiology 
pictures and support terminal-to-computer digital data transmission has 
been designed and installed (PR 19, F-7, F-8). A dual-cable 400 MHz system 
utilizes "off-the-shelf" cable television components to provide 
approximately 50 channels, achieved by frequency multiplexing channels of 
6 MHz each. The system provides a workbench environment for the evaluation 
of commercial digital transmission equipment in addition to supporting 
experiments related to digital picture networking and archiving studies. 
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Figure 1. PACS workbench picture network block diagram illustrating topology 





Over the past year, studies and subsequent designs have been 
directed at communicating radiological images using channels based on 
frequency division of the 400 MHz channel. Multiple shared­ Itransmit/receive channels were shown to have favorable cost-delay 
characteristics. 1 Most of the MIR efforts (F-11) have been directed at 
accessing and displaying images which are stored in a database, whereas the 
focus of our activities has been upon the digital and analog transmission I 
and reception of images. 
A variety of analog modulators and demodulators for both video I
transmission and reception were obtained and have been tested to determine 
their bandwidth limitations. 2 Such bandwidth limitations were demonstrated 
to have a direct effect upon the transmission and reception of picture Idetail. 
The lack of readily available high-speed modems, at reasonable cost, 
has fostered exploration of novel approaches to the problem. Two I 
approaches to greater than 1 Mbps rates are currently being explored. The 
first utilizes commercial TV modulators and demodulators with a specialized 
integrated circuit chip set developed for baseband digital communication I
applications. The second is based on the extension of a product by a 
recently formed data communications company. A pair of the proprietary 
modems have been provided for one evaluation. In order to test these 
digi tal communications schemes, a "bit error tester" has been des igned and I 
fabricated and is now under evaluation. Future digital tests will involve 
consideration of bandwidth, phase, and multiple device effects. I 
1. C. D. Shum, "Design Analysis of a Wideband Picture Communication ISystem," Master of Science thesis, Department of Computer Science, 
Washington University, St. Loui&, Missouri, December 1983. 
I2. J. C. Chabut, "Testing Modulator/Demodulator Frequency Response," BCL 
Working Note No. 57, April 1984. 
3. J. R. Cox, G. J. Blaine, R. L. Hill, R. G. Jost, and C. D. Shum, I
"Some Design Considerations for Picture Archiving and Communication 







F-7. Data	 Compression Studies 
Personnel:	 J. G. Dunham, BCL and Electrical Engineering 
S. E. Elnahas, M.S., Electrical Engineering 
R. G. Jost,	 M.D., Radiology 
Support:	 RR 01380 
RR 07054 
Mallinckrodt Institute of Radiology 
Washington University 
In radiology, the introduction of new technology has increased the 
number of images stored in digital form. Most studies are still recorded 
on film, but digitally generated examinations are becoming more common. 
Typically, digital exams have a greater number of images per study, so that 
half the images produced in some departments today are already generated in 
digital form. This trend toward digital imaging in radiology will continue 
and should accelerate as conventional examinations find their way into 
digital form. As radiologists turn their attention to problems associated 
with storing and transmitting these digitally generated images, the need 
for data compression will become increasingly important. 
A wide spectrum of images is found in a radiology department. The 
differences among modalities are significant enough to suggest that 
different data compression techniques may be appropriate for different 
image classes. In order to study the differences among and within various 
image modalities, we have developed1 an extensive database of digital 
diagnostic images for general compression studies. Thirteen different 
classes of images are included in the database to represent several imaging 
modalities including CT, nuclear medicine, ultrasound, and MRI. 
In a preliminary investigation (PR-19), the major classes of data 
compression were reviewed with respect to their suitability for picture 
archiving and communication systems (PACS) in radiology. In a PACS 
environment, noisy compression provides high compression ratios (20:1, 
30:1). The distortion introduced by noisy compression techniques has yet 
to be evaluated clinically for different classes of radiological images and 
diagnostic modalities. On the other hand, noiseless compression provides 
perfect image reproductions with low compression ratios (2:1, 3:1). We 
have investigated 1 the possibility of reducing the gap of compression 
ratios between noisy and noiseless systems. The compression limits of 
linear predictive coding, when followed by entropy coding, are determined 
by estimating the noiseless compressibility of the input images. 
Arithmetic coding as well as Huffman coding are considered for the entropy 
coding part. Formulation of the problem of designing optimal linear 
predictors has been studied and solutions discussed. In general, linear 
least squared-error (LLSE) predictors do not necessarily minimize the 
entropY-of the predictive coder output. However, the performance of most 
fourth-order predictors is very close to that of optimal predictors. For 
LLSE prediction. there is no need to consider predictors of order higher 
than four for all of the image classes in the database. This is an 






predictors. The use of image training sequences for the design of LLSE 
predictors has been proven experimentally to be successful and the results 
obtained when predictors are used outside the training sequences are Ipromising. On the average, one can expect compression ratios between 2.0:1 
and 6.3:1 from systems employing arithmetic cOding while one can expect 
ratios between 11.7:1 and 3.8:1 from systems employing Huffman coding. I 
With nonlinear block predictive coding, we have combined2 noisy and 
noiseless compression systems in a novel way that may have a potential 
impact on the PACS environment. The approach does not ignore the I 
investment in noisy compression systems that can provide attractive high 
compression ratios. It may also provide a technical solution to the 
sUitability issue, from a clinical standpoint, of noisy compression systems Iby allowing a means for perfect reproduction of the input images. We have 
investigated the application of adaptive fast discrete cosine transform 
CAFDCT) coding to compression of-MRI and CT images. The subjective quality 
of image imperfect reproductions from the AFDCT system, at a code rate of I 
one bit/pixel, is very promising and prompts future research on the 
transform coding of diagnostic images and the clinical evaluation of these 
systems. The off line storage requirements for archiving MRI and CT images I 
are reasonably reduced by the noiseless block nonlinear predictive coding 
system. The on line performance, however, seems to be bounded by that of 
linear predictive coding. We conjecture that, linear systems using Ipredictive coding techniques, determine the noiseless compressibility of 
diagnostic images in radiology. 
I 
1.	 S. E. Elnahas, R. G. Jost, and J. G. Dunham, "Compression of Digi tal 
Diagnostic Images in Radiology," Proceedings of the ACR 8th Conference I 
on Computer Applications in Radiology 1984, St. Louis, 
May 23-25, 1984, in press. 
2.	 S. E. Elnahas, "Data Compression," D.Sc. Dissertation, 
J. G. Dunham, in preparation. 




















The M68000-based VERSAmodule system was used as the host system for II 
running pattern matcher experiments (F-3). As previously reported CPR 19, 
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access is gained through two serial ports, one connected to a terminal as 
the console and the second connected to TERRANET. 
Minor modifications were made to the VERSAmodule system to 
accomodate the pattern matcher. A dual-ported memory was designed and 
interfaced to the system through the VERSAbus. A PLA on the VERSAmodule 
computer board was changed to allow the system to recognize the additional 
memory. The pattern matcher interfaces to the M68K system through a 
parallel port which already existed on the VERSAmodule computer board. The 
parallel interface is used only for control information; all data are 
transferred between the VERSAmodule system and pattern matcher through the 
dual-ported memory. 
When not used for pattern matcher experiments, the dual-ported 
memory can be used as data space for user programs. The memory is placed 
outside of the normal UNIX address space and can only be addressed when a 
user program informs the system of its presence. The memory is not 
designed to respond to byte references and so can only be used by programs 
which access the memory on a word (16 bit) basis. 
F-9. Systems Support for Programming and Image Processing 
Personnel: R. E. Hermes, BCL 
S. Husodo, BCL 
S. M. Moore,BCL 
R. J. Paisley, BCL 
S. R. Phillips, BCL 
D. W. Stein, Jr., BCL 
Support: RR 01380 
Hardware and software support of programming and image processing 
continues to be an important Resource activity (PR 19, F-11). Most of our 
scientific programming is supported by a PDP 11/34 running RSX11M. The 
system is configured with disk and tape storage devices which are 
predominant in the local computing community. This allows for data 
transfers from other research labs to the BCL via a common magnetic storage 
media. The system also includes a Lexidata 3400 color display system with 
a resolution of 640 by 512 pixels. Recent development of easy to use 
display software on this system has simplified the common problem of image 
display after the data is processed on the system. 
The system, although limited in memory and computational capacity, 
supports several simultaneous users doing program entry and debugging. 
Programs which require large amounts of system resources are run as 
background processes, often overnight. Programs which require extensive 
machine time can be run on a second PDP 11/34 running RSX11M. This second 







Additional computer and display capability is provided by a MASSCOMP 
MCS-500 system (F-10). Efforts are underway to provide means for data 
transfer between all systems via serial communication (F-5). Display Iutilities similar to those used on the Lexidata are being developed so that 





F-10. MASSCOMP Workstation System 
Personnel: R. E. Hermes, BCL IG. J. Blaine, BCL 
K. H. Haserodt, M.S., Computer Science 
S. Husodo, BCL 
R. J. Paisley, BCL I 
F. U. Rosenberger, BCL, and Computer Systems Laboratory 
Support: RR 01380 I 
To further develop image processing support, the laboratory has Iacquired a MASSCOMP MCS-500 system. The MASSCOMP system is based upon a 
Motorola 68000 processor capable of running UNIX System III. With a 
benchmark performance comparable to that of a VAX 11/750, the system can 
support a number of simultaneous users as well as support many of the I 
computational needs of those doing image processing and display. 
The system employs two 10 MHz 68000 processors in the CPU and for IIIO control. The CPU resides on a proprietary system bus with one megabyte. 
of system memory which may be expanded to six megabytes. The system bus is 
extended to a industry standard Multibus which can support many different 
peripheral controllers as well as being suitable for interfacing locally I 
designed subsystems or specialized processors. 
The current configuration consists of a chassis housing the system I 
busses and processor, a 27 megabyte Winchester disk, a 1 megabyte floppy 
disk drive, and four serial communication lines. An additional 52 megabyte 
Winchester disk will be added soon., I 
A vast amount of software is available on the system, including a 
large graphics and graphing library, a menu system called Quick Choice, and 
all of the software development aids found in most UNIX systems. Efforts I 
are underway to provide system users with convenient methods for displaying 





















A 512 x 512 x 8 Image Buffer 
Kumar, B.Tech., Radiology 
J. Blaine, BeL 
R. Cox, Jr., BCL and Computer Science 
L. Hill, BCL and Radiology 
G. Jost, M.D., Radiology 
P. Rueter, B.S., Radiology 
RR 01380 
RR 01379 
Mallinckrodt Institute of Radiology 
Washington University 
I 
I PACSV (for Picture Archiving and Communication System Viewing­Station) was designed in the first quarter of 1983. During the year 
reported here, a prototype was built to prove the design. PACSV addresses 
the need for an inexpensive frame-buffer and viewing-station in the PACS 
network that is taking shape at the Mallinckrodt Institute of Radiology 
(MIR). Its performance specifications are as follows: 
I	 1. It can store and display a 512 x 512 x 8 image. 
I 
2. The image can be read from an input environment at a maximum 
rate of just over 20 x 106 bits/sec. Tn other words, an image 
can be read in approximately 100 milliseconds. 
3. An image can be transmitted from the PA CSV to an out pu tI environment at the same rate. 
4. Picture display is not	 interrupted by data reads or writes. 
,I
I 5. PACSV can be configured to accept any input and output 
environment by replacing the input module, the output module, 
and a ROM chip. Two input modules have been designed, built, 
;,;/- and tested, with PACSV. One accepts a 9600 baud RS232 signal; 
~;	 the other obeys a high-speed, 32-bit-parallel, synchronous 
transfer protocol over a DR750 bus connected to a VAXll/750.,~:I
,/l 6.	 The composite-video output of PACSV, capable of driving a 
standard TV monitor, respects the ETA standard RS330 with only 




The PACSV chip-count is 92 integrated circuits (not including any~.'" input or output modules). Of these, 32 are 64K dynamic RAMS with an access 
pi~I' time of 200	 nanoseconds. The memory cost is $210 with the remaining chips';~~'" costing another $190 • 
~. At the heart of PACSV lies a ROM-based controller, a very simple microprogrammed machine that runs at 20 MHz and puts out a sequence of 32 control words every 1.5 ~sec. The following major functions are performed 






1.	 Four 32-bit data words are read from the RAM frame-buffer, and 
packed into synchronizing-buffer register files. These four 
words are destined for display. I 
2.	 Selected registers are opened in the synchronizing-buffer 
register files to a digital-to-analog converter in the 
video-generation circuit. I 
3.	 A single 32-bit data word may be read from or written into the 
RAM frame-buffer, for data I/O. I 
The ROM-based controller also generates the blanking and sync I 
signals for the video-generation circuit, and exchanges handshake signals 
with the input and output modules. A Motorola MC68000 microprocessor is 
used to initialize the system, and to conduct a dialog with the input and 
output environments. II 
I 
F-12. Word Processing at BCL 
IPersonnel: R. E. Hermes, BCL 
R. M. Arthur, BCL 
R. J. Bozesky, BCL 
K. W. Clark, BCL I 
. S. A. Gonzalez-Rubio, BCL 
G. C. Johns, B.S., Computer Systems Laboratory 
J. W. Matthews, D.Sc., Computer Systems Laboratory IP. E. Raith, BCL 
L. J. Thomas, Jr., BCL 
ISupport: RR 01380 
Approximately two years ago, a word processing committee was formed I 
to determine the word processing needs of the BCL and CSL. The committee 
cataloged an extensive list of prerequisites for a word processing system 
to support the technical and non-technical writing needs of the Ilaboratories. The committee reviewed available word processing systems to 
determine whether any could meet our demanding and specialized needs. 
Unfortunately, none were found suitable. I 
Within the past year, several circumstances, including the imminent 
demise of our current word processing system, caused us to pursue the word 
processing issue again. The prevalence of the UNIX operating system Iprompted the search for a word processing system supported by UNIX. The 
system chosen, called MUSE, has been installed for nearly three months on 
the Institute VAX-11/750. I 
The MUSE system is capable of supporting dozens of different 
terminals and printers. MUSE is a menu driven and function key controlled 





screen. It supports superscripting, subscripting, greek/math symbols, and 
underlining without the need for embedded control sequences found in most 
other systems. A spelling check system employs the use of a master 
dictionary, as well as dictionaries which can be user, site, or subject 
specific. Easy to use mechanisms are provided to control text formats and 
form generation. File management is part of the MUSE system, meaning that 
users do not need to know the UNIX system to manage their file directories. 
Output of documents is easily managed by MUSE, allowing the user to vary 
fonts, character spacing, and output format at print time. 
MUSE is a well documented, easily learned system. MUSE users have 
found the system very powerful, yet simple to use. This progress report 







VI. INDUSTRIAL COLLABORATION 
IIndustrial collaboration provides a mechanism for the deployment of 
laboratory developments and benefits the staff by keeping abreast of the 
practical considerations of reliability, maintainability, and cost. I 
The TERRANET system, which provides a simple low-cost interconnect 
to support terminal-to-computer and computer-to-computer communications for 
modest speeds (up to 9600 bps), is currently being produced and marketed in IJapan under a licensing agreement with Computer Services Corporation (CSK), 
a major facilities management consulting firm headquartered in Tokyo. As 
part of the initial agreement, CSK supplied two evaluation systems of 10 Itap-units each for installation in the Computer Science and Electrical 
Engineering Departments at Washington University. A follow-on research 
contract with CSK provided partial support of development activities which 
integrate voice and data transmission into the TERRANET system. I 
In conjunction with BCL activities in picture archiving and 
communications (F-6), Dr. G. James Blaine accepted an opportunity to serve Ifor three months as a member of the Applied Technology Department within 
Hewlett-Packard Laboratories, Palo Alto, California. IBCL has analyzed several tens of long-term ECG recordings for a 
Mead-Johnson (Evansville, Indiana) sponsored "Multicenter Placebo­
Controlled Study of Trazadone's Effects in Depressed Cardiac Patients." 
Trazadone, a recently marketed antidepressant drug, is chemically unrelated I 
to the tricyclic antidepressants. Studies in animals showed few cardiac 
effects, and ECG recordings in humans in initial clinical studies showed 
few changes. More recent studies in humans examined the cardiac effects of Itrazadone in patients with pre-existing cardiovascular disease and 
depression. Many of these patients had good responses to depression with 
minimal aggravation of their underlying cardiovascular condition, although 
a small number of patients developed a change in ventricular ectopic I 
activity while on trazadone. However, due to the considerable interpatient 
and intrapatient daily variability in ventricular ectopic activity and lack 
of a placebo control group in these studies, it had previously not been I 
possible to conclusively attribute changes in ectopic activity to 
trazadone. The current study is designed to address the issue of the 
cardiac safety of trazadone. The study plans to enroll 160 patients among I8 clinical units. Four long-term ECG recordings per patient (over 2 weeks) 
are sent to BCL for analysis. Results are interpreted by the study's 
cardiologist, Roger Winkle, M.D., of Stanford University. I 
BCL personnel have worked closely with Biosensor Corporation 
(Brooklyn Center, Minnesota) to implement Argus algorithms (A-1) in a 
"real-time analyzer," a device to analyze the ECG rhythm of a patient who I 
wears the small device and goes about normal activities. The device uses 
CMOS microprocessor technology powered with 5-day lithium batteries. 
Counts and waveforms of significant events are stored for subsequent Itelephone transmission (on demand or at suggested intervals) to a central 






brought a prototype of their device to BCL a year ago for intensive side­
by-side debugging; BCL personnel have visited Biosensor to observe first 
hand their development, manufacturing, and marketing procedures. 
Throughout the year, BCL has provided Biosensor with a variety of digitized 
waveforms; Biosensor runs a digital waveform through their implementation 
and returns to BCL beat-by-beat results; BCL then prints a condensed plot 






VII. TRAINING ACTIVITIES AND SEMINARS 
ITraining activities of the Biomedical Computer Laboratory are 
directed toward the goals of informing the local and national scientific 
communities about resource projects and facilities and of instructing a 
broad spectrum of people in the application of advanced computer-techniques I 
to problems in clinical medicine and biological research. Training 
activities include the teaching of formal courses at the School of Medicine 
and the School of Engineering as well as supervision of graduate students Iby Laboratory staff. Both individual and small-group training about 
resource facilities are made available to the biomedical scientist. 
National workshops and symposia on topics of interest and importance to the Iresource and community are supported. 
The bringing together of biomedical scientists, engineers, and 
computer scientists provides important cross-fertilization between I 
disciplines. In these settings, students and staff find the need and 
opportunity to test the relevance of theory and the usefulness of 
technology in applications to real problems. Also, the biomedical I
scientists are aided in learning new techniques for acquiring useful 
information. To this end, some of the courses offered are addressed to 
biologists without strong technical backgrounds who want and need a below­
the-surface appreciation of biomedical computing. Laboratory personnel I 
also participate in regularly scheduled conferences in the clinical 
departments where both the biological and technological issues are 
examined. 
Seminars and presentations relating to resource 
applications are conducted by Laboratory staff as well as 
engineers from the national community. During the year 
activities were supported: 
Seminars 
"Reconstruction Algorithm for 
Time-of-Flight Assisted Positron 
Emission Tomographs" 
September 19, 1983 
"A Description of the 
Laboratory of Neuro Imaging" 
November 22, 1983 
I 
projects and 
scientists and Ithe following 
I 
David G. Politte 
Biomedical Computer Laboratory I
Washington University 
St. Louis, Missouri 
Cosponsor: Department of Electrical 
Engineering I 
Arthur Toga I 
Research Assistant and 
Professor in Neurology 







"Coding of Speech in the 
Auditory Nerve" 
December 12, 1983 
"Toward the Prediction of 
Protein Function and Structure: 
Applications to Oncogene and 
MHC Products" 
April 5, 1984 
"The Future of Image Processing 
at Lexidata" 
Apr il 19, 1984 
"A Pattern Matcher for Searching 
Binary Trees" 
May 1, 1984 
"Experimental Evaluation of the 




May 10, 1984 
"A Preliminary Evaluation of the 
EM Algorithm for Estimating 
Parameters in Dynamic Tracer 
Studies" 




June 7, 1984 
Michael I. Miller 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 





Laboratory of Mathematical 
Biology 
National Cancer Institute 
Bethesda, Maryland 





Steve M. Moore 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
John Gorman 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
John Ollinger 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Michael I. Miller 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
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"Maximum-Likelihood Recon­
struction for Single-Photon 
Emission Computed-Tomography" 
June 14, 1984 
"Recent Results in Quantitative 
Ultrasonic Imaging" 
June 21, 1984 
"Picture Transmission" 
June 28, 1984 
"The MASSCOMP Raster Graphics 
Workstation" 
June 28, 1984 
Other Activities 
"A Workshop for Cardiologists:
 














Donald L. Snyder 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
R. M. Arthur 
Biomedical Computer Laboratory 





J. G. Miller 
Biomedical Computer Laboratory 
Department of Physics 
Washington University 
St. Louis, Missouri 
John Chabut 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Russell E. Hermes 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
faculty included: 
J. R. Cox, Jr., 
L. J. Thomas, Jr., and 
K. W. Clark 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
American College of Cardiology 
Bethesda, Maryland 
video film presentation by 
J. T. Maxwell III and 




St. Louis, Missouri 
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January 14, 1984 
A Lecture Series in support of Biomedical Engineering 3/2 Intensive Course 
Sponsored by the Program in Biomedical Engineering
 




"Scope of Biomedical Engineering" 
January 2, 1984 
"Biomedical Instrumentation and 
Transducers" 
January 3, 1984 
"Computers: Technology and Scale" 
January 4, 1984 
"Computers, Cardiologists and 
Cardiograms" 
January 5, 1984 
"An Engineer Looks at the Brain" 
and "New Techniques in EEG"" 
January 7, 1984 
"Physical Principles of Tracer 
Kinetics in Biological 
Applications" 
January 12, 1984 
"Biophysical Measurements" 
Harold W. Shipton 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
R. Martin Arthur 
Department of Electrical 
Engineering 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
G. James Blaine 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Lewis J. Thomas, Jr. 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Harold W. Shipton 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Kenneth B. Larson 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Harold W. Shipton 
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